
<html lang="en"     class="pb-page"  data-request-id="1fa73c49-aaf4-40aa-9002-ecec27db3cea"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-13;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00621;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate" /></meta><meta name="dc.Creator" content="Yong-Kang  Zhang" /></meta><meta name="dc.Creator" content="Jacob J.  Plattner" /></meta><meta name="dc.Creator" content="Eric E.  Easom" /></meta><meta name="dc.Creator" content="Robert T.  Jacobs" /></meta><meta name="dc.Creator" content="Denghui  Guo" /></meta><meta name="dc.Creator" content="Yvonne R.  Freund" /></meta><meta name="dc.Creator" content="Pamela  Berry" /></meta><meta name="dc.Creator" content="Vic  Ciaravino" /></meta><meta name="dc.Creator" content="John C. L.  Erve" /></meta><meta name="dc.Creator" content="Philip J.  Rosenthal" /></meta><meta name="dc.Creator" content="Brice  Campo" /></meta><meta name="dc.Creator" content="Francisco-Javier  Gamo" /></meta><meta name="dc.Creator" content="Laura M.  Sanz" /></meta><meta name="dc.Creator" content="Jianxin  Cao" /></meta><meta name="dc.Description" content="Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a molecule with satisfactory antimalarial activity, physicochemical properties, pharmacokinetic profile, in vivo ..." /></meta><meta name="Description" content="Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a molecule with satisfactory antimalarial activity, physicochemical properties, pharmacokinetic profile, in vivo ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 29, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00621" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00621" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00621" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00621" /></link>
        
    
    

<title>Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00621" /></meta><meta property="og:title" content="Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0012.jpeg" /></meta><meta property="og:description" content="Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a molecule with satisfactory antimalarial activity, physicochemical properties, pharmacokinetic profile, in vivo efficacy, and safety profile. This optimization effort discovered 46, which met our target candidate profile. Compound 46 had excellent activity against cultured Plasmodium falciparum, and in vivo against P. falciparum and P. berghei in infected mice. It exhibited good PK properties in mice, rats, and dogs. It was highly active against the other 11 P. falciparum strains, which are mostly resistant to chloroquine and pyrimethamine. The rapid parasite in vitro reduction and in vivo parasite clearance profile of 46 were similar to those of artemisinin and chloroquine, two rapid-acting antimalarials. It was nongenotoxic in an Ames assay, an in vitro micronucleus assay, and an in vivo rat micronucleus assay when dosed orally up to 2000 mg/kg. The combined properties of this novel benzoxaborole support its progression to preclinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00621"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00621">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00621&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00621&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00621&amp;href=/doi/10.1021/acs.jmedchem.7b00621" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5889-5908</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00582" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00702" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong-Kang++Zhang">Yong-Kang Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0013-639X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob+J.++Plattner">Jacob J. Plattner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+E.++Easom">Eric E. Easom</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Jacobs">Robert T. Jacobs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denghui++Guo">Denghui Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yvonne+R.++Freund">Yvonne R. Freund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pamela++Berry">Pamela Berry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vic++Ciaravino">Vic Ciaravino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+C.+L.++Erve">John C. L. Erve</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+J.++Rosenthal">Philip J. Rosenthal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brice++Campo">Brice Campo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco-Javier++Gamo">Francisco-Javier Gamo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura+M.++Sanz">Laura M. Sanz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianxin++Cao">Jianxin Cao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Anacor Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Department of Medicine, University of California, San Francisco, Box 0811, San Francisco, California 94143, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">Â§</span> <span class="aff-text">Medicines for Malaria Venture, International Center Cointrin, Block G, 20 Route de PrÃ©-Bois, POB 1826, CH - 1215 Geneva, Switzerland</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">â¥</span> <span class="aff-text">Diseases of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Spain</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">â¥</span> <span class="aff-text">Shanghai ChemPartner, 998 Ha-lei Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#dfa6b0b1b8b4beb1b8a5b7beb1b89fa6beb7b0b0f1bcb0b2"><span class="__cf_email__" data-cfemail="bfc6d0d1d8d4ded1d8c5d7ded1d8ffc6ded7d0d091dcd0d2">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00621&amp;href=/doi/10.1021%2Facs.jmedchem.7b00621" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5889â5908</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 21, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 April 2017</li><li><span class="item_label"><b>Published</b> online</span>29 June 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00621" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00621</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5889%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYong-Kang%2BZhang%252C%2BJacob%2BJ.%2BPlattner%252C%2BEric%2BE.%2BEasom%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D13%26contentID%3Dacs.jmedchem.7b00621%26title%3DBenzoxaborole%2BAntimalarial%2BAgents.%2BPart%2B5.%2BLead%2BOptimization%2Bof%2BNovel%2BAmide%2BPyrazinyloxy%2BBenzoxaboroles%2Band%2BIdentification%2Bof%2Ba%2BPreclinical%2BCandidate%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5908%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00621"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2724</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">30</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00621" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yong-Kang&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;J. Plattner&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;E. Easom&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Jacobs&quot;},{&quot;first_name&quot;:&quot;Denghui&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Yvonne&quot;,&quot;last_name&quot;:&quot;R. Freund&quot;},{&quot;first_name&quot;:&quot;Pamela&quot;,&quot;last_name&quot;:&quot;Berry&quot;},{&quot;first_name&quot;:&quot;Vic&quot;,&quot;last_name&quot;:&quot;Ciaravino&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. L. Erve&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;J. Rosenthal&quot;},{&quot;first_name&quot;:&quot;Brice&quot;,&quot;last_name&quot;:&quot;Campo&quot;},{&quot;first_name&quot;:&quot;Francisco-Javier&quot;,&quot;last_name&quot;:&quot;Gamo&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;M. Sanz&quot;},{&quot;first_name&quot;:&quot;Jianxin&quot;,&quot;last_name&quot;:&quot;Cao&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;5889-5908&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00621&quot;},&quot;abstract&quot;:&quot;Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a molecule with satisfactory antimalarial activity, physicochemical properties, pharmacokinetic profile, in vivo efficacy, and safety profile. This optimization effort discovered 46, which met our target candidate profile. Compound 46 had excellent activity against cultured Plasmodium falciparum, and in vivo against P. falciparum and P. berghei in infected mice. It exhibited good PK properties in mice, rats, and dogs. It was highly active against the other 11 P. falciparum strains, which are mostly resistant to chloroquine and pyrimethamine. The rapid parasite in vitro reduction and in vivo parasite clearance profile of 46 were similar to those of artemisinin and chloroquine, two rapid-acting antimalarials. It was nongenotoxic in an Ames assay, an in vitro micronucleus assay, and an in vivo rat micronucleus assay when dosed orally up to 2000 mg/kg. The combined properties of this novel benzoxaborole support its progression to &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00621&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00621" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00621&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00621" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00621&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00621" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00621&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00621&amp;href=/doi/10.1021/acs.jmedchem.7b00621" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00621" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00621" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00621%26sid%3Dliteratum%253Aachs%26pmid%3D28635296%26genre%3Darticle%26aulast%3DZhang%26date%3D2017%26atitle%3DBenzoxaborole%2BAntimalarial%2BAgents.%2BPart%2B5.%2BLead%2BOptimization%2Bof%2BNovel%2BAmide%2BPyrazinyloxy%2BBenzoxaboroles%2Band%2BIdentification%2Bof%2Ba%2BPreclinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D13%26spage%3D5889%26epage%3D5908%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/jmcmar.2017.60.issue-13/20170713/jmcmar.2017.60.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Carboxamide pyrazinyloxy benzoxaboroles were investigated with the goal to identify a molecule with satisfactory antimalarial activity, physicochemical properties, pharmacokinetic profile, <i>in vivo</i> efficacy, and safety profile. This optimization effort discovered <b>46</b>, which met our target candidate profile. Compound <b>46</b> had excellent activity against cultured <i>Plasmodium falciparum</i>, and <i>in vivo</i> against <i>P. falciparum</i> and <i>P. berghei</i> in infected mice. It exhibited good PK properties in mice, rats, and dogs. It was highly active against the other 11 <i>P. falciparum</i> strains, which are mostly resistant to chloroquine and pyrimethamine. The rapid parasite <i>in vitro</i> reduction and <i>in vivo</i> parasite clearance profile of <b>46</b> were similar to those of artemisinin and chloroquine, two rapid-acting antimalarials. It was nongenotoxic in an Ames assay, an <i>in vitro</i> micronucleus assay, and an <i>in vivo</i> rat micronucleus assay when dosed orally up to 2000 mg/kg. The combined properties of this novel benzoxaborole support its progression to preclinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria, a parasitic infection by the <i>Plasmodium</i> genera and spread through the bites of infected mosquitoes, was responsible for an estimated 212 million clinical cases and 429,000 deaths worldwide in 2015, mostly among children under the age of five.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This terrible disease, in particular infection with <i>Plasmodium falciparum</i>, the most virulent human malaria parasite, traps communities into poverty and disproportionately affects poor people who have limited access to health care. Following the discovery of artemisinin in the 1970s,<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7">(2-7)</a> semisynthetic artemisinin-based combination therapies (ACTs) have become frontline medicines to treat malaria.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, <i>Plasmodium falciparum</i> parasites in southeast Asia have shown evidence of resistance to artemisinins.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> A deterioration of the susceptibility of <i>P. falciparum</i> to artemisinins and the possibility that resistance will spread beyond the Greater Mekong subregion are threats to global strategies for the control, elimination, and eradication of malaria. In addition, resistance to available artemisinin partner drugs is already widespread.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, there is an urgent need to enhance the pipeline of antimalarial medications that counter resistance and that are safe and easy for use in the most vulnerable populations.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11-15)</a> In the process of creating richer antimalarial development pipelines, many new chemical entities with different structures and sometimes also with new mechanisms of action have entered preclinical and clinical development for the potential treatment of malaria in the past decade.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Maintaining such momentum as a sustained effort is very important to the future of antimalarial therapeutics because attrition is expected during drug development, and only a small portion of development compounds may reach the market.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, antimalarial drug discovery presents unique challenges. New antimalarials should ideally meet multiple criteria, including excellent potency, ideally against multiple plasmodial species; oral bioavailability, ideally with cure after a single dose; safety in children and pregnant women; and low cost of production.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">We recently reported that 6-(2-(methoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (<b>1</b> in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) demonstrated potent <i>in vitro</i> activity against cultured parasites (IC<sub>50</sub> = 1.4 nM and 1.9 nM against <i>P. falciparum</i> W2 and 3D7 strains, respectively) and excellent <i>in vivo</i> efficacy against <i>P. berghei</i> in infected mice (ED<sub>90</sub> = 7.0 mg/kg).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The limitation of this molecule was its poor oral pharmacokinetic (PK) profile, exemplified by a short half-life (<i>t</i><sub>1/2</sub> = 1 h) and low bioavailability (<i>F</i> = 23%) in mice. This profile is readily attributable to hydrolysis of the methyl ester to the corresponding carboxylic acid. During this phase of the project, it was also found that the primary carboxamide analogue (<b>2</b> in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) had a much-improved PK profile in mice (<i>t</i><sub>1/2</sub> = 2.1 h and <i>F</i> = 99%) and moderate <i>in vivo</i> efficacy (ED<sub>90</sub> = 38.7 mg/kg) despite being significantly less potent <i>in vitro</i> (IC<sub>50</sub> = 210 nM against W2 and 350 nM against 3D7).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We also learned that incorporation of a 7-Me substituent on the benzoxaborole core can improve PK properties. Therefore, we focused our effort on the 7-methyl benzoxaborole pyrazine carboxamide scaffold to optimize <i>in vitro</i> potency, stability of the carboxamide group, and PK profile in order to ultimately provide molecule(s) with better <i>in vivo</i> efficacy. More specifically, we report here systematic modification of the carboxamide region to generate analogues <b>3</b>â<b>51</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which were evaluated against <i>P. falciparum</i>; selected compounds were further profiled in a range of <i>in vitro</i> ADME, <i>in vivo</i> PK, and <i>in vivo</i> mouse efficacy models. The optimized lead molecule, 6-(2-((3-hydroxy-3-methylazetidin-1-yl)carbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-7-methyl-2,1-benzoxaborole (<b>46</b>), was progressed to evaluate potency against resistant <i>P. falciparum</i> strains, <i>in vivo</i> parasite reduction rate, and to preliminary genotoxicity studies. The results obtained on <b>46</b> support its progression to preclinical development.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Building on previous antimalarial benzoxaborole molecules (<b>1</b> and <b>2</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> novel compounds (<b>3</b>â<b>51</b>) were designed and synthesized for a lead optimization program to improve potency, pharmacokinetic property, and <i>in vivo</i> efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemistry for the synthesis of compounds <b>1</b> and <b>2</b> was described previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Preparation of molecules <b>3</b>â<b>51</b> shared a common benzoxaborole intermediate <b>58</b>, for which the synthetic route is illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Formylation of 2-methylresorcinol (<b>52</b>) generated the aldehyde <b>53</b>, which was selectively protected to give <b>54</b>. The remaining hydroxyl group of <b>54</b> was converted to a boronate ester in <b>56</b> via the triflate <b>55</b> and palladium-mediated boronylation. Reduction of the aldehyde <b>56</b> and simultaneous cyclization produced the 6-<i>O</i>-benzyl benzoxaborole <b>57</b>, which was deprotected by catalytic hydrogenation to give <b>58</b>. Methods for the synthesis of various substituted 2-aminoethanol intermediates are illustrated in <a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>â<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The condensation product <b>63</b> from <b>61</b> and <b>62</b> reacted with the Grignard reagent <b>60</b>, which was generated from <b>59</b>, to provide the silylmethyl adduct <b>64</b>. Oxidative desilylation of <b>64</b> gave <b>65</b>, followed by hydrolysis to yield the desired 2-aminoethanol <b>66</b>. Its enantiomer <b>68</b> was obtained by following the same methods starting from <b>67</b>. For the preparation of <b>74</b> in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, the triflate (<b>70</b>) of 3,3,3-trifluoro-<i>n</i>-propanol (<b>69</b>) was used to alkylate <b>71</b>, providing the alkylation product <b>72</b> that was hydrolyzed to provide the amino acid <b>73</b>, which was reduced to the aminoalcohol <b>74</b>. In <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, the ester group of the cyclization product <b>77</b> from <b>75</b> and <b>76</b> was reduced to the alcohol <b>78</b>. Methylation of <b>78</b> produced the ether <b>79</b>, which was hydrolyzed to give the 2-aminoethanol <b>80</b> containing the ether side group. For the synthesis of the thioether analogue <b>86</b>, the Boc-protected ester product <b>83</b> from <b>81</b> and <b>82</b> was methylated to give <b>84</b> that was hydrolyzed under acidic conditions to afford <b>85</b>, followed by reduction resulting in <b>86</b>. As shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, the tertiary alcohols <b>93</b>â<b>95</b> and <b>102</b>â<b>104</b> can be conveniently generated by the Grignard reaction from their corresponding amino acid methyl esters <b>90</b>â<b>92</b> and <b>99</b>â<b>101</b>, which were obtained from amino acids <b>87</b>â<b>89</b> and <b>96</b>â<b>98</b>, respectively. Synthesis of substituted azetidines <b>112</b>â<b>117</b> is shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Protected azetidinone <b>105</b> was reacted with nucleophilic agents, RMgBr or Me<sub>3</sub>SiCF<sub>3</sub>, to give the alcohols <b>106</b>â<b>111</b> that were deprotected by catalytic hydrogenation to provide the hydroxylated azetidines <b>112</b>â<b>117</b>. With both the key benzoxaborole and amine fragments in hand, two general methods to generate the amides <b>3</b>â<b>51</b> have been used as illustrated in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. In general method A, the pyrazine amides were prepared from amines <b>118</b> and acid <b>119</b> prior to the substitution reaction between the phenolic benzoxaborole <b>58</b> and the amide pyrazinyl chloride <b>120</b>. In general method B, the amide formation was conducted on the acid intermediate <b>123</b> derived from the ester <b>122</b>, which was produced by a substitution reaction between <b>58</b> and <b>121</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of a Common Benzoxaborole Intermediate <b>58</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, N<sub>2</sub>, 0â20 Â°C, 16 h, then iceâwater, 1 h; (b) BnBr, NaHCO<sub>3</sub>, MeCN, 90 Â°C, 48 h; (c) Tf<sub>2</sub>O, TEA, DCM, 0â20 Â°C, 4 h; (d) Pin<sub>2</sub>B<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, 1,4-dioxane, N<sub>2</sub>, 80 Â°C, 12 h; (e) NaBH<sub>4</sub>, MeOH, THF, 5 Â°C to rt, 2 h; (f) H<sub>2</sub>, Pd/C, EtOAc, 50 psi, 25 Â°C, 12 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Amino-2-alkylethanol Intermediates <b>66</b> and <b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mg, I<sub>2</sub>, THF, N<sub>2</sub>, reflux, 3 h; (b) Ti(OEt)<sub>4</sub>, DCM, 50 Â°C, 16 h; (c) Grignard reagent <b>60</b>, THF, rt, 1 h; (d) KHCO<sub>3</sub>, KF, H<sub>2</sub>O<sub>2</sub>, 45 Â°C, 2 h; (e) 4 N HCl, MeOH, rt, 2 h; (f) methods for <b>66</b> were used for <b>68</b>.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Amino-2-alkylethanol Intermediate <b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tf<sub>2</sub>O, 2,6-lutidine, DCM, â25 Â°C for 2 h and rt for 1 h; (b) LDA, THF, â78 Â°C to rt, 4 h; (c) 50% HCl, MeOH, reflux, 16 h; (d) LAH, THF, 70 Â°C for 16 h, workup, then HCl, 1,4-dioxane, rt, 30 min.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2-Amino-2-alkylethanol Intermediates <b>80</b> and <b>86</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClCH<sub>2</sub>CH<sub>2</sub>Cl, 84 Â°C, 16 h; (b) LAH, THF, 0 to 70 Â°C, 2 h; (c) NaH, MeI, 0 Â°C to rt, 16 h; (d) 4 N HCl, reflux, 16 h; (e) SOCl<sub>2</sub>, MeOH, 60 Â°C, 16 h; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt, 16 h; (g) MeI, DIPEA, DCM, rt, 16 h; (h) 4 N HCl, 1,4-dioxane, rt, 16 h; (i) LAH, THF, 70 Â°C, then HCl, 1,4-dioxane.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Substituted 2-Aminoethanol Intermediates <b>93</b>â<b>95</b> and <b>102</b>â<b>104</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, 0 Â°C to reflux, 2 h; (b) MeMgBr, THF, 0 Â°C to rt, 16 h.</p></p></figure><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of 3-Alkylazetidin-3-ol Intermediates <b>112</b>â<b>117</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for intermediates <b>106</b>â<b>110</b>, RMgBr, THF, â78 Â°C for 2 h and rt; for <b>111</b>, Me<sub>3</sub>SiCF<sub>3</sub>, CsF, THF, rt, 1 h; (b) H<sub>2</sub>, Pd/C, MeOH, rt, 16 h.</p></p></figure><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>3</b>â<b>51</b> Using Two General Methods<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) four methods used to synthesize amides: (i) the carboxylic acid, SOCl<sub>2</sub>, DCM, 50 Â°C, 16 h, then the corresponding amino alcohol, pyridine or TEA, 50 Â°C, 3 h; or (ii) HATU, DIPEA, DMF, rt, 1â2 h; or (iii) CMPI, DIPEA, NMP, rt, 16 h; or (iv) the corresponding acid, isobutyl chloroformate, TEA, DCM, 0 Â°C, 30 min, then the corresponding amino alcohol, 10 min; (b) <b>58</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 Â°C, 16 h; (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h; (d) LiOHÂ·H<sub>2</sub>O, MeOH, and H<sub>2</sub>O, rt, 16 h, then 1 N HCl; (e) the corresponding amino alcohol, HATU, DIPEA, DMF, rt, 0.5â2 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> StructureâActivity Relationships</h3><div class="NLM_p">The <i>in vitro</i> activities (IC<sub>50</sub>s) of test compounds for growth inhibition of the 3D7 (chloroquine sensitive) and W2 (chloroquine resistant) strains of <i>P. falciparum</i> were determined (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Compound <b>3</b> with a <i>N</i>-(2â²-methoxyethyl) group at the amide had potency similar to that of <b>4</b> with a <i>N</i>-(2â²-hydroxyethyl) group. Compound <b>5</b> with an extra 2â²-methyl, designed to decrease oxidative metabolism of the hydroxyl group, was slightly less potent than <b>4</b>, whereas the 2â²,2â²-dimethyl analogue <b>6</b> was equipotent with <b>4</b>. The corresponding 1â²,1â²-dimethyl analogue <b>7</b> was also equipotent with <b>4</b>, but its cyclopropyl analog <b>8</b> had decreased activity. More analogues (<b>9</b>â<b>29</b>) with various 1â²-monoalkyl substituents in the amide side chain, to modulate lipophilicities and improve PK properties, had potencies ranging from 31 to 1990 nM and showed that the (<i>R</i>)-enantiomer was generally slightly more active than the (<i>S</i>)-isomer. Compounds with 1â²,2â²-dialkyls (<b>30</b>â<b>33</b>) mostly gave potency around 200 nM. Similar activities were seen with (<b>34</b>â<b>39</b>) that have 1â²,2â²,2â²-trialkyls in the amide side chain. Targeting to improve the metabolic stability of the amide bond, N,N-disubstituted amide analogues (<b>40</b>â<b>44</b>) were synthesized, and their IC<sub>50</sub> values ranged from 48 to 437 nM indicating that these substitutions were tolerated. Considering this N,N-disubstitution pattern and a previous observation that compounds <b>37</b> and <b>38</b> containing a terminal tertiary alcohol had good activity promoted the idea to synthesize the cyclic pyrrolidinyl molecule <b>45</b>, which showed IC<sub>50</sub> = 139 nM (W2 strain). Further structural simplification to remove the chiral center in <b>45</b> resulted in the methylazetidinyl compound <b>46</b> with an improved potency of IC<sub>50</sub><b>33</b> nM (W2 strain) and <b>43</b> nM (3D7 strain). Five additional azetidinyl analogues (<b>47</b>â<b>51</b>) with ethyl, <i>n</i>-propyl, isopropyl, cyclopropyl, or trifluoromethyl replacing the 3â²-methyl at azetidine in <b>46</b> were also very active (IC<sub>50</sub> from 7 nM to 134 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Activity Results for Compounds <b>3</b>â<b>51</b> against Cultured <i>P. falciparum</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">group Y</th><th class="colsep0 rowsep0" align="center">cLogD<sub>7.4</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">tPSA<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (Î¼M, W2)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (Î¼M, 3D7)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>2</sub>CH<sub>2</sub>OMe</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">102.8</td><td class="colsep0 rowsep0" align="left">0.788</td><td class="colsep0 rowsep0" align="left">0.644</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.372</td><td class="colsep0 rowsep0" align="left">1.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>2</sub>CH(Me)OH</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">1.28</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">NHCH<sub>2</sub>C(Me<sub>2</sub>)OH</td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.334</td><td class="colsep0 rowsep0" align="left">0.554</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">NHC(Me<sub>2</sub>)CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.425</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">NHC(CH<sub>2</sub>)<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">2.01</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">NHCH(Me)CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.342</td><td class="colsep0 rowsep0" align="left">0.994</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">NHCH(Me)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.944</td><td class="colsep0 rowsep0" align="left">0.848</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">NHCH(Me)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.844</td><td class="colsep0 rowsep0" align="left">0.808</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">NHCH(Et)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.13</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.136</td><td class="colsep0 rowsep0" align="left">0.403</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">NHCH(Et)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.13</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.704</td><td class="colsep0 rowsep0" align="left">0.801</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>n</i>Pr)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.53</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.161</td><td class="colsep0 rowsep0" align="left">0.201</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>n</i>Pr)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.53</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.297</td><td class="colsep0 rowsep0" align="left">0.715</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>i</i>Pr)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.149</td><td class="colsep0 rowsep0" align="left">0.466</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>i</i>Pr)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.774</td><td class="colsep0 rowsep0" align="left">1.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>c</i>Pr)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.03</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.492</td><td class="colsep0 rowsep0" align="left">0.587</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>c</i>Pr)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.03</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.643</td><td class="colsep0 rowsep0" align="left">1.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>CF<sub>3</sub>)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.0822</td><td class="colsep0 rowsep0" align="left">0.149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>CF<sub>3</sub>)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.031</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>CH<sub>2</sub>CF<sub>3</sub>)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.79</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>CH<sub>2</sub>CF<sub>3</sub>)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.79</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.352</td><td class="colsep0 rowsep0" align="left">0.959</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>n</i>Bu)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.93</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.0849</td><td class="colsep0 rowsep0" align="left">0.215</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">NHCH(Ph)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">2.10</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.103</td><td class="colsep0 rowsep0" align="left">0.161</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">NHCH(Bn)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">2.35</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.115</td><td class="colsep0 rowsep0" align="left">0.505</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>OMe)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">123.0</td><td class="colsep0 rowsep0" align="left">0.455</td><td class="colsep0 rowsep0" align="left">0.796</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>SMe)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">0.99</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.037</td><td class="colsep0 rowsep0" align="left">0.074</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">NHCH(CH<sub>2</sub>SO<sub>2</sub>Me)CH<sub>2</sub>OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">â0.97</td><td class="colsep0 rowsep0" align="left">147.9</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.472</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">NHCH(Me)CH(Me)OH</td><td class="colsep0 rowsep0" align="left">1.08</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.513</td><td class="colsep0 rowsep0" align="left">1.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">NH((<i>1S,2S</i>)-2-hydroxycyclopentyl)</td><td class="colsep0 rowsep0" align="left">1.11</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.149</td><td class="colsep0 rowsep0" align="left">0.537</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">NH((<i>1R,2R</i>)-2-hydroxycyclopentyl)</td><td class="colsep0 rowsep0" align="left">1.11</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.133</td><td class="colsep0 rowsep0" align="left">0.245</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">NH(<i>cis</i>-(2-hydroxycyclopentyl))</td><td class="colsep0 rowsep0" align="left">1.11</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.292</td><td class="colsep0 rowsep0" align="left">0.181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">NHCH(Me)C(Me<sub>2</sub>)OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.202</td><td class="colsep0 rowsep0" align="left">0.327</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">NHCH(Me)C(Me<sub>2</sub>)OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.265</td><td class="colsep0 rowsep0" align="left">0.374</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">NHCH(Et)C(Me<sub>2</sub>)OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.279</td><td class="colsep0 rowsep0" align="left">0.829</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">NHCH(Et)C(Me<sub>2</sub>)OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.0918</td><td class="colsep0 rowsep0" align="left">0.222</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>n</i>Pr)C(Me<sub>2</sub>)OH-(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">2.02</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.129</td><td class="colsep0 rowsep0" align="left">0.217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">NHCH(<i>n</i>Pr)C(Me<sub>2</sub>)OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">2.02</td><td class="colsep0 rowsep0" align="left">113.8</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.553</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">N(Me)CH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.262</td><td class="colsep0 rowsep0" align="left">0.437</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">N(Me)CH(Pr)CH<sub>2</sub>OH-(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">1.78</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0481</td><td class="colsep0 rowsep0" align="left">0.252</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">N(CH<sub>2</sub>CH<sub>2</sub>OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">â0.25</td><td class="colsep0 rowsep0" align="left">125.2</td><td class="colsep0 rowsep0" align="left">0.328</td><td class="colsep0 rowsep0" align="left">0.184</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-2-(hydroxymethyl)piperazin-1-yl</td><td class="colsep0 rowsep0" align="left">â0.29</td><td class="colsep0 rowsep0" align="left">117.0</td><td class="colsep0 rowsep0" align="left">0.0982</td><td class="colsep0 rowsep0" align="left">0.171</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-2-(hydroxymethyl)piperazin-1-yl</td><td class="colsep0 rowsep0" align="left">â0.29</td><td class="colsep0 rowsep0" align="left">117.0</td><td class="colsep0 rowsep0" align="left">0.103</td><td class="colsep0 rowsep0" align="left">0.151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-methylpyrrolidin-1-yl</td><td class="colsep0 rowsep0" align="left">0.52</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.139</td><td class="colsep0 rowsep0" align="left">0.314</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-methylazetidin-1-yl</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0326</td><td class="colsep0 rowsep0" align="left">0.043</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-ethylazetidin-1-yl</td><td class="colsep0 rowsep0" align="left">0.94</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0289</td><td class="colsep0 rowsep0" align="left">0.055</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-propylazetidin-1-yl</td><td class="colsep0 rowsep0" align="left">1.33</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0159</td><td class="colsep0 rowsep0" align="left">0.054</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-isopropylazetidin-1-yl</td><td class="colsep0 rowsep0" align="left">1.34</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0407</td><td class="colsep0 rowsep0" align="left">0.057</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-cyclopropylazetidin-1-yl</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0517</td><td class="colsep0 rowsep0" align="left">0.134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">3-hydroxy-3-trifluoromethylazetidin-1-yl</td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left">105.0</td><td class="colsep0 rowsep0" align="left">0.0066</td><td class="colsep0 rowsep0" align="left">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">artemisinin</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">3.11</td><td class="colsep0 rowsep0" align="left">54.0</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chloroquine</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.88</td><td class="colsep0 rowsep0" align="left">28.2</td><td class="colsep0 rowsep0" align="left">0.021</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atovaquone</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">3.33</td><td class="colsep0 rowsep0" align="left">54.4</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.001</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Experimental procedures for the <i>in vitro</i> assays for the W2 and 3D7 strains were reported previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> IC<sub>50</sub> values were determined from two independent replicates for the W2 strain and three replicates for the 3D7 strain. Artemisinin and chloroquine were used as reference controls for the W2 strain assay, and atovaquone was used for the 3D7 assay. Compounds were incubated with parasites for 48 h.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">cLogD<sub>7.4</sub> and tPSA values were calculated using ChemAxon software.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Not applicable.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Metabolic Stability and Pharmacokinetic Study</h3><div class="NLM_p">As <i>in vitro</i> potency was maintained with a relatively broad array of amide substitution patterns, a key driver for the project was to build good pharmacokinetic properties into the series to enable provision of a single dose cure. This feature is critical for the treatment of malaria patients in disease endemic areas to ensure compliance. Therefore, the pharmacokinetic properties of selected compounds following oral administration to mice were determined (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The hydroxyethyl amide <b>9</b> had high plasma concentration, good exposure, moderate half-life, and excellent bioavailability. It was hypothesized that increasing length of exposure (as indicated by half-life) was important to achieve our goal of a single dose cure molecule. In order to achieve this goal, we further hypothesized that increasing molecule lipophilicity would lead to a higher volume of distribution and a longer half-life. Of course, it was important that changes in lipophilicity could not be large, as it was expected that metabolic stability could be adversely affected by such changes. Therefore, compounds <b>9</b> with methyl substitution on the amide side chain (cLogD = 0.66), <b>20</b> with trifluoroethyl (cLogD = 1.54), and <b>14</b> with <i>n</i>-propyl (cLogD = 1.53) were compared. Compound <b>14</b> gave a longer half-life (4.5 h) than <b>9</b> (2.7 h) and <b>20</b> (3.0 h), while higher clearance was unsurprisingly observed with more lipophilic compounds (CL = 243, 238, and 128 mL/h/kg with <b>14</b>, <b>20</b>, and <b>9</b>, respectively). To further improve the half-life of <b>14</b>, minimizing the amide hydrolysis was strategized by using N,N-disubstitution to generate steric hindrance around the amide bond. Encouragingly, the potent 3-methyl-3-hydroxyazetidinyl amide <b>46</b> had a longer half-life (6.8 h) in mice following oral administration which enabled us to combine high <i>in vitro</i> antiparasitic activity and good <i>in vivo</i> pharmacokinetic properties in a single molecule. Five additional azetidinyl amide analogues were designed and synthesized with variation of the alkyl to ethyl (<b>47</b>), <i>n</i>-propyl (<b>48</b>), isopropyl (<b>49</b>), cyclopropyl (<b>50</b>), or trifluoromethyl (<b>51</b>). In order to differentiate these six close analogues, their metabolic stabilities were assessed in <i>in vitro</i> rat and human hepatocyte assays, which incubated 7 Ã 10<sup>5</sup> cells/well and 20 Î¼M benzoxaborole for 44 h. In the experiment with rat heptocytes, as expected, an inverse relationship between metabolic stability and lipophilicity was observed. The rank order of stability was <b>46</b> (Me) > <b>47</b> (Et) > <b>50</b> (<i>c</i>-Pr) > <b>49</b> (<i>i</i>-Pr) > <b>48</b> (<i>n</i>-Pr) â« <b>51</b> (CF<sub>3</sub>). In human hepatocytes, the compounds were generally more stable than in rat hepatocytes, and the rank order was similar, e.g., <b>46</b> (Me) â <b>47</b> (Et) â <b>50</b> (<i>c</i>-Pr) > <b>49</b> (<i>i</i>-Pr) â <b>48</b> (<i>n</i>-Pr) â« <b>51</b> (CF<sub>3</sub>). These results indicated that the 3-methyl-3-hydroxyazetidine amide <b>46</b> was most stable among the six analogues and prompted us to further evaluate this compound in rat and dog pharmacokinetic studies. Data from these studies are presented in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Briefly, compound <b>46</b> exhibited excellent oral exposure, low clearance, and long half-life in both species.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters for <b>4</b>, <b>9</b>, <b>14</b>, <b>20</b>, and <b>46</b> in Mice, Rats, or Dogs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="5" align="center">oral PK parameters</th><th class="rowsep1 colsep0" colspan="4" align="center">intravenous PK parameters</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">cLogD<sub>7.4</sub></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (Î¼g/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0-inf</sub> (hÂ·Î¼g/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center">CL (mL/h/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (mL/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0-inf</sub> (hÂ·Î¼g/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">29.6</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">159</td><td class="colsep0 rowsep0" align="left">636</td><td class="colsep0 rowsep0" align="left">31.4</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">33.0</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">603</td><td class="colsep0 rowsep0" align="left">39.0</td><td class="colsep0 rowsep0" align="left">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.53</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">21.6</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">103</td><td class="colsep0 rowsep0" align="left">243</td><td class="colsep0 rowsep0" align="left">874</td><td class="colsep0 rowsep0" align="left">20.5</td><td class="colsep0 rowsep0" align="left">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">13.4</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">238</td><td class="colsep0 rowsep0" align="left">741</td><td class="colsep0 rowsep0" align="left">21.0</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">20.7</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">101</td><td class="colsep0 rowsep0" align="left">244</td><td class="colsep0 rowsep0" align="left">888</td><td class="colsep0 rowsep0" align="left">20.5</td><td class="colsep0 rowsep0" align="left">7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">20.8</td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">233</td><td class="colsep0 rowsep0" align="left">831</td><td class="colsep0 rowsep0" align="left">21.7</td><td class="colsep0 rowsep0" align="left">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">112</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">214</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">127</td><td class="colsep0 rowsep0" align="left">30.3</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">168</td><td class="colsep0 rowsep0" align="left">6.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Abbreviations: <i>C</i><sub>max</sub>, maximum concentration of drug in plasma; <i>T</i><sub>max</sub>, time to maximum concentration of drug in plasma; AUC<sub>0-inf</sub>, area under the curve extrapolated to infinity; <i>T</i><sub>1/2</sub> terminal half-life; <i>F</i>, oral bioavailability; CL, clearance; <i>V</i><sub>ss</sub>, volume of distribution at steady state.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Mice dosed at 5 mg/kg orally or intravenously.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Rats dosed at 5 mg/kg orally or intravenously.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Dogs dosed at 5 mg/kg orally or intravenously.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> <i>In Vivo</i> Efficacy in <i>P. berghei</i> and <i>P. falciparum</i> Mouse Models</h3><div class="NLM_p">Compounds were selected for <i>in vivo</i> testing based on their chemical diversity, <i>in vitro</i> potency, physicochemical properties, and pharmacokinetic properties. Twelve compounds (<b>4</b>, <b>9</b>, <b>12</b>, <b>14</b>, <b>16</b>, <b>20</b>, <b>46</b>, <b>47</b>, <b>48</b>, <b>49</b>, <b>50</b>, and <b>51</b>) were tested in a <i>P. berghei</i> mouse model (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In this model, compounds were dosed orally once a day for four consecutive days, beginning 1 h after infection by intraperitoneal administration of <i>P. berghei</i>-infected erythrocytes. Compound <b>4</b> with the hydroxyethyl side chain to the amide nitrogen had a low efficacy of ED<sub>90</sub> = 56.1 mg/kg. Because of the improved pharmacokinetic profiles exhibited by hydroxyethyl amides containing substituents, <i>in vivo</i> efficacy was also improved for compounds <b>9</b> (ED<sub>90</sub> = 44.3 mg/kg), <b>14</b> (ED<sub>90</sub> = 11.7 mg/kg), and <b>20</b> (ED<sub>90</sub> = 7.3 mg/kg). Compound <b>16</b> with a <i>i</i>-Pr group attached to the side chain did not follow this trend (ED<sub>90</sub> = 26.7 mg/kg). The azetidinyl amide analogues (<b>46</b>â<b>51</b>) further improved efficacies with the ED<sub>90</sub> values ranging from 1.9 to 10.3 mg/kg, and <b>46</b> had the best efficacy among these molecules, which was consistent with the result of <i>in vitro</i> metabolic stability evaluation.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Percent Survival of Mice and Efficacies of <b>4</b>, <b>9</b>, <b>12</b>, <b>14</b>, <b>16</b>, <b>20</b>, <b>46</b>, <b>47</b>, <b>48</b>, <b>49</b>, <b>50</b>, and <b>51</b> in a <i>P. berghei</i> Mouse Malaria Model<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="14" align="center">percent survival of mice on specific days (%)</th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">oral dosage</th><th class="colsep0 rowsep0" align="center">d4<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">d5</th><th class="colsep0 rowsep0" align="center">d6</th><th class="colsep0 rowsep0" align="center">d7</th><th class="colsep0 rowsep0" align="center">d8</th><th class="colsep0 rowsep0" align="center">d9</th><th class="colsep0 rowsep0" align="center">d10</th><th class="colsep0 rowsep0" align="center">d11</th><th class="colsep0 rowsep0" align="center">d12</th><th class="colsep0 rowsep0" align="center">d13</th><th class="colsep0 rowsep0" align="center">d14</th><th class="colsep0 rowsep0" align="center">d15</th><th class="colsep0 rowsep0" align="center">d16-d19</th><th class="colsep0 rowsep0" align="center">d20</th><th class="colsep0 rowsep0" align="center">ED<sub>90</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="6" align="left">56.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="6" align="left">44.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.3 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="6" align="left">43.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" rowspan="6" align="left">11.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="5" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="5" align="left">26.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="6" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="6" align="left">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">60â0<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="7" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="8" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" rowspan="8" align="left">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="8" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100â0<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" rowspan="8" align="left">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="8" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" rowspan="8" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100â80<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" rowspan="7" align="left">10.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.2 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="8" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" rowspan="7" align="left">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">33 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.7 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.4 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.1 mg/kg</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ 30 mg/kg<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t3fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">vehicle<a class="ref internalNav" href="#t3fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">NA</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">The model evaluated the therapeutic efficacy of a molecule against <i>Plasmodium berghei</i>. Mice were infected by an intraperitoneal injection of <i>Plasmodium berghei</i>-infected erythrocytes collected from a previously infected animal. Compounds were formulated in a vehicle composed of polyethylene glycol 300, propylene glycol, and water (weight ratio, 55/25/20), and dosed by oral administration once a day for 4 consecutive days.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">D4 to d20 represent the days of experiment.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">ED<sub>90</sub>s were based on comparisons of parasitemias with those of mice treated only with the vehicle on day 4 after the onset of therapy.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">60% on day 16 and 0% on day 17.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">100% on day 16 and 0% on day 17.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">100% on days 16 and 17 and 80% on days 18 and 19.</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">Because of the nature of the <i>in vivo</i> model, there was efficacy variation of the chloroquine positive control group, and 100% survival was commonly observed on day 20 on average;</p></div><div class="footnote" id="t3fn8"><sup>h</sup><p class="last">Because of the nature of the <i>in vivo</i> model, there was slight variation of the vehicle control group, and 100% survival was observed on days 4 to 6.</p></div><div class="footnote" id="t3fn9"><sup>i</sup><p class="last">NA = not applicable.</p></div></div></div><div class="NLM_p">Selected compounds were also tested in a <i>P. falciparum</i> mouse model, which evaluates the therapeutic efficacy of a compound against strain <i>Pf</i>3D7<sup>0087/N9</sup> growing in the peripheral blood of NODscidIL2RÎ³<sup>null</sup> mice engrafted with human erythrocytes (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Compounds were dosed orally once a day for four consecutive days. Compound <b>14</b> demonstrated excellent efficacy (ED<sub>90</sub> = 2.5 mg/kg), and the corresponding exposure was AUC<sub>ED90</sub> = 7.45 Î¼gÂ·hÂ·mL<sup>â1</sup>Â·day<sup>â1</sup>. For the azetidinyl amide analogues (<b>46</b>, <b>47</b>, <b>49</b>, <b>50</b>, and <b>51</b>), an initial test indicated that all of these five molecules were very efficacious (ED<sub>90</sub> < 5 mg/kg). On the basis of our understanding of metabolic stability and half-life from PK experiments, the two more stable analogues (<b>46</b> and <b>47</b>) were chosen for determination of their ED<sub>90</sub> values. In these experiments, potency and exposure of <b>46</b> (ED<sub>90</sub> = 0.85 mg/kg; AUCED<sub>90</sub> = 1.4 Î¼gÂ·h/mL) and <b>47</b> (ED<sub>90</sub> = 0.84 mg/kg; 1.6 Î¼gÂ·h/mL) were very similar (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Furthermore, as shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, the result of the <i>P. falciparum</i>-infected mouse model experiment demonstrated that the <i>in vivo</i> parasite clearance profile of <b>46</b> was rapid and similar to that of artesunate and chloroquine, two well-known fast parasite-killing antimalarial medicines.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Efficacy Results of <b>14</b>, <b>46</b>, <b>47</b>, <b>49</b>, <b>50</b>, and <b>51</b> in a <i>P. falciparum</i> Mouse Malaria Model<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">cLogD<sub>7.4</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">ED<sub>90</sub> (mg/kg)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">AUC<sub>ED90</sub> (Î¼gÂ·h/mL/day)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">1.53</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">7.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">0.94</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">1.34</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">1.10</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The model evaluated the therapeutic efficacy of a molecule against <i>Plasmodium falciparum Pf</i>3D7<sup>0087/N9</sup> growing in the peripheral blood of NODscidIL2RÎ³<sup>null</sup> mice engrafted with human erythrocytes. Compounds were formulated in a vehicle composed of polyethylene glycol 300, propylene glycol, and water (weight ratio, 55/25/20), and dosed by oral administration once a day for 4 consecutive days;</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">cLogD<sub>7.4</sub> values were calculated using ChemAxon software.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">ED<sub>90</sub> values were based on comparisons of parasitemias with those of mice treated only with vehicle on day 4 after the onset of therapy.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">AUC<sub>ED90</sub> was the compound exposure in whole blood necessary to reduce <i>P. falciparum</i> parasitemia in peripheral blood at day 7 after infection by 90% with respect to vehicle-treated mice.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Not determined.</p></div></div></div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>46</b> demonstrated rapid <i>in vivo</i> parasite clearance in the <i>P. falciparum</i>-infected mouse model, similar to artesunate and chloroquine of the two well-known fast parasite-killing antimalarial agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since compound <b>46</b> demonstrated the best overall profile of the <i>in vitro</i> potency, <i>in vitro</i> metabolic stability, PK properties, and <i>in vivo</i> efficacies among these amides <b>3</b>â<b>51</b>, it was further studied for activity against other <i>P. falciparum</i> strains, <i>in vitro</i> parasite reduction rate (PRR), and genotoxicity properties.</div><div class="NLM_p last">Since the malaria patient population includes many children and women within childbearing years, the safety of antimalarial treatment has profound priority. This research program adapted a strategy at research stage to screen representative compounds in micronucleus genetic toxicity assays. Compound <b>4</b> with a terminal hydroxyl group on the ethyl was <i>in vitro</i> micronucleus negative. It was further tested in a micronucleus <i>in vivo</i> rat model, and the result was also micronucleus negative.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Activities of Compound <b>46</b> against Multiple <i>P. falciparum</i> Parasite Strains</h3><div class="NLM_p">As summarized in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, compound <b>46</b> was tested against an additional 11 <i>P. falciparum</i> strains and demonstrated excellent potency with IC<sub>50</sub>âs in the range of 36â80 nM. Many of these parasite strains are chloroquine and pyrimethamine resistant, which indicated that compound <b>46</b> would not be expected to be cross-resistant against these multiple drug resistant strains and that it may have a possible novel mechanism of action or resistance distinct from those of chloroquine and pyrimethamine.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. <i>In Vitro</i> Activities of <b>46</b> against <i>P. falciparum</i> Parasite Strains<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="11" align="center">IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">NF-54</th><th class="colsep0 rowsep0" align="center">K1</th><th class="colsep0 rowsep0" align="center">T9/94</th><th class="colsep0 rowsep0" align="center">HB3</th><th class="colsep0 rowsep0" align="center">TM90C2A</th><th class="colsep0 rowsep0" align="center">TM90C2B</th><th class="colsep0 rowsep0" align="center">Dd2</th><th class="colsep0 rowsep0" align="center">V1/S</th><th class="colsep0 rowsep0" align="center">7G8</th><th class="colsep0 rowsep0" align="center">D6</th><th class="colsep0 rowsep0" align="center">FCB</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">0.062</td><td class="colsep0 rowsep0" align="left">0.054</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">0.064</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">0.053</td><td class="colsep0 rowsep0" align="left">0.063</td><td class="colsep0 rowsep0" align="left">0.035</td><td class="colsep0 rowsep0" align="left">0.062</td><td class="colsep0 rowsep0" align="left">0.066</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atovaquone</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0.0007</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">>0.035</td><td class="colsep0 rowsep0" align="left">0.002</td><td class="colsep0 rowsep0" align="left">0.001</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chloroquine</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">0.384</td><td class="colsep0 rowsep0" align="left">0.027</td><td class="colsep0 rowsep0" align="left">0.384</td><td class="colsep0 rowsep0" align="left">0.561</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">>1</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyrimethamine</td><td class="colsep0 rowsep0" align="left">0.045</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.038</td><td class="colsep0 rowsep0" align="left">3.381</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Experimental procedure for the <i>in vitro</i> assay was same as that reported previously for IC<sub>50</sub> determination against the <i>P.f.</i> 3D7 strain.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">NF-54, K1, T9/94, HB3, TM90C-2A, TM90C-2B, Dd2, V1/S, 7G8, D6, and FCB are <i>P. falciparum</i> parasite strains.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Not determined.</p></div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>In Vitro P. falciparum</i> Parasite Killing Rate of Compound <b>46</b></h3><div class="NLM_p">A PRR <i>P. falciparum in vitro</i> assay was used to compare parasite killing rates at different concentrations. The three concentrations used were 10Ã, 30Ã, and 100Ã IC<sub>50</sub>. The assay allowed us to determine the moleculeâs important antiparasitic parameters such as lag phase (the time needed to show maximal killing), PRR (parasite reduction ratio or number of parasites the compound could kill in a parasite life cycle), and PCT<sub>99.9%</sub> (parasite clearance time to kill 99.9% of the initial parasite population). The timeâkill curves for compound <b>46</b> in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> suggested that the concentration required for <b>46</b> to achieve a maximal rate of parasite-killing was 10Ã to 30Ã IC<sub>50</sub>. The data were analyzed to fit to the linear portion of the curve to determine the PRR parameters as summarized in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>, together with standard antimalarial agents for comparison. The result indicated that the antiparasitic rate of action of compound <b>46</b> was fast and similar to the rates for artemisinin and chloroquine.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Parasite-killing curves of compound <b>46</b> at 10Ã, 30Ã, and 100Ã IC<sub>50</sub> doses indicating that the concentration required for <b>46</b> to achieve a maximal rate of parasite-killing was 10Ã to 30Ã IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Parasite Reduction Ratio (PRR) Parameters of Compound <b>46</b> in Comparison with Those of Four Standard Antimalarial Agents<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">dose</th><th class="colsep0 rowsep0" align="center">lag phase (h)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">slope</th><th class="colsep0 rowsep0" align="center"><i>r</i></th><th class="colsep0 rowsep0" align="center">log PRR</th><th class="colsep0 rowsep0" align="center">PCT<sub>99.9%</sub> (h)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">10 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">â0.0913</td><td class="colsep0 rowsep0" align="left">â0.936</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">â0.1015</td><td class="colsep0 rowsep0" align="left">â0.998</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">â0.1015</td><td class="colsep0 rowsep0" align="left">â0.998</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">artemisinin</td><td class="colsep0 rowsep0" align="left">10 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">â0.101</td><td class="colsep0 rowsep0" align="left">â0.920</td><td class="colsep0 rowsep0" align="left">>4.8</td><td class="colsep0 rowsep0" align="left"><24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atovaquone</td><td class="colsep0 rowsep0" align="left">10 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">â0.061</td><td class="colsep0 rowsep0" align="left">â0.992</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pyrimethamine</td><td class="colsep0 rowsep0" align="left">10 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">â0.061</td><td class="colsep0 rowsep0" align="left">â0.994</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chloroquine</td><td class="colsep0 rowsep0" align="left">10 Ã IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">â0.094</td><td class="colsep0 rowsep0" align="left">â0.999</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">The killing curve data were analyzed to fit to the linear stretch to determine the PRR parameters indicating that the compound <b>46</b> antiparasitic action was fast and similar to that of artemisinin and chloroquine. PRR represents the parasite reduction ratio or number of parasites the compound could kill in a parasiteâs life cycle.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Lag phase was the time needed to show the maximal killing effects of the molecule.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">PCT<sub>99.9%</sub> was the parasite clearance time to kill 99.9% of the initial parasite population.</p></div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Ames and Genetic Toxicity Test Results of Compound <b>46</b></h3><div class="NLM_p">The bacterial reverse mutation assay (Ames test) was conducted to evaluate the potential of compound <b>46</b> to induce mutation in <i>Salmonella typhimurium</i> strains TA98, TA100, TA1535, and TA1537 as well as the <i>E. coli</i> strain WP2 <i>uvr</i>A in the presence and absence of an exogenous metabolic activation system (S9). The results are presented in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>, demonstrating that molecule <b>46</b> was not mutagenic in the Ames assay under the conditions tested. The molecule was also tested in the <i>in vitro</i> micronucleus assay using human lymphocytes in the presence and absence of an Aroclor 1254 induced rat liver S9 activation system for evaluating its clastogenic potential. A dose range cytotoxicity test was performed, establishing the dose range for the definitive micronucleus assay, which was â¤355.15 Î¼g/mL of <b>46</b>. In the <i>in vitro</i> micronucleus assay, human lymphocytes were treated for 3 and 28 h in the nonactivated test system and for 3 h in the S9 activated test system. As shown in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>, in comparison with the 1% DMSO control, there were no statistically significant increases in the frequency of micronucleated cells observed in the groups treated with compound <b>46</b> under any conditions, indicating that compound <b>46</b> was not clastogenic at 3 h, with and without S9 activation, and at 28 h without S9 activation. This encouraging result led us to test compound <b>46</b> in the <i>in vivo</i> rat micronucleus model for further genotoxicity assessment by analyzing micronuclei in polychromatic erythrocyte cells (PCEs) in rat bone marrow. Three single oral doses were tested at 500, 1000, and 2000 mg/kg. The toxicokinetic plasma samples were collected and analyzed. The exposure of <b>46</b> at the highest dose of 2000 mg/kg was 742 Î¼gÂ·h/mL, confirming that there was adequate exposure of <b>46</b> in the <i>in vivo</i> micronucleus assay. There were no statistically significant increases in the incidence of micronucleated PCEs (MnPCEs) in the <b>46</b>-treated groups relative to the negative control group, and therefore, the compound did not have a micronucleus risk at all three test doses in this study (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Results of the Bacterial Reverse Mutation Assay (Ames Assay) of Compound <b>46</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="10" align="center">average revertants/plate<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">TA98</th><th class="rowsep1 colsep0" colspan="2" align="center">TA100</th><th class="rowsep1 colsep0" colspan="2" align="center">TA1535</th><th class="rowsep1 colsep0" colspan="2" align="center">TA1537</th><th class="rowsep1 colsep0" colspan="2" align="center">WP2 <i>uvr</i>A</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (Î¼g/plate)</th><th class="colsep0 rowsep0" align="center">without activation</th><th class="colsep0 rowsep0" align="center">with activation<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">without activation</th><th class="colsep0 rowsep0" align="center">with activation</th><th class="colsep0 rowsep0" align="center">without activation</th><th class="colsep0 rowsep0" align="center">with activation</th><th class="colsep0 rowsep0" align="center">without activation</th><th class="colsep0 rowsep0" align="center">with activation</th><th class="colsep0 rowsep0" align="center">without activation</th><th class="colsep0 rowsep0" align="center">with activation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">14Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">19Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">154Â Â±Â 9</td><td class="colsep0 rowsep0" align="left">141Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">19Â Â±Â 9</td><td class="colsep0 rowsep0" align="left">11Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">45Â Â±Â 9</td><td class="colsep0 rowsep0" align="left">42Â Â±Â 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1.5<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">15Â Â±Â 7</td><td class="colsep0 rowsep0" align="left">20Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">144Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">150Â Â±Â 17</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">9Â Â±Â 2</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">40Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">39Â Â±Â 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">152Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">128Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">8Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">16Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 2</td><td class="colsep0 rowsep0" align="left">22Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">35Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">37Â Â±Â 8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">13Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">126Â Â±Â 15</td><td class="colsep0 rowsep0" align="left">149Â Â±Â 24</td><td class="colsep0 rowsep0" align="left">13Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">9Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">41Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">50Â Â±Â 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">14Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">17Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">132Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">136Â Â±Â 17</td><td class="colsep0 rowsep0" align="left">8Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">11Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">9Â Â±Â 2</td><td class="colsep0 rowsep0" align="left">35Â Â±Â 14</td><td class="colsep0 rowsep0" align="left">44Â Â±Â 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">13Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">148Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">154Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">8Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">12Â Â±Â 7</td><td class="colsep0 rowsep0" align="left">56Â Â±Â 6</td><td class="colsep0 rowsep0" align="left">53Â Â±Â 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">500</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">18Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">155Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">132Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">5Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">6Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">14Â Â±Â 12</td><td class="colsep0 rowsep0" align="left">17Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">55Â Â±Â 11</td><td class="colsep0 rowsep0" align="left">35Â Â±Â 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1500</td><td class="colsep0 rowsep0" align="left">13Â Â±Â 0</td><td class="colsep0 rowsep0" align="left">15Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">133Â Â±Â 8</td><td class="colsep0 rowsep0" align="left">144Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">7Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">8Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">33Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">26Â Â±Â 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5000</td><td class="colsep0 rowsep0" align="left">9Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">18Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">20Â Â±Â 13</td><td class="colsep0 rowsep0" align="left">31Â Â±Â 16</td><td class="colsep0 rowsep0" align="left">4Â Â±Â 1</td><td class="colsep0 rowsep0" align="left">6Â Â±Â 2</td><td class="colsep0 rowsep0" align="left">10Â Â±Â 4</td><td class="colsep0 rowsep0" align="left">9Â Â±Â 5</td><td class="colsep0 rowsep0" align="left">43Â Â±Â 3</td><td class="colsep0 rowsep0" align="left">34Â Â±Â 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">positive<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">162Â Â±Â 15</td><td class="colsep0 rowsep0" align="left">524Â Â±Â 42</td><td class="colsep0 rowsep0" align="left">484Â Â±Â 21</td><td class="colsep0 rowsep0" align="left">550Â Â±Â 47</td><td class="colsep0 rowsep0" align="left">356Â Â±Â 43</td><td class="colsep0 rowsep0" align="left">163Â Â±Â 21</td><td class="colsep0 rowsep0" align="left">430Â Â±Â 199</td><td class="colsep0 rowsep0" align="left">82Â Â±Â 2</td><td class="colsep0 rowsep0" align="left">357Â Â±Â 81</td><td class="colsep0 rowsep0" align="left">311Â Â±Â 39</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Testing strains were <i>Salmonella typhimurium</i> TA98, TA100, TA1535, TA1537, and <i>E. coli</i> WP2 <i>uvr</i>A.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">The data demonstrated that compound <b>46</b> was not mutagenic with or without metabolic activation under the conditions tested.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Rat liver S9 was used for the metabolic activation condition.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Vehicle (DMSO) was used as the negative control.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">The test article was prepared in DMSO and tested via the plate incorporation method at eight dose levels as shown in the same column of this table.</p></div><div class="footnote" id="t7fn6"><sup>f</sup><p class="last">Positive controls were 2-nitrofluorene (1.0 Î¼g/plate) for TA98 without activation, 2-aminoanthracene (2.0 Î¼g/plate) for TA98, TA100, TA1535, or TA1537 with activation, sodium azide (1.0 Î¼g/plate) for TA100 or TA1535 without activation, 9-aminoacridine (75 Î¼g/plate) for TA1537 without activation, methylmethanesulfonate (1000 Î¼g/plate) for WP2 <i>uvr</i>A without activation, and 2-aminoanthracene (15.0 Î¼g/plate) for WP2 <i>uvr</i>A with activation.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Results of the Definitive Assay for Micronucleus Induction <i>in Vitro</i> in Human Lymphocytes by Compound <b>46</b><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay group</th><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">replication index<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">cytotoxicity (%)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">% micronucleated cells</th><th class="colsep0 rowsep0" align="center">mean % micronucleated cells</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="10" align="left">3-h treatment with S9</td><td class="colsep0 rowsep0" rowspan="2" align="left">DMSO (1%)</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" rowspan="2" align="left">0</td><td class="colsep0 rowsep0" align="left">0.76</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.86</td><td class="colsep0 rowsep0" align="left">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMC (0.33 Î¼g/mL)</td><td class="colsep0 rowsep0" rowspan="2" align="left">ND<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" rowspan="2" align="left">ND</td><td class="colsep0 rowsep0" align="left">3.52</td><td class="colsep0 rowsep0" rowspan="2" align="left">2.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (80 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" rowspan="2" align="left">1</td><td class="colsep0 rowsep0" align="left">0.88</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (160 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" rowspan="2" align="left">8</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (355.15 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" rowspan="2" align="left">7</td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="10" align="left">3-h treatment without S9</td><td class="colsep0 rowsep0" rowspan="2" align="left">DMSO (1%)</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" rowspan="2" align="left">0</td><td class="colsep0 rowsep0" align="left">1.18</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.89</td><td class="colsep0 rowsep0" align="left">0.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMC (0.84 Î¼g/mL)</td><td class="colsep0 rowsep0" rowspan="2" align="left">ND</td><td class="colsep0 rowsep0" rowspan="2" align="left">ND</td><td class="colsep0 rowsep0" align="left">7.16</td><td class="colsep0 rowsep0" rowspan="2" align="left">5.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (80 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.86</td><td class="colsep0 rowsep0" rowspan="2" align="left">3</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.82</td><td class="colsep0 rowsep0" align="left">1.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (160 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" rowspan="2" align="left">2</td><td class="colsep0 rowsep0" align="left">1.22</td><td class="colsep0 rowsep0" rowspan="2" align="left">1.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">1.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (355.15 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" rowspan="2" align="left">7</td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">0.99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="12" align="left">28-h treatment without S9</td><td class="colsep0 rowsep0" rowspan="2" align="left">DMSO (1%)</td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" rowspan="2" align="left">0</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMC (0.33 Î¼g/mL)</td><td class="colsep0 rowsep0" rowspan="2" align="left">ND</td><td class="colsep0 rowsep0" rowspan="2" align="left">ND</td><td class="colsep0 rowsep0" align="left">6.60</td><td class="colsep0 rowsep0" rowspan="2" align="left">6.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (40 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" rowspan="2" align="left">7</td><td class="colsep0 rowsep0" align="left">1.18</td><td class="colsep0 rowsep0" rowspan="2" align="left">1.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">1.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (80 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" rowspan="2" align="left">7</td><td class="colsep0 rowsep0" align="left">1.07</td><td class="colsep0 rowsep0" rowspan="2" align="left">1.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.80</td><td class="colsep0 rowsep0" align="left">1.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (160 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" rowspan="2" align="left">13</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.74</td><td class="colsep0 rowsep0" align="left">1.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>46</b> (355.15 Î¼g/mL)</td><td class="colsep0 rowsep0" align="left">0.58</td><td class="colsep0 rowsep0" rowspan="2" align="left">33</td><td class="colsep0 rowsep0" align="left">0.89</td><td class="colsep0 rowsep0" rowspan="2" align="left">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.57</td><td class="colsep0 rowsep0" align="left">0.99</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">MMC (Mitomycin C) was the positive control. At least 1000 binucleated cells scored for micronuclei per culture. No statistically significant increase in the frequency of micronucleusâbinucleus cells in the compound <b>46</b> treated group was observed at any concentration relative to the concurrent solvent control group (<i>p</i> > 0.05 by Fisherâs exact test), and no dose-related response was observed either.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Replication index (RI) = (number of binucleated cells + 2 Ã number of multinucleated cells)/total number of cells.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Cytotoxicity (%) = 100 â (RI of treated culture/RI of vehicle control) Ã 100.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Bone Marrow Micronucleus Analysis from the <i>in Vivo</i> Rat Micronucleus Study of <b>46</b><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">rat gender</th><th class="colsep0 rowsep0" align="center">time (h)</th><th class="colsep0 rowsep0" align="center">animal number</th><th class="colsep0 rowsep0" align="center">%Â PCE<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a> (mean Â± SD)</th><th class="colsep0 rowsep0" align="center">change from control (%)</th><th class="colsep0 rowsep0" align="center">%Â MnPCE<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a> (mean Â± SD)</th><th class="colsep0 rowsep0" align="center">number of MnPCE/20000PCEs scored</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle 0Â mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">46.9Â Â±Â 3.6</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.07Â Â±Â 0.05</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b> 500 mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">45.0Â Â±Â 7.0</td><td class="colsep0 rowsep0" align="left">â4</td><td class="colsep0 rowsep0" align="left">0.03Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b> 1000 mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">46.7Â Â±Â 6.1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.08Â Â±Â 0.04</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b> 2000 mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">45.2Â Â±Â 7.0</td><td class="colsep0 rowsep0" align="left">â4</td><td class="colsep0 rowsep0" align="left">0.09Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CP 40 mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">40.1Â Â±Â 2.2*</td><td class="colsep0 rowsep0" align="left">â14</td><td class="colsep0 rowsep0" align="left">3.19Â Â±Â 0.44**</td><td class="colsep0 rowsep0" align="left">638</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle 0Â mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">42.5Â Â±Â 5.1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.10Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b> 2000 mg/kg</td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">37.5Â Â±Â 4.7</td><td class="colsep0 rowsep0" align="left">â12</td><td class="colsep0 rowsep0" align="left">0.10Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="left">19</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Route of administration was oral (PO); *<i>p</i> < 0.05 or **<i>p</i> < 0.01 using one-way ANOVA with posthoc analysis or <i>t</i> test. The positive control article was cyclophosphamide monohydrate (CP); bone marrow collection time was 24 or 48 h postdose; vehicle = 1% CMC (medium viscosity) in deionized water. Compound <b>46</b> was found not to have a micronucleus risk at all three doses tested, and positive and negative control values were found as expected.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">PCE stands for polychromatic erythrocyte cells.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">MnPCE stands for micronucleated polychromatic erythrocyte cells.</p></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06318" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06318" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, this lead optimization program has discovered a new potent antimalarial agent, 6-(2-((3-hydroxy-3-methylazetidin-1-yl)carbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-7-methyl-2,1-benzoxaborole (<b>46</b>). This molecule had good pharmacokinetic properties and demonstrated excellent <i>in vivo</i> efficacies against <i>P. falciparum</i> (ED<sub>90</sub> = 0.85 mg/kg) and against <i>P. berghei</i> (ED<sub>90</sub> = 1.92 mg/kg) in infected mice. It was highly active against various multidrug resistant <i>P. falciparum</i> strains, indicating no cross-resistance and a possible novel mechanism of action. In addition, the rapid parasite <i>in vitro</i> reduction and <i>in vivo</i> clearance profile of <b>46</b> was similar to those of artemisinin and chloroquine. Exploratory safety studies demonstrated that it was Ames negative and micronucleus negative in both <i>in vitro</i> and <i>in vivo</i> models. On the basis of the current data, this novel benzoxaborole has been selected as a preclinical development candidate.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Methods</h3><div class="NLM_p last">Starting materials and solvents purchased from chemical companies were used without further purification except where noted. High performance liquid chromatography (HPLC) was used to determine the purity of the compounds synthesized. The data confirmed that the target compounds had â¥95% purity. Proton (<sup>1</sup>H) NMR spectra were recorded at room temperature on Bruker 300 or 400 instruments (Bruker Corporation, Billerica, Massachusetts, USA) using DMSO-<i>d</i><sub>6</sub> as solvent. Chemical shifts are given in parts per million (ppm). Electrospray ionizationâmass spectrometry (ESIâMS) and LCâMS were carried out on an API2000 (AB Sciex, Framingham, Massachusetts, USA) or a Finnigan LCQ mass spectrometer (Thermo Fisher Scientific, Waltham, Massachusetts, USA). HPLC was conducted on an Agilent 1200 system (Agilent Technologies, Santa Clara, California, USA) using a BDS Hypersil C-18 column (150 Ã 4.6 mm, 5 Î¼m, 120 nm pore size, Thermo Fisher Scientific, Waltham, Massachusetts, USA). The mobile phase used was composed of buffer A (H<sub>2</sub>O containing 0.1% phosphoric acid) and buffer B (CH<sub>3</sub>CN). The column was eluted with a gradient of 95% buffer A and 5% buffer B to 40% buffer A and 60% buffer B over 10 min, followed by 40% buffer A and 60% buffer B for 1 min, followed by a gradient over 1 min to 95% buffer A and 5% buffer B that was maintained for three more minutes at a flow rate of 1.0 mL/min with a column temperature of 30 Â°C and UV detection at 220 and 254 nm. Silica gel 60 nm (200â425 mesh, Thermo Fisher Scientific, Waltham, Massachusetts, USA) was used for flash column chromatography.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Care and Use of Experimental Animals</h3><div class="NLM_p last">Pharmacokinetic studies with experimental animals were designed and performed with reference to the guidelines of the Institutional Animal Care and Use Committee (Anacor Pharmaceuticals, Inc., AN-7-2007). The <i>in vivo</i> efficacy work with experimental animals was performed in accordance with the institutional guidelines as defined by the Institutional Animal Care and Use Committee (UCSF, AN109984).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Methods for Testing <i>in Vitro</i> Antimalarial Activity</h3><div class="NLM_p last">Experimental procedures used for determining <i>in vitro</i> antimalarial activities of the newly synthesized benzoxaboroles against a variety of <i>P. falciparum</i> parasite strains can be found in a previous report.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Method for Pharmacokinetics Measurement</h3><div class="NLM_p last">Female CD-1 mice, male SD rats, and beagle dogs received the benzoxaborole test material either by intravenous injection or by oral gavage in formulated solutions. The dose of <b>4</b>, <b>9</b>, <b>14</b>, <b>20</b>, and <b>46</b> was set at 5 mg/kg for both iv and oral, and the formulation used was polyethylene glycol 300, propylene glycol, and water (ratio 55/25/20, pH 6). Blood samples were collected and analyzed for drug content using HPLC coupled to tandem mass spectrometry.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Method for Testing <i>in Vivo</i> Efficacy Using a <i>P. berghei</i> Mouse Model</h3><div class="NLM_p last">Molecules <b>4</b>, <b>9</b>, <b>12</b>, <b>14</b>, <b>16</b>, <b>20</b>, <b>46</b>, <b>47</b>, <b>48</b>, <b>49</b>, <b>50</b>, and <b>51</b> were tested in a <i>P. berghei</i> mouse malaria model by following the method reported previously.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Method for Testing <i>in Vivo</i> Efficacy Using a <i>P. falciparum</i> Mouse Model</h3><div class="NLM_p last">Efficacies of compounds <b>14</b>, <b>46</b>, <b>47</b>, <b>49</b>, <b>50</b>, and <b>51</b> in a <i>P. falciparum</i> mouse malaria model were evaluated by using the method described previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Method of <i>in Vitro</i> Parasite Reduction Ratio (PRR) Assay</h3><div class="NLM_p last">The parasite reduction ratio parameters of molecule <b>46</b> were determined by using the procedures reported previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Method for Testing <b>46</b> in Bacterial Reverse Mutation Assay (Ames Assay)</h3><div class="NLM_p last">The study evaluated the potential of molecule <b>46</b> to induce reverse mutation in <i>Salmonella typhimurium</i> strains TA98, TA100, TA1535, and TA1537 and the <i>E. coli</i> strain WP2 <i>uvr</i>A in the presence and absence of an exogenous metabolic activation system (rat liver S9). The compound was dissolved in DMSO and tested using the plate incorporation method<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> at eight dose levels (1.5, 5, 15, 50, 150, 500, 1500, and 5000 Î¼g/plate). All positive and vehicle control values were within acceptable ranges, and all criteria for a valid assay were met.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methods of <i>in Vitro</i> and <i>in Vivo</i> Micronucleus Assays</h3><div class="NLM_p">The compound was tested in the <i>in vitro</i> micronucleus assay in human lymphocytes in the presence or absence of a rat liver S9 metabolic activation system to evaluate its clastogenic/aneugenic potential. A dose range-finding assay was performed to establish the dose range for the definitive micronucleus assay. In the dose range-finding assay, human lymphocytes were treated for 3 and 28 h in the absence of S9 and for 3 h in the presence of S9. All cells were harvested 28 h after initiation of test article treatment. The test article was dissolved in DMSO at concentrations up to 355.15 mg/mL (1 mM). No precipitate was observed in the treatment medium at any concentration at the beginning and the end of the treatment period. Single cultures of human lymphocytes were incubated with the compound at 0.5, 1, 2.5, 5, 10, 25, 50, 100, 200, and 355 Î¼g/mL in all three exposure series. Selection of concentrations for the definitive micronucleus assay was based on the cytotoxicity of the test article relative to the concurrent solvent control. At least 1000 binucleated cells for each culture and 2000 for each concentration were scored. The validity of the assay was confirmed.</div><div class="NLM_p last">The <i>in vivo</i> mammalian erythrocyte micronucleus assay in rats was conducted according to established procedures.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> The test article was evaluated for its clastogenic activity and/or disruption of the mitotic apparatus by detecting micronuclei in polychromatic erythrocyte cells in rat bone marrow. Carboxymethylcellulose (CMC, 1%, medium viscosity) in deionized water was used as the vehicle. Test and control article formulations were administered at a dose volume of 10 mL/kg via oral gavage. In the dose range-finding assay, doses tested were 500, 1000, and 2000 mg/kg in three male rats/group. No mortality occurred at any dose. All animals appeared normal throughout the observation period. Therefore, the maximum tolerable dose for the definitive micronucleus assay was set at 2000 mg/kg, which is the maximum regulatory required dose. In the definitive assay, the study was designed to include eight groups (five rats/group): two vehicle groups for euthanasia 24 and 48 h after treatment, one 500 mg/kg/day group and one 1000 mg/kg/day for euthanasia at 24 h, two 2000 mg/kg/day groups for euthanasia at 24 and 48 h, one positive control (cyclophosphamide monohydrate, CP) group, and one vinblastine positive control group for CREST analysis. Femoral bone marrow was collected at approximately 24 or 48 h after the dose. Animals were euthanized by carbon dioxide inhalation. Immediately following euthanasia, the femurs were exposed and cut just above the knee. The bone marrow was transferred to a centrifuge tube containing approximately 2 mL of fetal bovine serum, and the cells were pelleted by centrifugation. The supernatant was drawn off leaving a small amount of fetal bovine serum with the pellet. Four precolumn slides for micronucleus evaluation and two postcolumn slides for CREST analysis were prepared from each animal. The slides were air-dried and fixed by dipping in methanol. One set of two precolumn slides was stained with acridine orange for microscopic evaluation. The other set of slides was kept as backup. Postcolumn slides for potential CREST staining were prepared by processing the remaining bone marrow suspensions through a cellulose column containing 0.6 g of a 50:50 mixture of cellulose type 50 and Î±-cellulose (one column per animal) and using 6 mL of fetal bovine serum as the eluate. Eluted cells were pelleted by centrifugation, and the supernatant was drawn off leaving a small amount of fetal bovine serum with the pellet. The cell pellet was resuspended for slide preparation. Two postcolumn slides per animal were prepared at relatively high cell density and stored at â10 to â30 Â°C for CREST analysis. Each pre- and postcolumn slide was identified by the harvest date, study number, and animal number. Slides were coded using a random number table by an individual not involved with the scoring process. Post-column slides were reserved only for CREST analysis. Initially, one set of postcolumn slides was stained with acridine orange for micronucleus evaluation, and the other set was kept as backup.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methods for the Syntheses of Final Amide Benzoxaborole Compounds <b>3</b>â<b>51</b></h3><div id="sec5_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> General Method A (Substitution Method)</h4><div class="NLM_p last">This method involved a substitution reaction between the benzoxaborole intermediate <b>58</b> and an amide intermediate <b>120</b> in the final step. Representative experimental procedures are described below. 7-Methylbenzo[<i>c</i>][1,2]oxaborole-1,6(3<i>H</i>)-diol (<b>58</b>), 5-chloropyrazine-2-carboxamide (<b>120</b>, 1.1 equiv), Cs<sub>2</sub>CO<sub>3</sub> (2.5 equiv), and DMF were added to a 3-necked flask. The reaction mixture was stirred at 40â50 Â°C until completion as monitored by HPLC. Water was added, and then HCl (0.2 N) was added dropwise to the mixture. It was stirred for 20 min, while a white solid was precipitated. It was filtered, and the solid cake was dissolved in NaOH (1 N) and extracted by dichloromethane. The separated inorganic layer was acidified by HCl (1 N) to pH 3, and the white solid precipitate was collected by filtration. The solid cake was stirred in water for 30 min and filtered, and then, the solid was stirred in acetone and filtered. The solid was dried under high vacuum to give the desired product. If the compound did not meet the HPLC purity requirement (â¥95%), it was further purified by column chromatography so that the material reached â¥95% purity by HPLC.</div></div><div id="sec600" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Method B (Amidation Method)</h4><div class="NLM_p last">This method included an amidation reaction from the benzoxaborole acid intermediate <b>123</b> and an amine intermediate in the final step. Representative experimental procedures are described below. To a solution of 5-chloropyrazine-2-carboxylic acid (7.9 g, 50 mmol) in MeOH (50 mL) was added SOCl<sub>2</sub> (3.0 g, 25 mmol) dropwise at 0 Â°C. The reaction mixture was stirred at 70 Â°C for 2 h and then concentrated under the reduced pressure to give methyl 5-chloropyrazine-2-carboxylate (4.5 g) as a white solid which was used in the next step without further purification. MS (ESI+): <i>m</i>/<i>z</i> = 173 (M + 1). A solution of this intermediate (2.9 g, 16.86 mmol), 7-methylbenzo[<i>c</i>][1,2]oxaborole-1,6(3<i>H</i>)-diol (1.94 g, 11.80 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (7.74 g, 23.60 mmol) in DMF (20 mL) was stirred at rt for 4 h. The mixture was poured into water (500 mL), and the solid was collected. The solid was dried under reduced pressure to give methyl 5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazine-2-carboxylate (2.6 g, yield 73%) as a light-brown solid. MS (ESI+): <i>m</i>/<i>z</i> = 301 (M + 1). To a solution of this ester intermediate (2.6 g, 8.7 mmol) in MeOH (30 mL) was added 1 N LiOH (34 mL). The reaction mixture was stirred at rt for 3 h, and then 1 N HCl was added to pH 5. The solid was collected and dried under reduced pressure to give the acid <b>123</b> (2.3 g, yield 93%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 13.40 (br. s, 1H), 9.09 (s, 1H), 8.73â8.72 (m, 1H), 8.68â8.67 (m, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.27 (d, <i>J</i> = 8.4 Hz, 1H), 5.01 (s, 2H), 2.24 (s, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 287 (M + 1). To a solution of <b>123</b> (100 mg, 0.35 mmol) and DIPEA (135 mg, 1.05 mmol) in DMF (3 mL) was added HATU (200 mg, 0.53 mmol). The reaction mixture was stirred at rt for 30 min, and then the corresponding amine (0.35 mmol) was added. The reaction mixture was stirred at rt overnight. The crude product obtained from a normal workup was purified by prep-HPLC to give the final product as a solid.</div></div><div id="sec5_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(2-methoxyethyl) pyrazine-2-carboxamide (<b>3</b>)</h4><div class="NLM_p last">To a solution of 5-chloropyrazine-2-carboxylic acid (2.0 g, 12.62 mmol) in DCM (42 mL) was added SOCl<sub>2</sub> (42 mL) at room temperature. The reaction was stirred at 50 Â°C overnight and then concentrated directly. To a solution of the residue in pyridine (42 mL) was added 2-methoxyethylamine (1.69 g, 22.52 mmol, 1.78 equiv) at room temperature. The reaction was stirred at 50 Â°C for 3 h. The mixture was poured into water (100 mL), and then extracted with EA (3 Ã 50 mL). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum to give the residue of 5-chloro-<i>N</i>-(2-methoxyethyl)pyrazine-2-carboxamide, which was used in the next step without further purification. The final step was conducted by following the procedure described in general method A. It was obtained in 13% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.66 (s, 1H), 8.62â8.59 (m, 1H), 8.60 (s, 1H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.25 (d, <i>J</i> = 8.1 Hz, 1H), 4.99 (s, 2H), 3.55â3.40 (m, 4H), 3.26 (s, 3H), 2.22 (s, 3H) ppm. HPLC purity: 98.2% at 220 nm and 96.9% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 344 (M + 1).</div></div><div id="sec5_10_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(2-hydroxyethyl) Pyrazine-2-carboxamide (<b>4</b>)</h4><div class="NLM_p last">To a solution of 5-chloropyrazine-2-carboxylic acid (500 mg, 3.16 mmol) and TEA (352 mg, 3.47 mmol, 1.1 equiv) in DCM (15.8 mL) was added isobutyl chloroformate (944 mg, 6.96 mmol, 1.1 equiv) at 0 Â°C. The reaction mixture was stirred for 20 min. Then, 2-aminoethanol (231 mg, 3.79 mmol, 1.2 equiv) was added at 0 Â°C, and the reaction mixture was stirred at rt for 1 h. After completion, the mixture was poured into water (100 mL) and extracted with DCM (2 Ã 20 mL). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified by column chromatography to give 5-chloro-<i>N</i>-(2-hydroxyethyl)pyrazine-2-carboxamide (480 mg, 75% yield) as a white solid. The next step was conducted by following general method A. The final product was obtained in 51% yield of the final step as an off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.05 (s, 1H), 8.65 (s, 1H), 8.59 (s, 1H), 8.58â8.55 (m, 1H), 7.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 1H), 4.98 (s, 2H), 4.76 (t, <i>J</i> = 5.4 Hz, 1H), 3.54â3.48 (m, 2H), 3.39â3.30 (m, 2H), 2.21 (s, 3H) ppm. HPLC purity: 99.6% at 220 nm and 99.3% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 330 (M + 1).</div></div><div id="sec5_10_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(2-hydroxypropyl) Pyrazine-2-carboxamide (<b>5</b>)</h4><div class="NLM_p last">This compound was synthesized by using 2-hydroxypropylamine as a starting material and following the procedures used for analogue <b>3</b>. It was obtained in 29% yield of the final step as a solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.06 (s, 1H), 8.66 (d, <i>J</i> = 1.2 Hz, 1H), 8.60 (d, <i>J</i> = 1.2 Hz, 1H), 8.48 (t, <i>J</i> = 6.0 Hz, 1H), 7.29 (d, <i>J</i> = 8 Hz, 1H), 7.25 (d, <i>J</i> = 8 Hz, 1H), 4.98 (s, 2H), 4.82 (d, <i>J</i> = 4.8 Hz, 1H), 3.83â3.76 (m, 1H), 3.28â3.19 (m, 2H), 2.22 (s, 3H), 1.06 (d, <i>J</i> = 6.0 Hz, 3H) ppm. HPLC purity: 99.1% at 220 nm and 98.9% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 344 (M + 1).</div></div><div id="sec5_10_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(2-Hydroxy-2-methylpropyl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxa-borole-6-yloxy)pyrazine-2-carboxamide (<b>6</b>)</h4><div class="NLM_p last">This compound was synthesized by using 2-hydroxy-2-methylpropylamine as a starting material and following the procedures used for analogue <b>7</b>. It was obtained in 68% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.68 (s, 1H), 8.64 (s, 1H), 8.25â8.40 (m, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.73 (s, 1H), 3.28 (d, <i>J</i> = 6.3 Hz, 2H), 2.22 (s, 3H), 1.11 (s, 6H) ppm. HPLC purity: 99.5% at 220 nm and 99.2% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 358 (M + 1).</div></div><div id="sec5_10_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(1-Hydroxy-2-methylpropan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborole-6-yloxy)pyrazine-2-carboxamide (<b>7</b>)</h4><div class="NLM_p last">This compound was synthesized by using 1-hydroxy-2-methylpropan-2-yl amine as a starting material and following the procedures used for analogue <b>3</b>. It was obtained in 38% yield of the final step as a solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.04 (s, 1H), 8.65 (s, 1H), 8.57 (s, 1H), 7.94 (s, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 1H), 5.13 (t, <i>J</i> = 5.0 Hz, 1H), 4.98 (s, 2H), 3.45 (d, <i>J</i> = 5.0 Hz, 2H), 2.21 (s, 3H), 1.35 (s, 6H) ppm. HPLC purity: 97.8% at 220 nm and 96.8% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 358 (M + 1).</div></div><div id="sec5_10_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-(hydroxymethyl)cyclopropyl)pyrazine-2-carboxamide (<b>8</b>)</h4><div class="NLM_p last">This compound was synthesized by using 1-(hydroxymethyl)cyclopropylamine as a starting material and following the procedures used for analogue <b>3</b>. It was obtained in 24% yield of the final step as a solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.67 (s, 1H), 8.64 (s, 1H), 8.57 (s, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.71 (t, <i>J</i> = 5.7 Hz, 1H), 3.52 (d, <i>J</i> = 5.7 Hz, 2H), 2.21 (s, 3H), 0.78 (s, 4H) ppm. HPLC purity: 96.5% at 220 nm and 99.2% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 356 (M + 1).</div></div><div id="sec5_10_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxypropan-2-yl)pyrazine-2-carboxamide (<b>9</b>)</h4><div class="NLM_p last">This compound was synthesized by using 2-aminopropan-1-ol as a starting material and following the procedures used for analogue <b>4</b>. It was obtained in 57% yield of the final step as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.04 (s, 1H), 8.66 (s, 1H), 8.59 (s, 1H), 8.27 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (d, <i>J</i> = 8.3 Hz, 1H), 7.25 (d, <i>J</i> = 8.3 Hz, 1H), 4.98 (s, 2H), 4.80 (t, <i>J</i> = 5.5 Hz, 1H), 4.10â4.00 (m, 1H), 3.50â3.40 (m, 2H), 2.22 (s, 3H), 1.15 (d, <i>J</i> = 7.0 Hz, 3H) ppm. HPLC purity: 96.5% at 220 nm and 95.1% at 254 nm; Mass (ESI+): <i>m</i>/<i>z</i> = 344 (M + 1).</div></div><div id="sec5_10_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy propan-2-yl)pyrazine-2-carboxamide (<b>10</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>R</i>)-2-aminopropan-1-ol as a starting material and following the procedures used for analogue <b>4</b>. It was obtained in 40% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (s, 1H), 8.60 (s, 1H), 8.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.83 (t, <i>J</i> = 5.5 Hz, 1H), 4.10â4.00 (m, 1H), 3.50â3.40 (m, 2H), 2.22 (s, 3H), 1.15 (d, <i>J</i> = 6.6 Hz, 3H) ppm. HPLC purity: 99.3% at 220 nm and 99.7% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 344 (M + 1).</div></div><div id="sec5_10_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>S</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy propan-2-yl)pyrazine-2-carboxamide (<b>11</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>S</i>)-2-aminopropan-1-ol as a starting material and following the procedures used for analogue <b>4</b>. It was obtained in 10% yield of the final step as a solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (s, 1H), 8.60 (s, 1H), 8.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.83 (t, <i>J</i> = 5.7 Hz, 1H), 4.10â4.00 (m, 1H), 3.50â3.40 (m, 2H), 2.22 (s, 3H), 1.15 (d, <i>J</i> = 6.6 Hz, 3H) ppm. HPLC purity: 99.3% at 220 nm and 99.6% at 254 nm. Chiral HPLC purity: 99.8% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 344 (M + 1).</div></div><div id="sec5_10_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy butan-2-yl)pyrazine-2-carboxamide (<b>12</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>R</i>)-2-aminobutan-1-ol as a starting material and following the procedures used for analogue <b>4</b>. It was obtained in 59% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (s, 1H), 8.61 (s, 1H), 8.23 (d, <i>J</i> = 9.0 Hz, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 4.99 (s, 2H), 4.77 (t, <i>J</i> = 5.6 Hz, 1H), 3.95â3.80 (m, 1H), 3.50â3.35 (m, 2H), 2.22 (s, 3H), 1.75â1.45 (m, 2H), 0.86 (t, <i>J</i> = 7.5 Hz, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 358 (M + 1).</div></div><div id="sec5_10_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy butan-2-yl)pyrazine-2-carboxamide (<b>13</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>S</i>)-2-aminobutan-1-ol as a starting material and following the procedures used for analogue <b>4</b>. It was obtained in 59% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (s, 1H), 8.61 (s, 1H), 8.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 4.99 (s, 2H), 4.78 (t, <i>J</i> = 5.0 Hz, 1H), 3.95â3.80 (m, 1H), 3.60â3.40 (m, 2H), 2.22 (s, 3H), 1.75â1.45 (m, 2H), 0.86 (t, <i>J</i> = 7.4 Hz, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 358 (M + 1).</div></div><div id="sec5_10_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy pentan-2-yl)pyrazine-2-carboxamide (<b>14</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-2-aminopentanoic acid (10 g, 85.4 mmol) in THF (200 mL) was added NaBH<sub>4</sub> (10g, 85.4 mmol, 2.4 equiv) at 0 Â°C under N<sub>2</sub>. A solution of I<sub>2</sub> (21.7 g, 85.4 mmol, 1 equiv) in THF (85 mL) was added dropwise into the mixture for 40 min until no gas was generated from the mixture. The reaction mixture was stirred overnight at 70 Â°C. After completion, methanol was added dropwise until the mixture was clear. It was added with 20% KOH (150 mL) and stirred for 4 h. The mixture was diluted with H<sub>2</sub>O (100 mL) and extracted with DCM (3 Ã 150 mL). The organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> After filtration, the filtrate was concentrated to give (<i>R</i>)-2-aminopentan-1-ol (8.1 g, 92% yield). A solution of (<i>R</i>)-2-aminopentan-1-ol (6 g, 58.1 mmol) in 4 N HCl MeOH (150 mL) was stirred at rt for 40 min. The residue after rotary evaporation was mixed with 40% EA/PE (150 mL). The precipitated solid was collected by filtration to give the (<i>R</i>)-2-aminopentan-1-ol HCl salt (4.6 g, 56.6% yield). To a solution of 5-chloropyrazine-2-carboxylic acid (1.13 g, 7.16 mmol) in NMP (48 mL) was added dropwise a solution of (<i>R</i>)-2-aminopentan-1-ol hydrochloride (1 g, 7.16 mmol, 1 equiv) and 2-chloro-1-methylpyridinium iodide (CMPI, 4.6 g, 18 mmol, 2.5 equiv) in NMP (5 mL) with stirring under N<sub>2</sub>. The reaction was stirred at rt for 2 h. After completion, the reaction was diluted with H<sub>2</sub>O (150 mL), adjusted to pH 3â4 with 1 N HCl, and extracted with EA (2 Ã 150 mL). The organic phases were washed with brine (3 Ã 250 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4.</sub> The residue after rotary evaporation was purified by column chromatography to give (<i>R</i>)-5-chloro-<i>N</i>-(1-hydroxypentan-2-yl)pyrazine-2-carboxamide (1.73g, 99% yield). The final step was conducted by following general method A. The product was obtained in 63% yield of the final step as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.66 (d, <i>J</i> = 1.0 Hz, 1H), 8.61 (d, <i>J</i> = 1.0 Hz, 1H), 8.24 (d, <i>J</i> = 9.0 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.78 (t, <i>J</i> = 5.5 Hz, 1H), 4.01â3.94 (m, 1H), 3.51â3.45 (m, 1H), 3.45â3.40 (m, 1H), 2.22 (s, 3H), 1.61â1.45 (m, 2H), 1.40â1.20 (m, 2H), 0.87 (t, <i>J</i> = 6.9 Hz, 3H) ppm. HPLC purity: 99.2% at 220 nm and 99.3% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 372 (M + 1).</div></div><div id="sec5_10_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxypentan-2-yl)pyrazine-2-carboxamide (<b>15</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>S</i>)-2-aminopentanoic acid as a starting material and following the procedures used for the isomer <b>14</b>. It was obtained in 31% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (s, 1H), 8.60 (s, 1H), 8.22 (d, <i>J</i> = 9.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.77 (t, <i>J</i> = 5.5 Hz, 1H), 4.05â3.90 (m, 1H), 3.55â3.35 (m, 2H), 2.22 (s, 3H), 1.68â1.40 (m, 2H), 1.40â1.20 (m, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H) ppm. HPLC purity: 99.7% at 220 nm and 99.5% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 372 (M + 1).</div></div><div id="sec5_10_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-<i>N</i>-(1-Hydroxy-3-methylbutan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] Oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>16</b>)</h4><div class="NLM_p last">This compound was synthesized by using <span class="smallcaps smallerCapital">d</span>-valine as a starting material and following the procedures used for analogue <b>14</b>. It was obtained in 20% yield of the final step as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.67 (s, 1H), 8.62 (s, 1H), 8.13 (d, <i>J</i> = 9.5 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.72 (t, <i>J</i> = 5.5 Hz, 1H), 3.82â3.70 (m, 1H), 3.65â3.49 (m, 2H), 2.22 (s, 3H), 1.98â1.92 (m, 1H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H), 0.87 (d, <i>J</i> = 6.5 Hz, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 372 (M + 1).</div></div><div id="sec5_10_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-<i>N</i>-(1-Hydroxy-3-methylbutan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>17</b>)</h4><div class="NLM_p last">This compound was synthesized by using <span class="smallcaps smallerCapital">l</span>-valine as a starting material and following the procedures used for analogue <b>14</b>. It was obtained in 36% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.67 (s, 1H), 8.62 (s, 1H), 8.13 (d, <i>J</i> = 9.5 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.72 (t, <i>J</i> = 5.5 Hz, 1H), 3.85â3.70 (m, 1H), 3.65â3.45 (m, 2H), 2.22 (s, 3H), 2.02â1.88 (m, 1H), 0.92 (d, <i>J</i> = 6.6 Hz, 3H), 0.87 (d, <i>J</i> = 6.6 Hz, 3H) ppm. HPLC purity: 99.8% at 220 nm and 99.6% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 372 (M + 1).</div></div><div id="sec5_10_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>R</i>)-<i>N</i>-(1-Cyclopropyl-2-hydroxyethyl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] Oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>18</b>)</h4><div class="NLM_p last">To a solution of cyclopropanecarbaldehyde (7.0 g, 99.12 mmol, 1.2 equiv) in DCM (138 mL) were added Ti(OEt)<sub>4</sub> (22.6 g, 99.12 mmol, 1.2 equiv) and (<i>S</i>)-2-methylpropane-2-sulfinamide (10 g, 82.6 mmol) at rt. The mixture was stirred at 50 Â°C overnight and then was poured into saturated NaHCO<sub>3</sub> (138 mL) and diatomite (30 g) with good stirring for 0.5 h. The mixture was filtered and separated. The organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum to give (<i>S</i>,<i>E</i>)-<i>N</i>-(cyclopropylmethylene)-2-methylpropane-2-sulfinamide (12.5 g, 87% yield) as an oil. To a mixture of Mg (2.86 g, 119.16 mmol, 1.65 equiv) in dry THF (75 mL) were added I<sub>2</sub> (40 mg) and (chloromethyl)(isopropoxy)dimethylsilane (6.0 g, 36.11 mmol, 0.5 equiv) under N<sub>2</sub>. The mixture was refluxed for 1 h, and then additional (chloromethyl)(isopropoxy)dimethylsilane (12 g, 72.22 mmol, 1.0 equiv) was added dropwise. The reaction mixture was refluxed for 2 h. A solution of (<i>S</i>,<i>E</i>)-<i>N</i>-(cyclopropylmethylene)-2-methylpropane-2-sulfinamide (12.5 g, 72.22 mmol, 1.0 equiv) in dry THF (38 mL) was added to the reaction mixture at â20 Â°C under N<sub>2</sub>. The mixture was stirred at rt for 1 h, poured into water (300 mL), and extracted with EA (3 Ã 100 mL). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum to give (<i>S</i>)-<i>N</i>-((<i>R</i>)-1-cyclopropyl-2-(isopropoxydimethylsilyl)ethyl)-2-methylpropane-2-sulfinamide (22.5 g, 100% yield) as an oil. To a solution of this intermediate (22.3 g, 73.07 mmol) in a mixed solution [MeOH (53.5 mL)/THF (53.5 mL)] were added KHCO<sub>3</sub> (7.32 g, 73.07 mmol, 1 equiv), KF (8.5 g, 146.14 mmol, 2 equiv), and H<sub>2</sub>O<sub>2</sub> (22.3 mL) under N<sub>2</sub> at 0 Â°C. The reaction mixture was stirred at 45 Â°C for 2 h, poured into water (300 mL), and extracted with EA (3 Ã 100 mL). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified by column chromatography to give (<i>S</i>)-<i>N</i>-((<i>R</i>)-1-cyclopropyl-2-hydroxyethyl)-2-methylpropane-2-sulfinamide (10 g, 67% yield) as a white solid. To a solution of this intermediate (2 g, 9.75 mmol) in MeOH (50 mL) was added 1 N HCl (24 mL) at 0 Â°C. The reaction was stirred at room temperature for 2 h and concentrated in vacuum to give (<i>R</i>)-2-amino-2-cyclopropylethan-1-ol hydrochloride (1.3 g, 100% yield) as a white solid that was used in the next step without further purification. The subsequent reactions were conducted by following the corresponding procedures used for analogue <b>14</b>. Compound <b>18</b> was obtained in 12% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.64 (s, 1H), 8.60 (s, 1H), 8.37 (d, <i>J</i> = 9.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 1H), 4.97 (s, 2H), 4.78 (t, <i>J</i> = 5.5 Hz, 1H), 3.65â3.50 (m, 2H), 3.40â3.30 (m, 1H), 2.20 (s, 3H), 1.10â1.00 (m, 1H), 0.50â0.20 (m, 4H) ppm. HPLC purity: 99.6% at 220 nm and 99.7% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>S</i>)-<i>N</i>-(1-Cyclopropyl-2-hydroxyethyl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] Oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>19</b>)</h4><div class="NLM_p last">This compound was prepared by following the methodology similar to that described above for <b>18</b> using (<i>R</i>)-2-methylpropane-2-sulfinamide to replace (<i>S</i>)-2-methylpropane-2-sulfinamide in the first step. Compound <b>19</b> was obtained in 6% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.66 (s, 1H), 8.61 (s, 1H), 8.37 (d, <i>J</i> = 9.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.79 (t, <i>J</i> = 5.5 Hz, 1H), 3.65â3.50 (m, 2H), 3.50â3.32 (m, 1H), 2.22 (s, 3H), 1.10â1.00 (m, 1H), 0.50â0.20 (m, 4H) ppm. HPLC purity: 96.6% at 220 nm and 95.9% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(4,4,4-trifluoro-1-hydroxybutan-2-yl)pyrazine-2-carboxamide (<b>20</b>)</h4><div class="NLM_p last">To a solution of 5-chloropyrazine-2-carboxylic acid (372 mg, 2.35 mmol) and HATU (1.07 g, 2.82 mmol) in DMF (10 mL) was added DIPEA (606 mg, 4.97 mmol). The mixture was stirred at rt for 30 min, and then 2-amino-4,4,4-trifluorobutan-1-ol hydrochloride (506 mg, 2.82 mmol) was added. The resulting mixture was stirred at rt for 1 h. Water (30 mL) was added, and the solution was extracted with EA (3 Ã 50 mL). The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by Combiflash (PE/EA = 1:1) to give 5-chloro-<i>N</i>-(4,4,4-trifluoro-1-hydroxybutan-2-yl)pyrazine-2-carboxamide (435 mg, 65%) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 284.0 (M + 1). For the next step, the racemic compound was prepared by general method A in 57% yield of the final step. Chiral HPLC method was used for the separation of the racemic mixture, and the chiral HPLC condition is shown as following: instrument SFC-80 (Thar, Waters), column CHIRALPAK AD 20 Ã 250 mm, 5 Î¼m, column temperature 35 Â°C, mobile phase CO<sub>2</sub>/methanol = 70/30, flow rate 80g/min, back pressure 100 bar, detection wavelength 214 or 230 nm, cycle time 6.0 min, sample solution 300 mg in 60 mL of MeOH, and injection volume of 4.5 mL (loading 23 mg per injection). The separation gave the enantiomer <b>20</b> in 94.4% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.74 (d, <i>J</i> = 8.8 Hz, 1H), 8.67 (d, <i>J</i> = 1.2 Hz, 1H), 8.63 (d, <i>J</i> = 1.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.2 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 1H), 5.12 (t, <i>J</i> = 6.0 Hz, 1H), 4.99 (s, 2H), 4.36â4.32 (m, 1H), 3.50â3.46 (m, 1H), 3.45â3.39 (m, 1H), 2.72â2.57 (m, 2H), 2.22 (s, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 412 (M + 1).</div></div><div id="sec5_10_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>S</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(4,4,4-trifluoro-1-hydroxybutan-2-yl)pyrazine-2-carboxamide (<b>21</b>)</h4><div class="NLM_p last">The racemic compound was prepared by the methodology described above for <b>20</b>. Chiral HPLC separation gave the enantiomer <b>21</b> in 18.4% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.73 (d, <i>J</i> = 9.6 Hz, 1H), 8.67 (d, <i>J</i> = 1.2 Hz, 1H), 8.63 (d, <i>J</i> = 1.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.2 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 1H), 5.11 (t, <i>J</i> = 6.0 Hz, 1H), 4.99 (s, 2H), 4.39â4.30 (m, 1H), 3.49â3.45 (m, 1H), 3.43â3.38 (m, 1H), 2.72â2.59 (m, 2H), 2.22 (s, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 98.8% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 412 (M + 1).</div></div><div id="sec5_10_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(5,5,5-trifluoro-1-hydroxypentan-2-yl)pyrazine-2-carboxamide (<b>22</b>)</h4><div class="NLM_p last">At â25 Â°C, 2,6-lutidine (1.41 g, 13.2 mmol) in DCM (50 mL) was mixed with Tf<sub>2</sub>O (3.47 g, 12.3 mmol), and the mixture was stirred for 5 min. To the mixture was added 3,3,3-trifluoropropan-1-ol (1.0 g, 8.8 mmol). After 2 h, it was warmed to rt and stirred for 1 h. The solvent was removed, and the residue was purified by silica gel column chromatography using PE/EA = 2:1 to give 3,3,3-trifluoropropyl trifluoromethanesulfonate (460 mg, yield 21%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 4.73â4.70 (m, 2H), 2.72â2.65 (m, 2H) ppm. A solution of <i>tert</i>-butyl 2-(diphenylmethyleneamino)acetate (424 mg, 1.44 mmol) in THF (20 mL) was cooled to â78 Â°C and treated dropwise with LDA (2 M in THF, 1.08 mL, 2.16 mmol), and then added to 3,3,3-trifluoropropyl trifluoromethanesulfonate (460 mg, 1.87 mmol) in THF (2 mL) dropwise. The reaction mixture was gradually warmed to rt and stirred for 4 h. The reaction was quenched with saturated NH<sub>4</sub>Cl (50 mL) at 0 Â°C and then extracted with ethyl acetate (2 Ã 100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using PE/EA = 40:1 to give <i>tert</i>-butyl 2-(diphenylmethyleneamino)-5,5,5-trifluoropentanoate (400 mg, yield 71%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): Î´ 7.66â7.16 (m, 10H), 3.98 (t, 1H), 2.18â2.07 (m, 4H), 1.43 (s, 9H) ppm. A solution of this intermediate (400 mg, 1.02 mmol) in 50% HCl (5 mL) was refluxed overnight. Water was removed to give 2-amino-5,5,5-trifluoropentanoic acid hydrochloride (210 mg, yield 99%) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 172 (M + 1). To a solution of 2-amino-5,5,5-trifluoropentanoic acid hydrochloride (210 mg, 1.0 mmol) in THF (10 mL) was added LAH (76 mg, 2.0 mmol). The mixture was stirred at 70 Â°C overnight. Several drops of water were added, and the mixture was filtered. The filtrate was concentrated under reduced pressure. 4 N HCl 1,4-dioxane solution (2 mL) was added at rt and stirred for 30 min. Water (10 mL) was added, and then, the mixture was extracted with EtOAc (2 Ã 10 mL). The aqueous layer was freeze-dried to give 2-amino-5,5,5-trifluoropentan-1-ol hydrochloride (150 mg, yield 77%) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 158 (M + 1). The subsequent reactions and chiral separation were performed by following the procedures described above for <b>20</b>. Compound <b>22</b> was obtained in 30% yield of the final step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.67 (s, 1H), 8.62 (s, 1H), 8.49 (d, <i>J</i> = 9.2 Hz, 2H), 7.30 (d, <i>J</i> = 8.2 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 1H), 4.99 (s, 2H), 4.93 (t, <i>J</i> = 6.0 Hz, 1H), 4.05â4.01 (m, 1H), 3.51â3.45 (m, 2H), 2.30â2.20 (m, 2H), 2.22 (s, 3H), 1.88â1.74 (m, 2H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 426 (M + 1).</div></div><div id="sec5_10_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>S</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(5,5,5-trifluoro-1-hydroxypentan-2-yl)pyrazine-2-carboxamide (<b>23</b>)</h4><div class="NLM_p last">This (<i>S</i>)-isomer was obtained by a chiral HPLC separation from its racemic mixture as described above for <b>22</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.67 (s, 1H), 8.62 (s, 1H), 8.49 (d, <i>J</i> = 9.2 Hz, 2H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.26 (d, <i>J</i> = 8.3 Hz, 1H), 4.99 (s, 2H), 4.94 (t, <i>J</i> = 6.0 Hz, 1H), 4.05â4.01 (m, 1H), 3.51â3.45 (m, 2H), 2.30â2.20 (m, 2H), 2.22 (s, 3H), 1.88â1.74 (m, 2H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 98.1% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 426 (M + 1).</div></div><div id="sec5_10_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy hexan-2-yl)pyrazine-2-carboxamide (<b>24</b>)</h4><div class="NLM_p last">This compound was synthesized by following the procedures used for analogue <b>14</b> with (<i>R</i>)-2-aminohexanoic acid as the starting material. Compound <b>24</b> was obtained in 23% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (s, 1H), 8.60 (s, 1H), 8.23 (d, <i>J</i> = 9.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 4.99 (s, 2H), 4.77 (t, <i>J</i> = 5.5 Hz, 1H), 3.98â3.85 (m, 1H), 3.55â3.35 (m, 2H), 2.22 (s, 3H), 1.70â1.42 (m, 2H), 1.35â1.15 (m, 4H), 0.85 (m, 3H) ppm. HPLC purity: 99.2% at 220 nm and 98.9% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 386 (M + 1).</div></div><div id="sec5_10_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>R</i>)-<i>N</i>-(2-Hydroxy-1-phenylethyl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxa borol-6-yloxy)pyrazine-2-carboxamide (<b>25</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>R</i>)-2-amino-2-phenylethan-1-ol as the starting material and following the procedures used for analogue <b>14</b>. Compound <b>25</b> was obtained in 33% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.92 (d, <i>J</i> = 8.4 Hz, 1H), 8.65 (s, 1H), 8.64 (s, 1H), 7.40â7.23 (m, 7H), 5.10â5.00 (m, 2H), 4.98 (s, 2H), 3.85â3.70 (m, 2H), 2.22 (s, 3H) ppm. HPLC purity: 99.9% at 220 nm and 99.8% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 406 (M + 1).</div></div><div id="sec5_10_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>R</i>)-<i>N</i>-(1-Hydroxy-3-phenylpropan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] Oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>26</b>)</h4><div class="NLM_p last">This compound was synthesized by using (<i>R</i>)-2-amino-3-phenylpropan-1-ol as a starting material and following the procedures used for analogue <b>14</b>. Compound <b>26</b> was obtained in 60% yield of the final step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.60 (s, 2H), 8.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.33â7.22 (m, 6H), 7.21â7.13 (m, 1H), 4.98 (s, 2H), 4.93 (t, <i>J</i> = 5.5 Hz, 1H), 4.25â4.15 (m, 1H), 3.52â3.41 (m, 2H), 2.98â2.84 (m, 2H), 2.21 (s, 3H) ppm. HPLC purity: 98.7% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 240 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 420 (M + 1).</div></div><div id="sec5_10_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-<i>N</i>-(1-Hydroxy-3-methoxypropan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>27</b>)</h4><div class="NLM_p last">To a solution of benzonitrile (10 g, 97 mmol) in CH<sub>3</sub>CH<sub>2</sub>OH (54 g, 1164 mmol) was added acetyl chloride (61 g, 776 mmol) at 0 Â°C. The reaction mixture was stirred at 25 Â°C overnight. Aqueous NaHCO<sub>3</sub> solution was added at 0 Â°C until no gas was generated. The solution was extracted with ether (3 Ã 100 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give ethyl benzimidate (11g) as a crude yellow oil which was used in next step without further purification. MS (ESI+): <i>m</i>/<i>z</i> = 150 (M + 1). To a solution of ethyl benzimidate (8.3 g, 55.8 mmol) in 1,2-dichloroethane (30 mL) was added (<i>S</i>)-methyl 2-amino-3-hydroxypropanoate hydrochloride (9.52 g, 61.38 mmol). The reaction mixture was stirred at 84 Â°C overnight. The solvent was removed under reduced pressure to give methyl (<i>S</i>)-2-phenyl-4,5-dihydrooxazole-4-carboxylate (10.6 g) as a crude yellow oil which was used in the next step without further purification. MS (ESI+): <i>m</i>/<i>z</i> = 206 (M + 1). To a solution of LiAlH<sub>4</sub> (2.9 g, 77.5 mmol) in THF (70 mL) was added methyl (<i>S</i>)-2-phenyl-4,5-dihydrooxazole-4-carboxylate (10.6 g, 51.7 mmol) in THF (70 mL) at 0 Â°C. The reaction mixture was stirred at 70 Â°C for 2 h, and then, water was added dropwise until no gas was generated. It was filtered, and the filtering cake was washed with EA. The combined organic phase was concentrated in vacuum, and the residue was purified by Combiflash (EA) to give (<i>R</i>)-(2-phenyl-4,5-dihydrooxazol-4-yl)methanol (2.0 g, 16%, over 3 steps) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 178 (M + 1). To a solution of this intermediate (2.0 g, 11.2 mmol) in THF (60 mL) was added NaH (542 mg, 22.4 mmol) at 0 Â°C. After being stirred at 0 Â°C for 15 min, CH<sub>3</sub>I (3.98 g, 28.0 mmol) was added. The reaction mixture was stirred at rt overnight. The solvent was removed, and the residue was purified by silica gel column chromatography using PE/EA = 5:1 to give (<i>R</i>)-4-(methoxymethyl)-2-phenyl-4,5-dihydrooxazole (1.9 g, yield 88%) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 192 (M + 1). The solution of this intermediate (1.9 g, 11.8 mmol) in 4 N HCl (60 mL) was refluxed overnight. After being cooled to rt, it was filtered, and the filtrate washed with ether (3 Ã 50 mL). The water layer was lyophilizated to give (<i>S</i>)-2-amino-3-methoxypropan-1-ol hydrochloride (1.5 g, yield 83%) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 106 (M + 1). The subsequent reactions were performed by following the procedures described above for <b>20</b>. Compound <b>27</b> was acquired in 52.5% yield of the final step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.67 (d, <i>J</i> = 1.2 Hz, 1H), 8.62 (d, <i>J</i> = 1.2 Hz, 1H), 8.25 (d, <i>J</i> = 8.8 Hz, 1H), 7.30 (d, <i>J</i> = 9.0 Hz, 1H), 7.26 (d, <i>J</i> = 9.0 Hz, 1H), 4.99 (s, 2H), 4.91 (t, <i>J</i> = 5.2 Hz, 1H), 4.17â4.09 (m, 1H), 3.55â3.44 (m, 4H), 3.27 (s, 3H), 2.22 (s, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 200 nm. MS (ESI+): <i>m</i>/<i>z</i> = 374 (M + 1).</div></div><div id="sec5_10_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>S</i>)-<i>N</i>-(1-Hydroxy-3-(methylthio)propan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>28</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-2-amino-3-mercaptopropanoic acid hydrochloride hydrate (3.0 g, 17.0 mmol) in CH<sub>3</sub>OH (50 mL) was added SOCl<sub>2</sub> (4.1 g, 34.0 mmol) at 0 Â°C. The reaction mixture was stirred at 60 Â°C overnight. It was concentrated under reduced pressure to give (<i>S</i>)-methyl 2-amino-3-mercaptopropanoate hydrochloride (2.3 g) as a white solid, which was used in the next step without further purification. MS (ESI+): <i>m</i>/<i>z</i> = 136 (M + 1). To a solution of this intermediate (2.0 g, 11.4 mmol) in DCM (50 mL) was added (Boc)<sub>2</sub>O (3.7 g, 17.1 mmol). The reaction mixture was stirred at rt for 2 h. After being cooled to rt, EA (150 mL) and ammoniaâwater (50 mL) were added. The organic layer after separation was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give (<i>S</i>)-methyl 2-(<i>tert</i>-butoxycarbonylamino)-3-mercaptopropanoate (4 g) as a white solid. MS (ESI+): <i>m</i>/<i>z</i> = 136 (M-99). To a solution of this intermediate (4.0 g, 17.0 mmol) in DCM (50 mL) was added MeI (4.8 g, 34.0 mmol) and DIPEA (4.4 g, 34.0 mmol). The reaction mixture was stirred at 25 Â°C overnight. The solvent was removed, and the residue was purified by silica gel column chromatography using PE/EA = 2:1 to give (<i>S</i>)-methyl 2-(<i>tert</i>-butoxycarbonylamino)-3-(methylthio)propanoate (2.34g, yield 54%) as a colorless oil. MS (ESI+): <i>m</i>/<i>z</i> = 150 (M-99). To a solution of this intermediate in 1,4-dioxane (30 mL) was added 4 N HCl 1,4-dioxane solution (30 mL). The reaction mixture was stirred at 25 Â°C overnight and concentrated under reduced pressure to give crude (<i>S</i>)-methyl 2-amino-3-(methylthio)propanoate hydrochloride (1.4 g) as a white solid that was used in the next step without further purification. MS (ESI+): <i>m</i>/<i>z</i> = 150 (M + 1). To a solution of LiAlH<sub>4</sub> (0.53 g, 14.0 mmol) in THF (25 mL) was added a solution of this intermediate (1.4 g, 9.3 mmol) in THF (5 mL) at 0 Â°C. The reaction mixture was stirred at 70 Â°C for 2 h, and then water was added dropwise until no gas was generated. It was filtered off, and the filtered cake was washed with EA. The combined organic phase was concentrated in vacuum. Then, 4 N HCl/1,4-dioxane solution (20 mL) was added, and the resulting mixture was stirred at rt for 30 min. After removing the solvent, water (30 mL) was added, and it was extracted with EA (3 Ã 30 mL) to remove organically soluble impurities. The water layer was lyophilized to give (<i>S</i>)-2-amino-3-(methylthio)propan-1-ol hydrochloride (880 mg, yield 58%) as a colorless oil. MS (ESI+): <i>m</i>/<i>z</i> = 122 (M + 1). The subsequent reactions were performed by following the procedures described above for <b>20</b>. Compound <b>33</b> was acquired in 47% yield of the final step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.68 (s, 1H), 8.63 (s, 1H), 8.41 (d, <i>J</i> = 9.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.26 (d, <i>J</i> = 8.4 Hz, 1H), 4.99 (s, 2H), 4.95 (t, <i>J</i> = 5.2 Hz, 1H), 4.16â4.08 (m, 1H), 3.62â3.47 (m, 2H), 2.79â2.65 (m, 2H), 2.22 (s, 3H), 2.08 (s, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 390 (M + 1).</div></div><div id="sec5_10_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-<i>N</i>-(1-Hydroxy-3-(methylsulfonyl)propan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>29</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-5-chloro-<i>N</i>-(1-hydroxy-3-(methylthio)propan-2-yl)pyrazine-2-carboxamide (100 mg, 0.383 mmol), obtained during the synthesis of <b>28</b>, in DCM (10 mL) was added <i>m</i>-CPBA (132 mg, 0.766 mmol) at 0 Â°C. The mixture was stirred at rt for 90 min. Water (20 mL) was added, and the mixture was extracted with DCM (2 Ã 30 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by Combiflash (PE/EA = 1:8) to give ((<i>S</i>)-5-chloro-<i>N</i>-(1-hydroxy-3-(methylsulfonyl)propan-2-yl)pyrazine-2-carboxamide (89 mg, yield 79%) as a yellow solid. MS (ESI+): <i>m</i>/<i>z</i> = 294 (M + 1). The last step was conducted by following general method A. Compound <b>29</b> was obtained in 45% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.78 (d, <i>J</i> = 9.2 Hz, 1H), 8.68 (d, <i>J</i> = 1.4 Hz, 1H), 8.64 (d, <i>J</i> = 1.4 Hz, 1H), 7.30 (d, <i>J</i> = 8.2 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 1H), 5.15 (t, <i>J</i> = 5.6 Hz, 1H), 4.99 (s, 2H), 4.60â4.45 (m, 1H), 3.61â3.31 (m, 4H), 2.97 (s, 3H), 2.22 (s, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 422 (M + 1).</div></div><div id="sec5_10_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(3-hydroxybutan-2-yl)pyrazine-2-carboxamide (<b>30</b>)</h4><div class="NLM_p last">The solution of 3-nitrobutan-2-ol (1.0 g, 8.4 mmol) in MeOH (30 mL) was hydrogenated using 10% Pd/C (100 mg) as a catalyst under H<sub>2</sub> overnight. The catalyst was removed by filtration through Celite, and the solvent was evaporated under reduced pressure to give 3-aminobutan-2-ol (740 mg, yield 99%) as a colorless oil. The next step was performed by following general method B. Compound <b>30</b> was acquired in 41% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.11 (s, 1H), 8.67â8.66 (m, 1H), 8.62â8.60 (m, 1H), 8.32 (d, <i>J</i> = 9.2 Hz, 1H), 8.10 (d, <i>J</i> = 9.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 3.90â3.85 (m, 1H), 3.73â3.64 (m, 1H), 2.22 (s, 3H), 1.14 (dd, <i>J</i><sub>1</sub> = 12.0 Hz, <i>J</i><sub>2</sub> = 6.8 Hz, 3H), 1.05 (dd, <i>J</i><sub>1</sub> = 11.6 Hz, <i>J</i><sub>2</sub> = 6.4 Hz, 3H) ppm. HPLC purity: 99.0% at 220 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 358 (M + 1).</div></div><div id="sec5_10_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-((<i>1S,2S</i>)-2-hydroxycyclopentyl)pyrazine-2-carboxamide (<b>31</b>)</h4><div class="NLM_p last">This compound was prepared by general method B from (1<i>S</i>,2<i>S</i>)-2-aminocyclopentanol and the acid <b>123</b>. It was obtained in 15% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.65 (d, <i>J</i> = 0.8 Hz, 1H), 8.60 (d, <i>J</i> = 0.8 Hz, 1H), 8.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.79 (d, <i>J</i> = 4.4 Hz, 1H), 4.04â4.00 (m, 2H), 2.21 (s, 3H), 1.99â1.95 (m, 1H), 1.86â1.83 (m, 1H), 1.67â1.62 (m, 2H), 1.54â1.46 (m, 2H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-((<i>1R</i>,<i>2R</i>)-2-hydroxycyclopentyl)pyrazine-2-carboxamide (<b>32</b>)</h4><div class="NLM_p last">This compound was prepared by general method B from (1<i>R</i>,2<i>R</i>)-2-aminocyclopentanol and acid <b>123</b>. It was obtained in 31% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.65 (d, <i>J</i> = 1.2 Hz, 1H), 8.61 (d, <i>J</i> = 1.2 Hz, 1H), 8.48 (d, <i>J</i> = 7.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.03â4.00 (m, 2H), 2.21 (s, 3H), 1.99â1.95 (m, 1H), 1.86â1.83 (m, 1H), 1.67â1.61 (m, 2H), 1.54â1.45 (m, 2H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(<i>cis</i>-2-hydroxycyclopentyl)pyrazine-2-carboxamide (<b>33</b>)</h4><div class="NLM_p last">This compound was prepared by general method B from <i>cis</i>-2-aminocyclopentan-1-ol and acid <b>123</b>. It was obtained in 18% yield as a white solid. The ratio of these two cis-isomers in the racemic product was 50.2:49.8 by chiral HPLC analysis. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.67 (d, <i>J</i> = 0.8 Hz, 1H), 8.62 (d, <i>J</i> = 0.8 Hz, 1H), 8.18 (d, <i>J</i> = 7.6 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 5.12 (d, <i>J</i> = 4.4 Hz, 1H), 4.99 (s, 2H), 4.10â4.00 (m, 2H), 2.21 (s, 3H), 2.00â1.85 (m, 1H), 1.85â1.70 (m, 2H), 1.70â1.50 (m, 3H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>S</i>)-<i>N</i>-(3-Hydroxy-3-methylbutan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>34</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-2-aminopropanoic acid (1.0 g, 11.23 mmol) in MeOH (30 mL) at 0 Â°C was added dropwise SOCl<sub>2</sub> (2.67 g, 22.47 mmol). The reaction mixture was refluxed for 2 h, and then, the solvent was removed to give crude (<i>S</i>)-methyl 2-aminopropanoate hydrochloride (1.6 g) as a white solid. To a solution of this intermediate (1.6 g, 11.51 mmol) in THF (30 mL) at 0 Â°C was added MeMgBr (3 N, 15 mL, 46.04 mmol) dropwise. The reaction mixture was stirred at rt overnight. The mixture was quenched with saturated NH<sub>4</sub>Cl and extracted with EA (3 Ã 20 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel eluted with MeOH/DCM/Et<sub>3</sub>N (10:80:3) to give crude (<i>S</i>)-3-amino-2-methylbutan-2-ol (100 mg) as a colorless oil. MS (ESI+): <i>m</i>/<i>z</i> = 104 (M + 1). The subsequent reaction of this intermediate with acid <b>123</b> was conducted by general method B. Compound <b>34</b> was obtained in 11% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.67 (d, <i>J</i> = 1.2 Hz, 1H), 8.62 (s, 1H), 8.11 (d, <i>J</i> = 9.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.72 (s, 1H), 3.92â3.87 (m, 1H), 2.22 (s, 3H), 1.15 (s, 3H), 1.12 (d, <i>J</i> = 6.4 Hz, 3H), 1.09 (s, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 372 (M + 1).</div></div><div id="sec5_10_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>R</i>)-<i>N</i>-(3-Hydroxy-3-methylbutan-2-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>35</b>)</h4><div class="NLM_p last">This compound was prepared by starting from (<i>R</i>)-2-aminopropanoic acid and following the procedures described above for <b>34</b>. Compound <b>35</b> was acquired in 10% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.67 (d, <i>J</i> = 1.2 Hz, 1H), 8.62 (s, 1H), 8.12 (d, <i>J</i> = 9.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.72 (s, 1H), 3.92â3.87 (m, 1H), 2.22 (s, 3H), 1.15 (s, 3H), 1.12 (d, <i>J</i> = 6.4 Hz, 3H), 1.09 (s, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 220 nm. MS (ESI+): <i>m</i>/<i>z</i> = 372 (M + 1).</div></div><div id="sec5_10_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>S</i>)-<i>N</i>-(2-Hydroxy-2-methylpentan-3-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>36</b>)</h4><div class="NLM_p last">This compound was prepared by starting from (<i>S</i>)-2-aminobutanoic acid and following the procedures described above for <b>34</b>. Compound <b>36</b> was obtained in 10% yield as a white solid. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.68 (d, <i>J</i> = 1.2 Hz, 1H), 8.62 (d, <i>J</i> = 1.2 Hz, 1H), 7.98 (d, <i>J</i> = 10.4 Hz, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H), 4.59 (s, 1H), 3.75 (td, <i>J</i><sub><i>t</i></sub> = 10.4 Hz, <i>J</i><sub><i>d</i></sub> = 2.2 Hz, 1H), 2.23 (s, 3H), 1.79â1.76 (m, 1H), 1.47â1.45 (m, 1H), 1.15 (s, 3H), 1.06 (s, 3H), 0.81 (t, <i>J</i> = 7.4 Hz, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 386 (M + 1).</div></div><div id="sec5_10_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>R</i>)-<i>N</i>-(2-Hydroxy-2-methylpentan-3-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>37</b>)</h4><div class="NLM_p last">This compound was prepared by starting from (<i>R</i>)-2-aminobutanoic acid and following the procedures described above for <b>34</b>. Compound <b>37</b> was acquired in 18% yield as a white solid. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.68 (d, <i>J</i> = 1.2 Hz, 1H), 8.62 (d, <i>J</i> = 1.2 Hz, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 4.98 (s, 2H), 4.59 (s, 1H), 3.74 (td, <i>J</i><sub><i>t</i></sub> = 10.8 Hz, <i>J</i><sub><i>d</i></sub> = 2.8 Hz, 1H), 2.22 (s, 3H), 1.80â1.74 (m, 1H), 1.48â1.42 (m, 1H), 1.14 (s, 3H), 1.05 (s, 3H), 0.80 (t, <i>J</i> = 7.6 Hz, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 386 (M + 1).</div></div><div id="sec5_10_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>S</i>)-<i>N</i>-(2-Hydroxy-2-methylhexan-3-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>38</b>)</h4><div class="NLM_p last">This compound was prepared by starting from (<i>S</i>)-2-aminopentanoic acid and following the procedures described above for <b>34</b>. Compound <b>38</b> was obtained in 10% yield as a white solid. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (br. s, 1H), 8.66 (s, 1H), 8.61 (s, 1H), 7.98 (d, <i>J</i> = 10.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 1H), 7.24 (d, <i>J</i> = 8.4 Hz, 1H), 4.97 (s, 2H), 4.60 (s, 1H), 3.83 (t, <i>J</i> = 9.4 Hz, 1H), 2.22 (s, 3H), 1.69â1.61 (m, 1H), 1.50â1.45 (m, 1H), 1.34â1.16 (m, 2H), 1.13 (s, 3H), 1.04 (s, 3H), 0.84 (t, <i>J</i> = 7.4 Hz, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 400 (M + 1).</div></div><div id="sec5_10_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>R</i>)-<i>N</i>-(2-Hydroxy-2-methylhexan-3-yl)-5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>] [1,2]oxaborol-6-yloxy)pyrazine-2-carboxamide (<b>39</b>)</h4><div class="NLM_p last">This compound was prepared by starting from (<i>R</i>)-2-aminopentanoic acid and following the procedures described above for <b>34</b>. Compound <b>39</b> was obtained in 10% yield as a white solid. <sup>1</sup>HNMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.66 (d, <i>J</i> = 1.2 Hz, 1H), 8.61 (d, <i>J</i> = 1.2 Hz, 1H), 7.97 (d, <i>J</i> = 10.4 Hz, 1H), 7.28 (d, <i>J</i> = 8.2 Hz, 1H), 7.25 (d, <i>J</i> = 8.2 Hz, 1H), 4.98 (s, 2H), 4.58 (s, 1H), 3.84 (td, <i>J</i><sub><i>t</i></sub> = 10.8 Hz, <i>J</i><sub><i>d</i></sub> = 2.4 Hz, 1H), 2.22 (s, 3H), 1.70â1.62 (m, 1H), 1.52â1.42 (m, 1H), 1.34â1.16 (m, 2H), 1.14 (s, 3H), 1.05 (s, 3H), 0.85 (t, <i>J</i> = 7.6 Hz, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 400 (M + 1).</div></div><div id="sec5_10_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(2-hydroxyethyl)-<i>N</i>-methylpyrazine-2-carboxamide (<b>40</b>)</h4><div class="NLM_p last">This compound was synthesized by using 2-(methylamino)ethanol as a starting material and following the procedures used for analogue <b>4</b>. Compound <b>40</b> was obtained in 26% yield of the last step as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.60â8.45 (m, 1H), 8.40â8.25 (m, 1H), 7.35â7.20 (m, 2H), 4.98 (s, 2H), 4.82â4.62 (m, 1H), 3.70â3.30 (m, 4H), 3.12â2.95 (m, 3H), 2.24 (s, 3H) ppm. HPLC purity: 100% at 220 nm and 98.0% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 344 (M + 1).</div></div><div id="sec5_10_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>R</i>)-5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N</i>-(1-hydroxy pentan-2-yl)-<i>N</i>-methylpyrazine-2-carboxamide (<b>41</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-methyl 2-aminopentanoate hydrochloride (1.6 g) and Et<sub>3</sub>N (3.7 mL, 25.65 mmol) in DCM (20 mL) was added (Boc)<sub>2</sub>O (3.7 g, 17.09 mmol). The reaction mixture was stirred at rt overnight. Solvent was removed, and the residue was purified by silica gel column chromatography using PE/EA (8:1) as eluent to give (<i>R</i>)-methyl 2-(<i>tert</i>-butoxycarbonylamino)pentanoate (1.8 g, yield 91%) as a colorless oil. MS (ESI+): <i>m</i>/<i>z</i> = 254 (M + 23). To a solution of this intermediate (500 mg, 2.16 mmol) in THF (30 mL) was added LiAlH<sub>4</sub> (247 mg, 6.49 mmol). The reaction mixture was refluxed overnight. Water (0.3 mL) was added, and the solid was removed by filtration. The filtrate was concentrated, and the residue was purified by silica gel column chromatography using DCM/MeOH/Et<sub>3</sub>N (80:10:3) as eluent to give (<i>R</i>)-2-(methylamino)pentan-1-ol (100 mg) as a colorless oil. MS (ESI+): <i>m</i>/<i>z</i> = 118 (M + 1). The subsequent reaction of this intermediate with acid <b>123</b> was conducted by general method B. Compound <b>41</b> was obtained in 35% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.55 (d, <i>J</i> = 1.0 Hz, 0.34H), 8.53 (d, <i>J</i> = 1.0 Hz, 0.66H), 8.30 (d, <i>J</i> = 1.0 Hz, 0.34H), 8.23 (d, <i>J</i> = 1.0 Hz, 0.66H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 4.98 (s, 2H), 4.77â4.74 (m, 1H), 4.60â4.50 (m, 0.35H), 3.75â3.65 (m, 0.65H), 3.55â3.31 (m, 2H), 2.83 (s, 3H), 2.23 (s, 3H), 1.48â1.23 (m, 4H), 0.91 (t, <i>J</i> = 7.2 Hz, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 2H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral purity 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 386 (M + 1).</div></div><div id="sec5_10_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)-<i>N,N</i>-bis(2-hydroxy ethyl)pyrazine-2-carboxamide (<b>42</b>)</h4><div class="NLM_p last">This compound was synthesized by using diethanolamine as a starting material and following the procedures described for <b>4</b>. Compound <b>42</b> was obtained in 8% yield as a white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.02 (s, 1H), 8.49 (s, 1H), 8.30 (s, 1H), 7.27 (d, <i>J</i> = 8.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 4.97 (s, 2H), 4.76 (t, <i>J</i> = 5.0 Hz, 1H), 4.66 (s, 1H), 3.61â3.59 (m, 2H), 3.54â3.51 (m, 2H), 3.49 (s, 4H), 2.22 (s, 3H) ppm. HPLC purity: 93.3% at 220 nm and 96.7% at 254 nm. Mass (ESI+): <i>m</i>/<i>z</i> = 374 (M + 1).</div></div><div id="sec5_10_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (<i>S</i>)-(5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazin-2-yl)(2-(hydroxymethyl)piperazin-1-yl)methanone Hydrochloric Acid Salt (<b>43</b>)</h4><div class="NLM_p last">General method B was used for the reaction of (<i>S</i>)-<i>tert</i>-butyl 3-(hydroxymethyl)piperazine-1-carboxylate with acid <b>123</b> providing (<i>S</i>)-<i>tert</i>-butyl 4-(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazine-2-carbonyl)-3-(hydroxymethyl)piperazine-1-carboxylate as a white solid in 38% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.53 (s, 1H), 8.34â8.31 (m, 1H), 7.27 (d, <i>J</i> = 8.0 Hz, 1H), 7.23 (d, <i>J</i> = 8.0 Hz, 1H), 4.97 (s, 2H), 4.90â4.80 (m, 1H), 4.22â4.19 (m, 1H), 4.04â3.71 (m, 3H), 3.49 (s, 1H), 3.21â2.92 (m, 4H), 2.23 (s, 3H), 1.39 (s, 9H) ppm. MS (ESI+): <i>m</i>/<i>z</i> = 429 (M â 55). This Boc-protected intermediate was deprotected with 4 N HCl 1,4-dioxane solution in DCM generating the residue, which was purified by prep-HPLC to give compound <b>43</b> in 13% yield as a white solid. HPLC purity: 98.4% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 98.7% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 385 (M + 1).</div></div><div id="sec5_10_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (<i>R</i>)-(5-(1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazin-2-yl)(2-(hydroxymethyl)piperazin-1-yl)methanone Hydrochloric Acid Salt (<b>44</b>)</h4><div class="NLM_p last">General method B was used for the reaction of (<i>R</i>)-<i>tert</i>-butyl 3-(hydroxymethyl)piperazine-1-carboxylate with acid <b>123</b> providing (<i>R</i>)-<i>tert</i>-butyl 4-(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazine-2-carbonyl)-3-(hydroxymethyl)piperazine-1-carboxylate in 38% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.07 (s, 1H), 8.53 (s, 1H), 8.35â8.29 (m, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 4.97 (s, 2H), 4.90â4.79 (m, 1H), 4.23â4.20 (m, 1H), 4.02â3.68 (m, 3H), 3.48 (s, 2H), 3.05â2.91 (m, 3H), 2.23 (s, 3H), 1.39 (s, 9H) ppm. MS (ESI+): <i>m</i>/<i>z</i> = 429 (M-55). This Boc-protected intermediate was deprotected with 4 N HCl 1,4-dioxane solution in DCM generating the residue, which was purified by prep-HPLC to give compound <b>44</b> in 12% yield as a white solid. HPLC purity: 100% at 214 nm and 100% at 254 nm. Chiral HPLC purity: 100% at 230 nm. MS (ESI+): <i>m</i>/<i>z</i> = 385 (M + 1).</div></div><div id="sec5_10_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (3-Hydroxy-3-methylpyrrolidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>45</b>)</h4><div class="NLM_p last">This compound was prepared from 3-methylpyrrolidin-3-ol hydrochloride and acid <b>123</b> by general method B. Compound <b>45</b> was obtained in 12% yield as a white solid. The ratio of the two stereoisomers in this racemic product was about 60:40 from <sup>1</sup>HNMR data. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.57â8.56 (m, 1H), 8.50â8.48 (m, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 4.99 (s, 2H), 4.85 (s, 0.4H), 4.79 (s, 0.6H), 3.80â3.49 (m, 4H), 2.23 (s, 3H), 1.85â1.80 (m, 2H), 1.33 (s, 1.2H), 1.27 (s, 1.8H) ppm. HPLC purity: 100% at 220 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (3-Hydroxy-3-methylazetidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>46</b>)</h4><div class="NLM_p last">To a solution of 1-benzhydrylazetidin-3-one (7.11 g, 30 mmol) in dry THF (150 mL) was added methylmagnesium bromide (3N, 30 mL, 90 mmol) dropwise at â78 Â°C. After being stirred at â78 Â°C for 2 h, the reaction mixture was gradually warmed to rt and stirred overnight. Saturated NH<sub>4</sub>Cl (100 mL) was added and extracted with EA (3 Ã 100 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography and eluted with PE/EA (4:1) to give 1-benzhydryl-3-methylazetidin-3-ol (7.0 g, yield 92%) as a yellow solid. MS (ESI+): <i>m</i>/<i>z</i> = 254 (M + 1). The solution of this intermediate (7.0 g, 27.7 mmol) and HCl (1 N, 28 mL) in MeOH (100 mL) was hydrogenated using 10% Pd/C (800 mg) as the catalyst under atmospheric pressure of H<sub>2</sub> overnight. The catalyst was removed, and the solvent was evaporated to give 3-methylazetidin-3-ol hydrochloride (3.0 g, yield 88%) as a light yellow solid. The subsequent reaction of this intermediate with acid <b>123</b> was performed by using general method B to provide compound <b>46</b> in 47% yield as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.61 (d, <i>J</i> = 1.2 Hz, 1H), 8.56 (d, <i>J</i> = 1.2 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 5.70 (s, 1H), 4.99 (s, 2H), 4.41 (d, <i>J</i> = 9.6 Hz, 1H), 4.35 (d, <i>J</i> = 9.6 Hz, 1H), 3.95 (d, <i>J</i> = 9.6 Hz, 1H), 3.90 (d, <i>J</i> = 9.6 Hz, 1H), 2.21 (s, 3H), 1.40 (s, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 356 (M + 1).</div></div><div id="sec5_10_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (3-Ethyl-3-hydroxyazetidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>47</b>)</h4><div class="NLM_p last">This compound was prepared by using ethylmagnesium bromide as a starting material and following the procedures described above for <b>46</b>. Compound <b>47</b> was obtained in 37% yield of the last step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.60 (d, <i>J</i> = 1.2 Hz, 1H), 8.55 (d, <i>J</i> = 1.2 Hz, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 1H), 5.60 (s, 1H), 4.98 (s, 2H), 4.40 (d, <i>J</i> = 10.0 Hz, 1H), 4.29 (d, <i>J</i> = 10.0 Hz, 1H), 3.95 (d, <i>J</i> = 10.0 Hz, 1H), 3.83 (d, <i>J</i> = 10.0 Hz, 1H), 2.20 (s, 3H), 1.65 (q, <i>J</i> = 7.2 Hz, 2H), 0.87 (t, <i>J</i> = 7.2 Hz, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 370 (M + 1).</div></div><div id="sec5_10_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (3-Hydroxy-3-propylazetidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>48</b>)</h4><div class="NLM_p last">This compound was prepared by using propylmagnesium chloride as a starting material and following the procedures described above for <b>46</b>. Compound <b>48</b> was obtained in 36% yield of the final step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.61 (d, <i>J</i> = 0.8 Hz, 1H), 8.56 (d, <i>J</i> = 0.8 Hz, 1H), 7.29 (d, <i>J</i> = 6.4 Hz, 1H), 7.25 (d, <i>J</i> = 6.4 Hz, 1H), 5.60 (s, 1H), 4.99 (s, 2H), 4.41 (d, <i>J</i> = 8.0 Hz, 1H), 4.31 (d, <i>J</i> = 8.0 Hz, 1H), 3.96 (d, <i>J</i> = 8.4 Hz, 1H), 3.85 (d, <i>J</i> = 8.4 Hz, 1H), 2.22 (s, 3H), 1.63 (t, <i>J</i> = 6.4 Hz, 2H), 1.39â1.35 (m, 2H), 0.90 (t, <i>J</i> = 6.0 Hz, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 384 (M + 1).</div></div><div id="sec5_10_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (3-Hydroxy-3-isopropylazetidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2] oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>49</b>)</h4><div class="NLM_p last">This compound was prepared by using isopropylmagnesium chloride as a starting material and following the procedures described above for <b>46</b>. Compound <b>49</b> was obtained in 36% yield of the last step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.10 (s, 1H), 8.62 (d, <i>J</i> = 1.2 Hz, 1H), 8.58 (d, <i>J</i> = 1.2 Hz, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 5.56 (s, 1H), 4.99 (s, 2H), 4.45 (d, <i>J</i> = 10.4 Hz, 1H), 4.27 (d, <i>J</i> = 10.4 Hz, 1H), 4.01 (d, <i>J</i> = 10.4 Hz, 1H), 3.80 (d, <i>J</i> = 10.4 Hz, 1H), 2.21 (s, 3H), 1.85â1.82 (m, 1H), 0.87â0.85 (m, 6H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 384 (M + 1).</div></div><div id="sec5_10_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (3-Cyclopropyl-3-hydroxyazetidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>50</b>)</h4><div class="NLM_p last">This compound was prepared by using cyclopropylmagnesium bromide as a starting material and following the procedures described above for <b>46</b>. Compound <b>50</b> was obtained in 32% yield of the last step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.09 (s, 1H), 8.61 (d, <i>J</i> = 1.2 Hz, 1H), 8.56 (d, <i>J</i> = 1.2 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 5.66 (s, 1H), 4.99 (s, 2H), 4.35 (d, <i>J</i> = 10.4 Hz, 1H), 4.29 (d, <i>J</i> = 10.4 Hz, 1H), 3.89 (d, <i>J</i> = 10.4 Hz, 1H), 3.82 (d, <i>J</i> = 10.4 Hz, 1H), 2.22 (s, 3H), 1.22â1.18 (m, 1H), 0.43â0.40 (m, 2H), 0.34â0.31 (m, 2H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 382 (M + 1).</div></div><div id="sec5_10_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (3-Hydroxy-3-(trifluoromethyl)azetidin-1-yl)(5-(1-hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yloxy)pyrazin-2-yl)methanone (<b>51</b>)</h4><div class="NLM_p last">To a solution of 1-benzhydrylazetidin-3-one (2.0 g, 8.45 mmol) in THF (25 mL) was added trimethyl(trifluoromethyl)silane (1.80 g, 12.65 mmol) and cesium fluoride (1.95 g, 12.85 mmol). The reaction mixture was stirred at rt for 1 h and quenched with saturated NH<sub>4</sub>Cl solution. The mixture was extracted with EtOAc (3 Ã 20 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum. The crude product was purified by column chromatography on silica gel using PE/EA (4:1) as eluent to give 1-benzhydryl-3-(trifluoromethyl)azetidin-3-ol (1.55 g, yield 60%) as a yellow solid. MS (ESI+): <i>m</i>/<i>z</i> = 308 (M + 1). The subsequent reactions were conducted by following the procedures described above for <b>46</b>. Compound <b>51</b> was obtained in 25% yield of the last step as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.08 (s, 1H), 8.65 (d, <i>J</i> = 1.4 Hz, 1H), 8.57 (d, <i>J</i> = 1.4 Hz, 1H), 7.48 (s, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 1H), 4.98 (s, 2H), 4.80 (d, <i>J</i> = 11.1 Hz, 1H), 4.55 (d, <i>J</i> = 11.1 Hz, 1H), 4.31 (d, <i>J</i> = 11.1 Hz, 1H), 4.07 (d, <i>J</i> = 11.1 Hz, 1H), 2.21 (s, 3H) ppm. HPLC purity: 100% at 214 nm and 100% at 254 nm. MS (ESI+): <i>m</i>/<i>z</i> = 410 (M + 1).</div></div><div id="sec5_10_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 7-Methylbenzo[<i>c</i>][1,2]oxaborole-1,6(3<i>H</i>)-diol (<b>58</b>)</h4><div class="NLM_p last">Phosphorus oxychloride (11 mL, 118.3 mmol, 2.33 equiv) was added dropwise to DMF (150 mL) stirring at 0 Â°C in a round-bottomed flask under N<sub>2</sub>, and the mixture was stirred at rt for 0.5 h. It was transferred via cannula to a solution of 2-methylbenzene-1,3-diol (7.0 g, 50.7 mmol) in DMF (100 mL) stirring at 0 Â°C under N<sub>2</sub>. The mixture was stirred for 1.5 h and was slowly warmed to rt. It was poured into iceâwater (2 L) and neutralized with 2 N NaOH to pH 6. The mixture was extracted with EA (3 Ã 600 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum. The resulting residue was purified by column chromatography to give 2,4-dihydroxy-3-methylbenzaldehyde (5.0 g, 63% yield) as a yellow solid. To the mixture of this intermediate (5.0 g, 30 mmol), NaHCO<sub>3</sub> (3.3 g, 39 mmol, 1.3 equiv), and KI (996 mg, 6 mmol, 0.2 equiv) in MeCN (80 mL) was added BnBr (4.3 mL, 36.14 mmol, 1.2 equiv) at 60 Â°C. The mixture was stirred at 80 Â°C overnight, cooled to rt, and evaporated. The residue was quenched with 2 N HCl (200 mL) and extracted with EA (3 Ã 60 mL). The combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified by column chromatography to give 4-(benzyloxy)-2-hydroxy-3-methylbenzaldehyde (5.0 g, 65% yield) as a light yellow solid. To a solution of this intermediate (11.5 g, 44.87 mmol) and pyridine (18 mL, 224.35 mmol, 5 equiv) in DCM (224 mL) was added dropwise a solution of Tf<sub>2</sub>O (15 mL, 89.74 mmol, 2 equiv) in DCM (30 mL) at 0 Â°C. The reaction mixture was stirred at rt for 1 h, added with 0.5 N HCl (100 mL), and extracted with DCM (3 Ã 30 mL). The combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified by column chromatography to give 3-(benzyloxy)-6-formyl-2-methylphenyl trifluoromethanesulfonate (11 g, 65% yield) as an oil. To the mixture of this intermediate (10 g, 25.75 mmol), Pin<sub>2</sub>B<sub>2</sub> (7.8 g, 30.90 mmol, 1.2 equiv) and KOAc (7.57 g, 77.25 mmol, 3 equiv) in 1,4-dioxane (130 mL) was added Pd(dppf)Cl<sub>2</sub> (2 g, 2.575 mmol, 0.1 equiv). The reaction mixture was stirred at 95 Â°C under N<sub>2</sub> overnight, poured into water (1.2 L), and extracted with EA (3 Ã 400 mL). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified by column chromatography to give 4-(benzyloxy)-3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde (5.1 g, 54% yield) as an oil. To a solution of this intermediate (1.7 g, 4.64 mmol) in MeOH (23 mL) was added NaBH<sub>4</sub> (176 mg, 4.64 mmol, 1 equiv). The reaction was stirred at rt for 1 h and acidified with 2 N HCl (6 mL) to pH 2. It was stirred at rt for an additional 1 h, poured into water (100 mL), and extracted with EA (3 Ã 30 mL). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuum. The residue was purified by column chromatography to give 6-(benzyloxy)-7-methylbenzo[<i>c</i>][1,2]oxaborol-1(3<i>H</i>)-ol (942 mg, 80% yield) as a white solid. The solution of this intermediate (1.0 g, 3.73 mmol) in MeOH (19 mL) was hydrogenated overnight using 10% Pd/C (0.2 g) as a catalyst. The catalyst was removed by filtration through Celite, and the solvent was evaporated under reduced pressure. The residue was purified by column chromatography to give the desired compound <b>58</b> (0.4 g, 61% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): Î´ 9.03 (s, 1H), 8.76 (s, 1H), 6.98 (d, <i>J</i> = 8.1 Hz, 1H), 6.88 (d, <i>J</i> = 8.1 Hz, 1H), 4.83 (s, 2H), 2.25 (s, 3H) ppm. HPLC purity: 97.3% at 220 nm. Compound <b>58</b> was used as a common intermediate for the syntheses of <b>3</b>â<b>51</b>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00621">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00621" class="ext-link">10.1021/acs.jmedchem.7b00621</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures illustrating mouse survival and efficacy ED<sub>90</sub> data from a <i>P. berghei</i> mouse malaria model (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with the associated biochemical and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_001.pdf">jm7b00621_si_001.pdf (2.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_002.csv">jm7b00621_si_002.csv (3.89 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00621" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong-Kang Zhang</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0013-639X" title="Orcid link">http://orcid.org/0000-0003-0013-639X</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#31485e5f565a505f564b59505f56714850595e5e1f525e5c"><span class="__cf_email__" data-cfemail="e89187868f8389868f928089868fa89189808787c68b8785">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob J. Plattner</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric E. Easom</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Jacobs</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denghui Guo</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, University of California, San
Francisco, Box 0811, San Francisco, California 94143, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yvonne R. Freund</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamela Berry</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vic Ciaravino</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. L. Erve</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip J. Rosenthal</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, University of California, San
Francisco, Box 0811, San Francisco, California 94143, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brice Campo</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, International Center
Cointrin, Block G, 20
Route de PrÃ©-Bois, POB 1826, CH - 1215 Geneva, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco-Javier Gamo</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura M. Sanz</span> - <span class="hlFld-Affiliation affiliation">Diseases
of the Developing World, GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianxin Cao</span> - <span class="hlFld-Affiliation affiliation">Shanghai
ChemPartner, 998 Ha-lei Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai 201203, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e10948-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Medicines for Malaria Venture (MMV) and the National Institutes of Health (AI095324) for financial support. We appreciate many MMV partners that have assisted with this program. We also thank Dr. David Sullivan for calculating cLogD<sub>7.4</sub> and tPSA values of the compounds.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> Abbreviations Used</h2><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">KHMDS</td><td class="NLM_def"><p class="first last">potassium hexamethyldisilazide</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">m-CPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperbenzoic acid</p></td></tr><tr><td class="NLM_term">HOBT</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methylmorpholine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>World Health Organizationâs World Malaria Report 2016; <a href="http://www.who.int" class="extLink">www.who.int</a> (accessed Jul 17,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization%E2%80%99s+World+Malaria+Report+2016%3B+www.who.int+%28accessed+Jul+17%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Collaboration Research Group for Qinghaosu</span><span> </span><span class="NLM_article-title">A new sesquiterpene lactoneâqinghaosu</span> <span class="citation_source-journal">Kexue Tongbao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1977&pages=142&author=Collaboration+Research+Group+for+Qinghaosu&title=A+new+sesquiterpene+lactone%E2%80%94qinghaosu"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DA%2520new%2520sesquiterpene%2520lactone%25E2%2580%2594qinghaosu%26jtitle%3DKexue%2520Tongbao%26date%3D1977%26volume%3D3%26spage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Liu, J. M.</span><span> </span><span class="NLM_article-title">Structure and reaction of qinghaosu</span> <span class="citation_source-journal">Acta Chimi. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADyaL3cXpsVGqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1979&pages=129-143&author=J.+M.+Liu&title=Structure+and+reaction+of+qinghaosu"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and reaction of arteannuin</span></div><div class="casAuthors">Liu, Jing-Ming; Ni, Mu-Yun; Fan, Ju-Fen; Tu, You-You; Wu, Zhao-Hua; Wu, Yu-Lin; Chou, Wei-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Huaxue Xuebao</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-43</span>CODEN:
                <span class="NLM_cas:coden">HHHPA4</span>;
        ISSN:<span class="NLM_cas:issn">0567-7351</span>.
    </div><div class="casAbstract">Arteannuin (I), along with the known arteannuin B (II), were isolated from Artemisia annua and the mol. structure of I detd. on the basis of its IR, NMR, and mass spectra and by chem. correlations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpmAcfTOb8-bVg90H21EOLACvtfcHk0ljrSWJbmjVaDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXpsVGqtg%253D%253D&md5=9b557a87886e2423c4a58860e46892c0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520and%2520reaction%2520of%2520qinghaosu%26jtitle%3DActa%2520Chimi.%2520Sin.%26date%3D1979%26volume%3D37%26spage%3D129%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Collaboration research group for Qinghaosu</span><span> </span><span class="NLM_article-title">Studies on new anti-malarial drug qinghaosu</span> <span class="citation_source-journal">Yaoxue Tongbao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1979&pages=49-53&author=Collaboration+research+group+for+Qinghaosu&title=Studies+on+new+anti-malarial+drug+qinghaosu"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DStudies%2520on%2520new%2520anti-malarial%2520drug%2520qinghaosu%26jtitle%3DYaoxue%2520Tongbao%26date%3D1979%26volume%3D14%26spage%3D49%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Collaboration research group for Qinghaosu</span><span> </span><span class="NLM_article-title">Antimalarial studies on qinghaosu</span> <span class="citation_source-journal">Chin. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">â</span> <span class="NLM_lpage">816</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=117984" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1979&pages=811-816&author=Collaboration+research+group+for+Qinghaosu&title=Antimalarial+studies+on+qinghaosu"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAntimalarial%2520studies%2520on%2520qinghaosu%26jtitle%3DChin.%2520Med.%2520J.%26date%3D1979%26volume%3D92%26spage%3D811%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Tu, Y. Y.</span>, Ed.  <span class="citation_source-book">Qinghao Ji Qinghaosulei Yaowu (Artemisia annua L., Artemisinin and Its Derivatives)</span>; <span class="NLM_publisher-name">Chemical Industry Press</span>, <span class="NLM_publisher-loc">Beijing, China</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Y.+Tu&title=Qinghao+Ji+Qinghaosulei+Yaowu+%28Artemisia+annua+L.%2C+Artemisinin+and+Its+Derivatives%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DY.%2BY.%26btitle%3DQinghao%2520Ji%2520Qinghaosulei%2520Yaowu%2520%2528Artemisia%2520annua%2520L.%252C%2520Artemisinin%2520and%2520Its%2520Derivatives%2529%26pub%3DChemical%2520Industry%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tu, Y. Y.</span><span> </span><span class="NLM_article-title">the discovery of artemisinin (qinghaosu) and gifts from Chinese medicine</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">â</span> <span class="NLM_lpage">1220</span><span class="refDoi">Â DOI: 10.1038/nm.2471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnm.2471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=21989013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12iu7vK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1217-1220&author=Y.+Y.+Tu&title=the+discovery+of+artemisinin+%28qinghaosu%29+and+gifts+from+Chinese+medicine&doi=10.1038%2Fnm.2471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine</span></div><div class="casAuthors">Tu, Youyou</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1217-1220</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria, caused by Plasmodium falciparum, has been a life-threatening disease for thousands of years.  After the failure of international attempts to eradicate malaria in the 1950s, the disease rebounded, largely due to the emergence of parasites resistant to the existing antimalarial drugs of the time, such as chloroquine.  This created an urgent need for new antimalarial medicines.  In 1967, a national project against malaria was set up in China under the leadership of the Project 523 office.  My institute quickly became involved in the project and appointed me to be the head of a malaria research group comprising both phytochem. and pharmacol. researchers.  Our group of young investigators started working on the extn. and isolation of constituents with possible antimalarial activities from Chinese herbal materials.  During the first stage of our work, we investigated more than 2,000 Chinese herb prepns. and identified 640 hits that had possible antimalarial activities.  More than 380 exts. obtained from â¼200 Chinese herbs were evaluated against a mouse model of malaria.  However, progress was not smooth, and no significant results emerged easily.  The turning point came when an Artemisia annua L. ext. showed a promising degree of inhibition against parasite growth.  However, this observation was not reproducible in subsequent expts. and appeared to be contradictory to what was recorded in the literature.  Seeking an explanation, we carried out an intensive review of the literature.  The only ref. relevant to use of qinghao (the Chinese name of Artemisia annua L.) for alleviating malaria symptoms appeared in Ge Hong's A Handbook of Prescriptions for Emergencies: "A handful of qinghao immersed with 2 L of water, wring out the juice and drink it all" (Fig. 1).  This sentence gave me the idea that the heating involved in the conventional extn. step we had used might have destroyed the active components, and that extn. at a lower temp. might be necessary to preserve antimalarial activity.  Indeed, we obtained much better activity after switching to a lower-temp. procedure.  We subsequently sepd. the ext. into its acidic and neutral portions and, at long last, on 4 Oct. 1971, we obtained a nontoxic, neutral ext. that was 100% effective against parasitemia in mice infected with Plasmodium berghei and in monkeys infected with Plasmodium cynomolgi.  This finding represented the breakthrough in the discovery of artemisinin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPPcf3cZ2WFLVg90H21EOLACvtfcHk0ljrSWJbmjVaDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12iu7vK&md5=d751f12196cf4f3d316bdaada5d38e02</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm.2471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2471%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DY.%2BY.%26atitle%3Dthe%2520discovery%2520of%2520artemisinin%2520%2528qinghaosu%2529%2520and%2520gifts%2520from%2520Chinese%2520medicine%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1217%26epage%3D1220%26doi%3D10.1038%2Fnm.2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Dondorp, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phyo, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarning, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lwin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanpithakpong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silamut, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imwong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chotivanich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhasivanon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, N. P.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindegardh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socheat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. J.</span><span> </span><span class="NLM_article-title">Artemisinin resistance in <i>Plasmodium falciparum</i> malaria</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span><span class="refDoi">Â DOI: 10.1056/NEJMoa0808859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1056%2FNEJMoa0808859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=19641202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=455-467&author=A.+M.+Dondorpauthor=F.+Nostenauthor=P.+Yiauthor=D.+Dasauthor=A.+P.+Phyoauthor=J.+Tarningauthor=K.+M.+Lwinauthor=F.+Arieyauthor=W.+Hanpithakpongauthor=S.+J.+Leeauthor=P.+Ringwaldauthor=K.+Silamutauthor=M.+Imwongauthor=K.+Chotivanichauthor=P.+Limauthor=T.+Herdmanauthor=S.+S.+Anauthor=S.+Yeungauthor=P.+Singhasivanonauthor=N.+P.J.+Dayauthor=N.+Lindegardhauthor=D.+Socheatauthor=N.+J.+White&title=Artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa0808859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Dondorp, Arjen M.; Nosten, Francois; Yi, Poravuth; Das, Debashish; Phyo, Aung Phae; Tarning, Joel; Lwin, Khin Maung; Ariey, Frederic; Hanpithakpong, Warunee; Lee, Sue J.; Ringwald, Pascal; Silamut, Kamolrat; Imwong, Mallika; Chotivanich, Kesinee; Lim, Pharath; Herdman, Trent; Sam An, Sen; Yeung, Shunmay; Singhasivanon, Pratap; Day, Nicholas P. J.; Lindegardh, Niklas; Socheat, Duong; White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-467</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease.  There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance.  METHODS: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kg of body wt. per day, for 7 days, and artesunate given at a dose of 4 mg per kg per day, for 3 days, followed by mefloqine at two doses totaling 25 mg per kg.  We assessed in vitro and in vivo Plasmodium-falciparum susceptibility, artesunate pharmacokinetics, and mol. markers of resistance.  RESULTS: We studied 40 patients in each of the two locations.  The overall median parasite clearance times were 84 h (interquartile range, 60 to 96) in Pailin and 48 h (interquartile range, 36 to 66) in Wang Pha (P < 0.001).  Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloqine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), resp., in Wang Pha (P = 0.31).  These markedly different parasitol. responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative mol. correlates of P.falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]).  Adverse events were mild and did not differ significantly between the two treatment groups.  CONCLUSIONS: P.falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand.  Resistance is characterized by slow parasite clearance in vivo without corresponding redns. on conventional in vitro susceptibility testing.  Containment measures are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfVvi4ozTDSLVg90H21EOLACvtfcHk0ljc1kBcDtomSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D&md5=ae3098a15e9fb82c80fa0ddd05378220</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808859%26sid%3Dliteratum%253Aachs%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DLwin%26aufirst%3DK.%2BM.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DHanpithakpong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DHerdman%26aufirst%3DT.%26aulast%3DAn%26aufirst%3DS.%2BS.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DSinghasivanon%26aufirst%3DP.%26aulast%3DDay%26aufirst%3DN.%2BP.J.%26aulast%3DLindegardh%26aufirst%3DN.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DArtemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D455%26epage%3D467%26doi%3D10.1056%2FNEJMoa0808859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span> </span><span class="NLM_article-title">The interplay between drug resistance and fitness in malaria parasites</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">â</span> <span class="NLM_lpage">1038</span><span class="refDoi">Â DOI: 10.1111/mmi.12349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1111%2Fmmi.12349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=23899091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWrurzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=1025-1038&author=P.+J.+Rosenthal&title=The+interplay+between+drug+resistance+and+fitness+in+malaria+parasites&doi=10.1111%2Fmmi.12349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The interplay between drug resistance and fitness in malaria parasites</span></div><div class="casAuthors">Rosenthal, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1025-1038</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Summary : Controlling the spread of antimalarial drug resistance, esp. resistance of Plasmodium falciparum to artemisinin-based combination therapies, is a high priority.  Available data indicate that, as with other microorganisms, the spread of drug-resistant malaria parasites is limited by fitness costs that frequently accompany resistance.  Resistance-mediating polymorphisms in malaria parasites have been identified in putative drug transporters and in target enzymes.  The impacts of these polymorphisms on parasite fitness have been characterized in vitro and in animal models.  Addnl. insights have come from analyses of samples from clin. studies, both evaluating parasites under different selective pressures and detg. the clin. consequences of infection with different parasites.  With some exceptions, resistance-mediating polymorphisms lead to malaria parasites that, compared with wild type, grow less well in culture and in animals, and are replaced by wild type when drug pressure diminishes in the clin. setting.  In some cases, the fitness costs of resistance may be offset by compensatory mutations that increase virulence or changes that enhance malaria transmission.  However, not enough is known about effects of resistance mediators on parasite fitness.  A better appreciation of the costs of fitness-mediating mutations will facilitate the development of optimal guidelines for the treatment and prevention of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDYsc1v8XWbrVg90H21EOLACvtfcHk0ljc1kBcDtomSw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWrurzP&md5=425130d0f9f72ae19408290c825a28f1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fmmi.12349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.12349%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520interplay%2520between%2520drug%2520resistance%2520and%2520fitness%2520in%2520malaria%2520parasites%26jtitle%3DMol.%2520Microbiol.%26date%3D2013%26volume%3D89%26spage%3D1025%26epage%3D1038%26doi%3D10.1111%2Fmmi.12349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuor, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bout, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ©nard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandeur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bras, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ©nard, D.</span><span> </span><span class="NLM_article-title">A molecular marker of artemisinin-resistant <i>Plasmodium falciparum</i> malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span><span class="refDoi">Â DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+M%C3%A9nardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+L.+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+M%C3%A9nard&title=A+molecular+marker+of+artemisinin-resistant+Plasmodium+falciparum+malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2eamXTlvR0QVULntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DBras%26aufirst%3DJ.%2BL.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DA%2520molecular%2520marker%2520of%2520artemisinin-resistant%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papastogiannidis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingelin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">4400</span><span class="NLM_x">â</span> <span class="NLM_lpage">4405</span><span class="refDoi">Â DOI: 10.1073/pnas.1015762108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1073%2Fpnas.1015762108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=21300861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=4400-4405&author=S.+A.+Charmanauthor=S.+Arbe-Barnesauthor=I.+C.+Bathurstauthor=R.+Brunauthor=M.+Campbellauthor=W.+N.+Charmanauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=J.+C.+Craftauthor=D.+J.+Creekauthor=Y.+Dongauthor=H.+Matileauthor=M.+Maurerauthor=J.+Morizziauthor=T.+Nguyenauthor=P.+Papastogiannidisauthor=C.+Scheurerauthor=D.+M.+Shacklefordauthor=K.+Sriraghavanauthor=L.+Stingelinauthor=Y.+Tangauthor=H.+Urwylerauthor=X.+Wangauthor=K.+L.+Whiteauthor=S.+Wittlinauthor=L.+Zhouauthor=J.+L.+Vennerstrom&title=Synthetic+ozonide+drug+candidate+OZ439+offers+new+hope+for+a+single-dose+cure+of+uncomplicated+malaria&doi=10.1073%2Fpnas.1015762108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</span></div><div class="casAuthors">Charman, Susan A.; Arbe-Barnes, Sarah; Bathurst, Ian C.; Brun, Reto; Campbell, Michael; Charman, William N.; Chiu, Francis C. K.; Chollet, Jacques; Craft, J. Carl; Creek, Darren J.; Dong, Yuxiang; Matile, Hugues; Maurer, Melanie; Morizzi, Julia; Nguyen, Tien; Papastogiannidis, Petros; Scheurer, Christian; Shackleford, David M.; Sriraghavan, Kamaraj; Stingelin, Lukas; Tang, Yuanqing; Urwyler, Heinrich; Wang, Xiaofang; White, Karen L.; Wittlin, Sergio; Zhou, Lin; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4400-4405, S4400/1-S4400/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ozonide OZ439 is a synthetic peroxide antimalarial drug candidate designed to provide a single-dose oral cure in humans.  OZ439 has successfully completed Phase I clin. trials, where it was shown to be safe at doses up to 1,600 mg and is currently undergoing Phase Ila trials in malaria patients.  Herein, we describe the discovery of OZ439 and the exceptional antimalarial and pharmacokinetic properties that led to its selection as a clin. drug development candidate.  In vitro, OZ439 is fast-acting against all asexual erythrocytic Plasmodium falciparum stages with ICs0 values comparable to those for the clin. used artemisinin derivs.  Unlike all other synthetic peroxides and semisynthetic artemisinin derivs., OZ439 completely cures Plasmodium berghei-infected mice with a single oral dose of 20 mg/kg and exhibits prophylactic activity superior to that of the benchmark chemoprophylactic agent, mefloquine.  Compared with other peroxide-contg. antimalarial agents, such as the artemisinin derivs. and the first-generation ozonide OZ277, OZ439 exhibits a substantial increase in the pharmacokinetic half-life and blood concn. vs. time profile in three preclin. species.  The outstanding efficacy and prolonged blood concns. of OZ439 are the result of a design strategy that stabilizes the intrinsically unstable pharmacophoric peroxide bond, thereby reducing clearance yet maintaining the necessary Fe(II)-reactivity to elicit parasite death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxoUteI8z2bVg90H21EOLACvtfcHk0lgcIGz2Yiwv5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D&md5=5da13be1d57a8dd58b21246814f6c268</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015762108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015762108%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBathurst%26aufirst%3DI.%2BC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DJ.%2BC.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMaurer%26aufirst%3DM.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPapastogiannidis%26aufirst%3DP.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DStingelin%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSynthetic%2520ozonide%2520drug%2520candidate%2520OZ439%2520offers%2520new%2520hope%2520for%2520a%2520single-dose%2520cure%2520of%2520uncomplicated%2520malaria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D4400%26epage%3D4405%26doi%3D10.1073%2Fpnas.1015762108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kappe, S. H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowman, A. F.</span><span> </span><span class="NLM_article-title">That was then but this is now: malaria research in the time of an eradication agenda</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">â</span> <span class="NLM_lpage">866</span><span class="refDoi">Â DOI: 10.1126/science.1184785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.1184785" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=862-866&author=S.+H.+I.+Kappeauthor=A.+M.+Vaughanauthor=J.+A.+Boddeyauthor=A.+F.+Cowman&title=That+was+then+but+this+is+now%3A+malaria+research+in+the+time+of+an+eradication+agenda&doi=10.1126%2Fscience.1184785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1184785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1184785%26sid%3Dliteratum%253Aachs%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26aulast%3DVaughan%26aufirst%3DA.%2BM.%26aulast%3DBoddey%26aufirst%3DJ.%2BA.%26aulast%3DCowman%26aufirst%3DA.%2BF.%26atitle%3DThat%2520was%2520then%2520but%2520this%2520is%2520now%253A%2520malaria%2520research%2520in%2520the%2520time%2520of%2520an%2520eradication%2520agenda%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D862%26epage%3D866%26doi%3D10.1126%2Fscience.1184785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mackinnon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span> </span><span class="NLM_article-title">The selection landscape of malaria parasites</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">â</span> <span class="NLM_lpage">871</span><span class="refDoi">Â DOI: 10.1126/science.1185410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.1185410" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=866-871&author=M.+J.+Mackinnonauthor=K.+Marsh&title=The+selection+landscape+of+malaria+parasites&doi=10.1126%2Fscience.1185410"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1185410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1185410%26sid%3Dliteratum%253Aachs%26aulast%3DMackinnon%26aufirst%3DM.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%26atitle%3DThe%2520selection%2520landscape%2520of%2520malaria%2520parasites%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D866%26epage%3D871%26doi%3D10.1126%2Fscience.1185410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Enserink, M.</span><span> </span><span class="NLM_article-title">Redrawing Africaâs malaria map</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">842</span><span class="refDoi">Â DOI: 10.1126/science.328.5980.842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.328.5980.842" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=842&author=M.+Enserink&title=Redrawing+Africa%E2%80%99s+malaria+map&doi=10.1126%2Fscience.328.5980.842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.328.5980.842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.328.5980.842%26sid%3Dliteratum%253Aachs%26aulast%3DEnserink%26aufirst%3DM.%26atitle%3DRedrawing%2520Africa%25E2%2580%2599s%2520malaria%2520map%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D842%26doi%3D10.1126%2Fscience.328.5980.842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rottmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Paez, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwanarusk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jegla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span> </span><span class="NLM_article-title">Spiroindolones, a potent compound class for the treatment of malaria</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">â</span> <span class="NLM_lpage">1180</span><span class="refDoi">Â DOI: 10.1126/science.1193225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.1193225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=20813948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=1175-1180&author=M.+Rottmannauthor=C.+McNamaraauthor=B.+K.+Yeungauthor=M.+C.+Leeauthor=B.+Zouauthor=B.+Russellauthor=P.+Seitzauthor=D.+M.+Plouffeauthor=N.+V.+Dhariaauthor=J.+Tanauthor=S.+B.+Cohenauthor=K.+R.+Spencerauthor=G.+E.+Gonzalez-Paezauthor=S.+B.+Lakshminarayanaauthor=A.+Gohauthor=R.+Suwanaruskauthor=T.+Jeglaauthor=E.+K.+Schmittauthor=H.+P.+Beckauthor=R.+Brunauthor=F.+Nostenauthor=L.+Reniaauthor=V.+Dartoisauthor=T.+H.+Kellerauthor=D.+A.+Fidockauthor=E.+A.+Winzelerauthor=T.+T.+Diagana&title=Spiroindolones%2C+a+potent+compound+class+for+the+treatment+of+malaria&doi=10.1126%2Fscience.1193225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Spiroindolones, a Potent Compound Class for the Treatment of Malaria</span></div><div class="casAuthors">Rottmann, Matthias; McNamara, Case; Yeung, Bryan K. S.; Lee, Marcus C. S.; Zou, Bin; Russell, Bruce; Seitz, Patrick; Plouffe, David M.; Dharia, Neekesh V.; Tan, Jocelyn; Cohen, Steven B.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Lakshminarayana, Suresh B.; Goh, Anne; Suwanarusk, Rossarin; Jegla, Timothy; Schmitt, Esther K.; Beck, Hans-Peter; Brun, Reto; Nosten, Francois; Renia, Laurent; Dartois, Veronique; Keller, Thomas H.; Fidock, David A.; Winzeler, Elizabeth A.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">5996</span>),
    <span class="NLM_cas:pages">1175-1180</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Recent reports of increased tolerance to artemisinin derivs.-the most recently adopted class of antimalarials-have prompted a need for new treatments.  The spirotetrahydro-Î²-carbolines, or spiroindolones, are potent drugs that kill the blood stages of Plasmodium falciparum and Plasmodium vivax clin. isolates at low nanomolar concn.  Spiroindolones rapidly inhibit protein synthesis in P. falciparum, an effect that is ablated in parasites bearing nonsynonymous mutations in the gene encoding the P-type cation-transporter ATPase4 (PfATP4).  The optimized spiroindolone NITD609 shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6O1WaX-1b7Vg90H21EOLACvtfcHk0ljRLCy_Lsk3wQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ&md5=239bc9babd5cb5f07e2be38741038e2c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1193225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1193225%26sid%3Dliteratum%253Aachs%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DYeung%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BC.%26aulast%3DZou%26aufirst%3DB.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSeitz%26aufirst%3DP.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DSpencer%26aufirst%3DK.%2BR.%26aulast%3DGonzalez-Paez%26aufirst%3DG.%2BE.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DJegla%26aufirst%3DT.%26aulast%3DSchmitt%26aufirst%3DE.%2BK.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DSpiroindolones%252C%2520a%2520potent%2520compound%2520class%2520for%2520the%2520treatment%2520of%2520malaria%26jtitle%3DScience%26date%3D2010%26volume%3D329%26spage%3D1175%26epage%3D1180%26doi%3D10.1126%2Fscience.1193225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span>Medicines for Malaria Venture 2015 Annual Report. <a href="http://www.mmv.org" class="extLink">www.mmv.org</a> (accessed Jul 17, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Medicines+for+Malaria+Venture+2015+Annual+Report.+www.mmv.org+%28accessed+Jul+17%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis of antimalarial agents</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">â</span> <span class="NLM_lpage">374</span><span class="refDoi">Â DOI: 10.1080/00304948.2012.697708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1080%2F00304948.2012.697708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFejsbnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=340-374&author=Y.-K.+Zhangauthor=M.+Geauthor=J.+J.+Plattner&title=Recent+progress+in+the+synthesis+of+antimalarial+agents&doi=10.1080%2F00304948.2012.697708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Synthesis of Antimalarial Agents</span></div><div class="casAuthors">Zhang, Yong-Kang; Ge, Min; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">340-374</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent progress in the synthesis of Antimalarial agents is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0FJDs0_g-BbVg90H21EOLACvtfcHk0ljRLCy_Lsk3wQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFejsbnI&md5=e102da32695f98afe7cf7cde0886b755</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F00304948.2012.697708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304948.2012.697708%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520of%2520antimalarial%2520agents%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2012%26volume%3D44%26spage%3D340%26epage%3D374%26doi%3D10.1080%2F00304948.2012.697708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wells, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Malaria medicines: a glass half full?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">â</span> <span class="NLM_lpage">442</span><span class="refDoi">Â DOI: 10.1038/nrd4573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnrd4573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=26000721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=424-442&author=T.+N.+Wellsauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhis&title=Malaria+medicines%3A+a+glass+half+full%3F&doi=10.1038%2Fnrd4573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria medicines: a glass half full?</span></div><div class="casAuthors">Wells, Timothy N. C.; Hooft van Huijsduijnen, Rob; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">424-442</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite substantial scientific progress over the past two decades, malaria remains a worldwide burden that causes hundreds of thousands of deaths every year.  New, affordable and safe drugs are required to overcome increasing resistance against artemisinin-based treatments, treat vulnerable populations, interrupt the parasite life cycle by blocking transmission to the vectors, prevent infection and target malaria species that transiently remain dormant in the liver.  In this Review, we discuss how the antimalarial drug discovery pipeline has changed over the past 10 years, grouped by the various target compd. or product profiles, to assess progress and gaps, and to recommend priorities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAJNZa5gyvg7Vg90H21EOLACvtfcHk0lioqPqfSEnnPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM&md5=43f35590f86c240a4150b5cb4f5670ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd4573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4573%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DMalaria%2520medicines%253A%2520a%2520glass%2520half%2520full%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D424%26epage%3D442%26doi%3D10.1038%2Fnrd4573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mytelka, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunwiddie, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persinger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munos, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindborg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schacht, A. L.</span><span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industryâs grand challenge</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">â</span> <span class="NLM_lpage">214</span><span class="refDoi">Â DOI: 10.1038/nrd3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge&doi=10.1038%2Fnrd3078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lioqPqfSEnnPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214%26doi%3D10.1038%2Fnrd3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easom, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. Part 4. discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5344</span><span class="NLM_x">â</span> <span class="NLM_lpage">5354</span><span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00678</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVans7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5344-5354&author=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=E.+E.+Easomauthor=R.+T.+Jacobsauthor=D.+Guoauthor=V.+Sandersauthor=Y.+Freundauthor=B.+Campoauthor=P.+J.+Rosenthalauthor=W.+Buauthor=F.-J.+Gamoauthor=L.+M.+Sanzauthor=M.+Geauthor=L.+Liauthor=J.+Dingauthor=Y.+Yang&title=Benzoxaborole+antimalarial+agents.+Part+4.+discovery+of+potent+6-%282-%28alkoxycarbonyl%29pyrazinyl-5-oxy%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1021%2Facs.jmedchem.5b00678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Easom, Eric E.; Jacobs, Robert T.; Guo, Denghui; Sanders, Virginia; Freund, Yvonne R.; Campo, Brice; Rosenthal, Philip J.; Bu, Wei; Gamo, Francisco-Javier; Sanz, Laura M.; Ge, Min; Li, Liang; Ding, Jie; Yang, Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5344-5354</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Hetaryloxy benzoxaborole compds. were designed and synthesized for a structure-activity relation (SAR) study to assess the changes in antimalarial activity which result from 6-aryloxy structural variation, substituent modification on the pyrazine ring, and optimization of the side chain ester group.  This SAR study discovered highly potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles (9, 27-34) with IC50s = 0.2-22 nM against cultured Plasmodium falciparum W2 and 3D7 strains.  Compd. 9 also demonstrated excellent in vivo efficacy against P. berghei in infected mice (ED90 = 7.0 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNOCdVBsF4LVg90H21EOLACvtfcHk0liS-mYfOEpMPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVans7jK&md5=32ac4a49fdf60084bfc351c74f6a6c67</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00678%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520Part%25204.%2520discovery%2520of%2520potent%25206-%25282-%2528alkoxycarbonyl%2529pyrazinyl-5-oxy%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5344%26epage%3D5354%26doi%3D10.1021%2Facs.jmedchem.5b00678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JimÃ©nez-DÃ­az, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JimÃ©nez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regadera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GÃ³mez de las Heras, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span> </span><span class="NLM_article-title">A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2252</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0002252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1371%2Fjournal.pone.0002252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=18493601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2252&author=I.+Angulo-Barturenauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=T.+Muletauthor=J.+Rullasauthor=E.+Herrerosauthor=S.+Ferrerauthor=E.+Jim%C3%A9nezauthor=A.+Mendozaauthor=J.+Regaderaauthor=P.+J.+Rosenthalauthor=I.+Bathurstauthor=D.+L.+Pomplianoauthor=F.+G%C3%B3mez+de+las+Herasauthor=D.+Gargallo-Viola&title=A+murine+model+of+falciparum-malaria+by+in+vivo+selection+of+competent+strains+in+non-myelodepleted+mice+engrafted+with+human+erythrocytes&doi=10.1371%2Fjournal.pone.0002252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span></div><div class="casAuthors">Angulo-Barturen Inigo; Jimenez-Diaz Maria Belen; Mulet Teresa; Rullas Joaquin; Herreros Esperanza; Ferrer Santiago; Jimenez Elena; Mendoza Alfonso; Regadera Javier; Rosenthal Philip J; Bathurst Ian; Pompliano David L; Gomez de las Heras Federico; Gargallo-Viola Domingo</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2252</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To counter the global threat caused by Plasmodium falciparum malaria, new drugs and vaccines are urgently needed.  However, there are no practical animal models because P. falciparum infects human erythrocytes almost exclusively.  Here we describe a reliable falciparum murine model of malaria by generating strains of P. falciparum in vivo that can infect immunodeficient mice engrafted with human erythrocytes.  We infected NOD(scid/beta2m-/-) mice engrafted with human erythrocytes with P. falciparum obtained from in vitro cultures.  After apparent clearance, we obtained isolates of P. falciparum able to grow in peripheral blood of engrafted NOD(scid/beta2m-/-) mice.  Of the isolates obtained, we expanded in vivo and established the isolate Pf3D7(0087/N9) as a reference strain for model development.  Pf3D7(0087/N9) caused productive persistent infections in 100% of engrafted mice infected intravenously.  The infection caused a relative anemia due to selective elimination of human erythrocytes by a mechanism dependent on parasite density in peripheral blood.  Using this model, we implemented and validated a reproducible assay of antimalarial activity useful for drug discovery.  Thus, our results demonstrate that P. falciparum contains clones able to grow reproducibly in mice engrafted with human erythrocytes without the use of myeloablative methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGBUV1EinlYVHFYivNCdPRfW6udTcc2eZJw21Jn_lKlbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D&md5=02f4475ecc0524005f4538e98a0649d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002252%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRegadera%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DG%25C3%25B3mez%2Bde%2Blas%2BHeras%26aufirst%3DF.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26atitle%3DA%2520murine%2520model%2520of%2520falciparum-malaria%2520by%2520in%2520vivo%2520selection%2520of%2520competent%2520strains%2520in%2520non-myelodepleted%2520mice%2520engrafted%2520with%2520human%2520erythrocytes%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2252%26doi%3D10.1371%2Fjournal.pone.0002252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De-CÃ³zar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llergo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GarcÃ­a-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J. P.</span><span> </span><span class="NLM_article-title">falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30949</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-C%C3%B3zarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.-J.+P.+Gamo&title=falciparum+in+vitro+killing+rates+allow+to+discriminate+between+different+antimalarial+mode-of-action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0lhwB35MVUN2WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-C%25C3%25B3zar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.-J.%2BP.%26atitle%3Dfalciparum%2520in%2520vitro%2520killing%2520rates%2520allow%2520to%2520discriminate%2520between%2520different%2520antimalarial%2520mode-of-action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Maron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B. N.</span><span> </span><span class="NLM_article-title">Revised Methods for the Salmonella Mutagenicity Test</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">â</span> <span class="NLM_lpage">215</span><span class="refDoi">Â DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+Methods+for+the+Salmonella+Mutagenicity+Test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0lhwB35MVUN2WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520Methods%2520for%2520the%2520Salmonella%2520Mutagenicity%2520Test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tice, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakey, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch-Volders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleson, F. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchierotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannier, B.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> rodent erythrocyte micronucleus assay</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">â</span> <span class="NLM_lpage">304</span><span class="refDoi">Â DOI: 10.1016/0165-1161(94)90039-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1016%2F0165-1161%2894%2990039-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=7514741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1yksr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=1994&pages=293-304&author=M.+Hayashiauthor=R.+R.+Ticeauthor=J.+T.+MacGregorauthor=D.+Andersonauthor=D.+H.+Blakeyauthor=M.+Kirsch-Voldersauthor=F.+B.+Olesonauthor=F.+Pacchierottiauthor=F.+Romagnaauthor=H.+Shimadaauthor=S.+Sutouauthor=B.+Vannier&title=In+vivo+rodent+erythrocyte+micronucleus+assay&doi=10.1016%2F0165-1161%2894%2990039-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo rodent erythrocyte micronucleus assay</span></div><div class="casAuthors">Hayashi, Makoto; Tice, Raymond R.; MacGregor, James T.; Anderson, Diana; Blakey, David H.; Kirsh-Volders, M.; Oleson, Frederick B. Jr.; Pacchierotti, Francesca; Romagna, Felix; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The anal. of immature erythrocytes in either bone marrow or peripheral blood is equally acceptable for those species in which the spleen does not remove micronucleated erythrocytes.  In the mouse, mature erythrocytes are also an acceptable cell population for micronucleus anal. when the exposure duration exceeds 4 wk.  Org. solvents such as DMSO are not recommended.  Freshly prepd. solns. or suspensions should be used unless stability data demonstrate the acceptability of storage.  Vegetable oils are acceptable as solvents or vehicles.  Suspension of the test chems. is acceptable for p.o. or i.p. administration but not for i.v. injection.  The use of any unusual solvent should be justified.  Any commonly used lab. rodent species is acceptable.  There is no strain preference.  The size of expt. (i.e., no. of cells per animal, no. of animals per group) should be finalized based on statistical considerations.  Although a consensus was not achieved, operationally it was agreed that 2000 cells per animal and four animals per group was a min. requirement.  In general, the available database suggests that the use of one gender is adequate for screening.  However, if there is evidence indicating a significant difference in the toxicity between male and female, then both sexes should be used.  No unique treatment schedule can be recommended.  Results from extended dose regimens are acceptable as long as pos.  For neg. studies, toxicity should be demonstrated or the limit dose should be used, and dosing continued until sampling.  At least three dose levels sepd. by a factor between 2 and 10 should be used.  The highest dose tested should be the max. tolerated dose based on mortality, bone marrow cell toxicity, or clin. symptoms of toxicity.  The limit dose is 2 g/kg/day for treatment periods of 14 days or less and 1 g/kg/day for treatment periods greater than 14 days.  A single dose level (the limit dose) is acceptable if there is no evidence of toxicity.  Concurrent solvent (vehicle) controls should be included at all sampling times.  A pretreatment sample, however, may also be acceptable only in the short treatment period peripheral blood studies.  A concurrent pos. control group should be included for each expt.  It is acceptable that the pos. control may be administered by a route different from the test agent and sampled at only a single time.  For the bone marrow assay, two sample times (24 and 48 h) should be used after a single administration, or one sample time between 18 and 24 h after the last of two or more repeated administrations.  For the peripheral blood assay, two sample times (48 and 72 h) are used after a single administration, or one sample time between 36 and 48 h is used after the last of two or more repeated administrations.  For a longer treatment study, one sample time any time up to 48 h after the last dose is acceptable.  All slides should be coded.  The frequency of micronucleated immature erythrocytes is the principal endpoint.  The frequencies of micronucleated mature erythrocytes in the mouse can also be the endpoint for the longer repeated treatment study (4 wk or more).  When analyzing slides, the percentage of immature erythrocytes among total erythrocytes should not be less than 20% of the control value (i.e., 10% for 50% in the control).  To assess cytotoxicity, at least 200 bone marrow erythrocytes per animal or at least 1000 peripheral blood erythrocytes per animal should be obsd.  Although a consensus was not achieved, it was generally agreed that both a trend test and also pairwise tests were appropriate.  Historical neg. control data should be used to det. if the concurrent control response is acceptable.  The test response will be deemed pos. if there is a statistically significant increase in micronucleated erythrocytes and the increase is significantly dose-dependent.  If neither of the above conditions is met, the test response will be classified as neg.  If either, but not both, of the above conditions is met, the assay results will be classified as equivocal and, only in this case, a repeat or confirmatory test will be required.  These topics were discussed by all participants involved in the in vivo micronucleus and chromosomal aberration groups.  Some general topics were also discussed at the in vivo working group.  Many of these topics had been discussed by mail between invited discussants (members listed above plus those who could not attend the workshop) and the Chairmen prior to the Melbourne workshop.  This proposed protocol is based on the following principles. (1) Recognition of the minimal requirements to produce a reliable, interpretable assay. (2)That uniform criteria should be applied to different in vivo assays. (3)That the primary purpose of these assays is hazard identification and not risk assessment. (4)That acceptable criteria should be based on exptl. data whenever possible, rather than theor. expectations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb8eiS6oiDh7Vg90H21EOLACvtfcHk0lhwB35MVUN2WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1yksr4%253D&md5=0d477bbcd12e8ff78c6dfeb3b63d3cab</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2894%2990039-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252894%252990039-6%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DTice%26aufirst%3DR.%2BR.%26aulast%3DMacGregor%26aufirst%3DJ.%2BT.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DBlakey%26aufirst%3DD.%2BH.%26aulast%3DKirsch-Volders%26aufirst%3DM.%26aulast%3DOleson%26aufirst%3DF.%2BB.%26aulast%3DPacchierotti%26aufirst%3DF.%26aulast%3DRomagna%26aufirst%3DF.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSutou%26aufirst%3DS.%26aulast%3DVannier%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520rodent%2520erythrocyte%2520micronucleus%2520assay%26jtitle%3DMutat.%2520Res.%26date%3D1994%26volume%3D312%26spage%3D293%26epage%3D304%26doi%3D10.1016%2F0165-1161%2894%2990039-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>OECD Guidelines for Testing of Chemicals, Guideline 474 (Genetic Toxicology: Mammalian Erythrocyte Micronucleus Test); updated guidance adopted Sep 26,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=OECD+Guidelines+for+Testing+of+Chemicals%2C+Guideline+474+%28Genetic+Toxicology%3A+Mammalian+Erythrocyte+Micronucleus+Test%29%3B+updated+guidance+adopted+Sep+26%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DOECD%2520Guidelines%2520for%2520Testing%2520of%2520Chemicals%252C%2520Guideline%2520474%2520%2528Genetic%2520Toxicology%253A%2520Mammalian%2520Erythrocyte%2520Micronucleus%2520Test%2529%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 30 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tsutomu Akama, Yvonne R. Freund, Pamela W. Berry, David S. Carter, Eric E. Easom, Kurt Jarnagin, Christopher S. Lunde, Jacob J. Plattner, Fernando Rock, Rianna Stefanakis, Chelsea Fischer, Christina A. Bulman, Kee Chong Lim, Brian M. Suzuki, Nancy Tricoche, Abdelmoneim Mansour, Utami DiCosty, Scott McCall, Ben Carson, John W. McCall, James McKerrow, Marc P. HÃ¼bner, Sabine Specht, Achim Hoerauf, Sara Lustigman, Judy A. Sakanari, <span class="NLM_string-name hlFld-ContribAuthor">Robert T. Jacobs</span>. </span><span class="cited-content_cbyCitation_article-title">Macrofilaricidal BenzimidazoleâBenzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked Analogs. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (2)
                                     , 173-179. <a href="https://doi.org/10.1021/acsinfecdis.9b00396" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00396%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DMacrofilaricidal%252BBenzimidazole%2525E2%252580%252593Benzoxaborole%252BHybrids%252Bas%252Ban%252BApproach%252Bto%252Bthe%252BTreatment%252Bof%252BRiver%252BBlindness%25253A%252BPart%252B1.%252BAmide%252BLinked%252BAnalogs%26aulast%3DAkama%26aufirst%3DTsutomu%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D18102019%26date%3D14012020%26date%3D26122019%26volume%3D6%26issue%3D2%26spage%3D173%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David S. Carter, Robert T. Jacobs, Yvonne R. Freund, Pamela W. Berry, Tsutomu Akama, Eric E. Easom, Christopher S. Lunde, Fernando Rock, Rianna Stefanakis, James McKerrow, Chelsea Fischer, Christina A. Bulman, Kee Chong Lim, Brian M. Suzuki, Nancy Tricoche, Judy A. Sakanari, Sara Lustigman, <span class="NLM_string-name hlFld-ContribAuthor">Jacob J. Plattner</span>. </span><span class="cited-content_cbyCitation_article-title">Macrofilaricidal BenzimidazoleâBenzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (2)
                                     , 180-185. <a href="https://doi.org/10.1021/acsinfecdis.9b00397" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00397%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DMacrofilaricidal%252BBenzimidazole%2525E2%252580%252593Benzoxaborole%252BHybrids%252Bas%252Ban%252BApproach%252Bto%252Bthe%252BTreatment%252Bof%252BRiver%252BBlindness%25253A%252BPart%252B2.%252BKetone%252BLinked%252BAnalogs%26aulast%3DCarter%26aufirst%3DDavid%2BS.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D18102019%26date%3D28012020%26date%3D26122019%26volume%3D6%26issue%3D2%26spage%3D180%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Haibo Mei, Jianlin Han, Ryosuke Takeda, Tsubasa Sakamoto, Toshio Miwa, Yutaka Minamitsuji, Hiroki Moriwaki, Hidenori Abe, <span class="NLM_string-name hlFld-ContribAuthor">Vadim A. Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Method for Preparation of (S)-2-Amino-5,5,5-trifluoropentanoic Acid via Dynamic Kinetic Resolution. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (7)
                                     , 11844-11851. <a href="https://doi.org/10.1021/acsomega.9b01537" title="DOI URL">https://doi.org/10.1021/acsomega.9b01537</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b01537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b01537%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPractical%252BMethod%252Bfor%252BPreparation%252Bof%252B%252528S%252529-2-Amino-5%25252C5%25252C5-trifluoropentanoic%252BAcid%252Bvia%252BDynamic%252BKinetic%252BResolution%26aulast%3DMei%26aufirst%3DHaibo%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26052019%26date%3D25062019%26volume%3D4%26issue%3D7%26spage%3D11844%26epage%3D11851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiong Zhang, Jinyi Zhang, Guiyun Hao, Weixiang Xin, Fei Yang, Mingyan Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Huchen Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and StructureâActivity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6765-6784. <a href="https://doi.org/10.1021/acs.jmedchem.9b00736" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00736%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252B7-Propanamide%252BBenzoxaboroles%252Bas%252BPotent%252BAnticancer%252BAgents%26aulast%3DZhang%26aufirst%3DJiong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05052019%26date%3D02072019%26date%3D20062019%26volume%3D62%26issue%3D14%26spage%3D6765%26epage%3D6784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo Saul  Coghi</span>, <span class="hlFld-ContribAuthor ">Yinghuai  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongming  Xie</span>, <span class="hlFld-ContribAuthor ">Narayan S.  Hosmane</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3309. <a href="https://doi.org/10.3390/molecules26113309" title="DOI URL">https://doi.org/10.3390/molecules26113309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113309%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOrganoboron%252BCompounds%25253A%252BEffective%252BAntibacterial%252Band%252BAntiparasitic%252BAgents%26aulast%3DCoghi%26aufirst%3DPaolo%2BSaul%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anu  Saini</span>, <span class="hlFld-ContribAuthor ">Sumit  Kumar</span>, <span class="hlFld-ContribAuthor ">Raghu  Raj</span>, <span class="hlFld-ContribAuthor ">Shefali  Chowdhary</span>, <span class="hlFld-ContribAuthor ">Mathieu  Gendrot</span>, <span class="hlFld-ContribAuthor ">Joel  Mosnier</span>, <span class="hlFld-ContribAuthor ">Isabelle  Fonta</span>, <span class="hlFld-ContribAuthor ">Bruno  Pradines</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiplasmodial evaluation of 1H-1,2,3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104733. <a href="https://doi.org/10.1016/j.bioorg.2021.104733" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104733%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiplasmodial%252Bevaluation%252Bof%252B1H-1%25252C2%25252C3-triazole%252Bgrafted%252B4-aminoquinoline-benzoxaborole%252Bhybrids%252Band%252Bbenzoxaborole%252Banalogues%26aulast%3DSaini%26aufirst%3DAnu%26date%3D2021%26volume%3D109%26spage%3D104733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna N.  Tevyashova</span>, <span class="hlFld-ContribAuthor ">Mikhail V.  Chudinov</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the medicinal chemistry of organoboron compounds. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2021,</strong> <em>90 </em>
                                    (4)
                                     , 451-487. <a href="https://doi.org/10.1070/RCR4977" title="DOI URL">https://doi.org/10.1070/RCR4977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4977%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DProgress%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Borganoboron%252Bcompounds%26aulast%3DTevyashova%26aufirst%3DAnna%2BN.%26date%3D2021%26volume%3D90%26issue%3D4%26spage%3D451%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the medicinal chemistry of single boron atom-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>73 </em><a href="https://doi.org/10.1016/j.apsb.2021.01.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bsingle%252Bboron%252Batom-containing%252Bcompounds%26aulast%3DSong%26aufirst%3DShu%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hari  Madhav</span>, <span class="hlFld-ContribAuthor ">Nasimul  Hoda</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112955. <a href="https://doi.org/10.1016/j.ejmech.2020.112955" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112955%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Binto%252Bthe%252Brecent%252Bdevelopment%252Bof%252Bthe%252Bclinical%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252Bmalaria%252Band%252Btheir%252Btarget%252Bproteins%26aulast%3DMadhav%26aufirst%3DHari%26date%3D2021%26volume%3D210%26spage%3D112955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeria  Bellini</span>, <span class="hlFld-ContribAuthor ">Christopher  Swale</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Brenier-Pinchart</span>, <span class="hlFld-ContribAuthor ">Tiffany  Pezier</span>, <span class="hlFld-ContribAuthor ">Sonia  Georgeault</span>, <span class="hlFld-ContribAuthor ">Fabrice  Laurent</span>, <span class="hlFld-ContribAuthor ">Mohamed-Ali  Hakimi</span>, <span class="hlFld-ContribAuthor ">Alexandre  Bougdour</span>. </span><span class="cited-content_cbyCitation_article-title">Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2020,</strong> <em>23 </em>
                                    (12)
                                     , 101871. <a href="https://doi.org/10.1016/j.isci.2020.101871" title="DOI URL">https://doi.org/10.1016/j.isci.2020.101871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2020.101871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2020.101871%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DTarget%252BIdentification%252Bof%252Ban%252BAntimalarial%252BOxaborole%252BIdentifies%252BAN13762%252Bas%252Ban%252BAlternative%252BChemotype%252Bfor%252BTargeting%252BCPSF3%252Bin%252BApicomplexan%252BParasites%26aulast%3DBellini%26aufirst%3DValeria%26date%3D2020%26volume%3D23%26issue%3D12%26spage%3D101871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elahe  Yazdani</span>, <span class="hlFld-ContribAuthor ">Farzane  Pazoki</span>, <span class="hlFld-ContribAuthor ">Arefe  Salamatmanesh</span>, <span class="hlFld-ContribAuthor ">Masoume Jadidi  Nejad</span>, <span class="hlFld-ContribAuthor ">Maryam Kazemi  Miraki</span>, <span class="hlFld-ContribAuthor ">Akbar  Heydari</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of acetamides via oxidative CâC bond cleavage of ketones catalyzed by Cuâimmobilized magnetic nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2020,</strong> <em>34 </em>
                                    (10)
                                     <a href="https://doi.org/10.1002/aoc.5855" title="DOI URL">https://doi.org/10.1002/aoc.5855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.5855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.5855%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bacetamides%252Bvia%252Boxidative%252BC%2525E2%252580%252593C%252Bbond%252Bcleavage%252Bof%252Bketones%252Bcatalyzed%252Bby%252BCu%2525E2%252580%252590immobilized%252Bmagnetic%252Bnanoparticles%26aulast%3DYazdani%26aufirst%3DElahe%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana Pereira  Silva</span>, <span class="hlFld-ContribAuthor ">LucÃ­lia  Saraiva</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>, <span class="hlFld-ContribAuthor ">Maria EmÃ­lia  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4323. <a href="https://doi.org/10.3390/molecules25184323" title="DOI URL">https://doi.org/10.3390/molecules25184323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184323%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBoronic%252BAcids%252Band%252BTheir%252BDerivatives%252Bin%252BMedicinal%252BChemistry%25253A%252BSynthesis%252Band%252BBiological%252BApplications%26aulast%3DSilva%26aufirst%3DMariana%2BPereira%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of boronic acid drugs. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112270. <a href="https://doi.org/10.1016/j.ejmech.2020.112270" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112270%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252Bboronic%252Bacid%252Bdrugs%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2020%26volume%3D195%26spage%3D112270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yupiao  Zou</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>, <span class="hlFld-ContribAuthor ">Ashot S.  Saghyan</span>, <span class="hlFld-ContribAuthor ">Anna F.  Mkrtchyan</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Konno</span>, <span class="hlFld-ContribAuthor ">Hiroki  Moriwaki</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Synthesis of Tailor-Made Amino Acids Using Chiral Ni(II) Complexes of Schiff Bases. An Update of the Recent Literature. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2739. <a href="https://doi.org/10.3390/molecules25122739" title="DOI URL">https://doi.org/10.3390/molecules25122739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25122739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25122739%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAsymmetric%252BSynthesis%252Bof%252BTailor-Made%252BAmino%252BAcids%252BUsing%252BChiral%252BNi%252528II%252529%252BComplexes%252Bof%252BSchiff%252BBases.%252BAn%252BUpdate%252Bof%252Bthe%252BRecent%252BLiterature%26aulast%3DZou%26aufirst%3DYupiao%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirthana M. V.  Sindhe</span>, <span class="hlFld-ContribAuthor ">Wesley  Wu</span>, <span class="hlFld-ContribAuthor ">Jenny  Legac</span>, <span class="hlFld-ContribAuthor ">Yong-Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Eric E.  Easom</span>, <span class="hlFld-ContribAuthor ">Roland A.  Cooper</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Yvonne R.  Freund</span>, <span class="hlFld-ContribAuthor ">Joseph L.  DeRisi</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, . </span><span class="cited-content_cbyCitation_article-title">Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/mBio.02640-19" title="DOI URL">https://doi.org/10.1128/mBio.02640-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.02640-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.02640-19%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DPlasmodium%252Bfalciparum%252BResistance%252Bto%252Ba%252BLead%252BBenzoxaborole%252BDue%252Bto%252BBlocked%252BCompound%252BActivation%252Band%252BAltered%252BUbiquitination%252Bor%252BSumoylation%26aulast%3DSindhe%26aufirst%3DKirthana%2BM.%2BV.%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ren</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Damin  Zhao</span>, <span class="hlFld-ContribAuthor ">Qinglin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiayun  Chang</span>, <span class="hlFld-ContribAuthor ">Xiangyi  He</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Gao</span>, <span class="hlFld-ContribAuthor ">Peng  Lu</span>, <span class="hlFld-ContribAuthor ">Xiquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongjiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yinsheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 115236. <a href="https://doi.org/10.1016/j.bmc.2019.115236" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115236%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bboron-containing%252Bdiphenylpyrimidines%252Bas%252Bpotent%252BBTK%252Band%252BJAK3%252Bdual%252Binhibitors%26aulast%3DRen%26aufirst%3DJing%26date%3D2020%26volume%3D28%26issue%3D2%26spage%3D115236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katrien  Van Bocxlaer</span>, <span class="hlFld-ContribAuthor ">Diana  Caridha</span>, <span class="hlFld-ContribAuthor ">Chad  Black</span>, <span class="hlFld-ContribAuthor ">Brian  Vesely</span>, <span class="hlFld-ContribAuthor ">Susan  Leed</span>, <span class="hlFld-ContribAuthor ">Richard J.  Sciotti</span>, <span class="hlFld-ContribAuthor ">Gert-Jan  Wijnant</span>, <span class="hlFld-ContribAuthor ">Vanessa  Yardley</span>, <span class="hlFld-ContribAuthor ">StÃ©phanie  Braillard</span>, <span class="hlFld-ContribAuthor ">Charles E.  Mowbray</span>, <span class="hlFld-ContribAuthor ">Jean-Robert  Ioset</span>, <span class="hlFld-ContribAuthor ">Simon L.  Croft</span>. </span><span class="cited-content_cbyCitation_article-title">Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology: Drugs and Drug Resistance</span><span> <strong>2019,</strong> <em>11 </em>, 129-138. <a href="https://doi.org/10.1016/j.ijpddr.2019.02.002" title="DOI URL">https://doi.org/10.1016/j.ijpddr.2019.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpddr.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpddr.2019.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%253A%2520Drugs%2520and%2520Drug%2520Resistance%26atitle%3DNovel%252Bbenzoxaborole%25252C%252Bnitroimidazole%252Band%252Baminopyrazoles%252Bwith%252Bactivity%252Bagainst%252Bexperimental%252Bcutaneous%252Bleishmaniasis%26aulast%3DVan%2BBocxlaer%26aufirst%3DKatrien%26date%3D2019%26volume%3D11%26spage%3D129%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher S.  Lunde</span>, <span class="hlFld-ContribAuthor ">Erin E.  Stebbins</span>, <span class="hlFld-ContribAuthor ">Rajiv S.  Jumani</span>, <span class="hlFld-ContribAuthor ">Md Mahmudul  Hasan</span>, <span class="hlFld-ContribAuthor ">Peter  Miller</span>, <span class="hlFld-ContribAuthor ">John  Barlow</span>, <span class="hlFld-ContribAuthor ">Yvonne R.  Freund</span>, <span class="hlFld-ContribAuthor ">Pamela  Berry</span>, <span class="hlFld-ContribAuthor ">Rianna  Stefanakis</span>, <span class="hlFld-ContribAuthor ">Jiri  Gut</span>, <span class="hlFld-ContribAuthor ">Philip J.  Rosenthal</span>, <span class="hlFld-ContribAuthor ">Melissa S.  Love</span>, <span class="hlFld-ContribAuthor ">Case W.  McNamara</span>, <span class="hlFld-ContribAuthor ">Eric  Easom</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Robert T.  Jacobs</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Huston</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-10687-y" title="DOI URL">https://doi.org/10.1038/s41467-019-10687-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-10687-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-10687-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DIdentification%252Bof%252Ba%252Bpotent%252Bbenzoxaborole%252Bdrug%252Bcandidate%252Bfor%252Btreating%252Bcryptosporidiosis%26aulast%3DLunde%26aufirst%3DChristopher%2BS.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwin G.  Tse</span>, <span class="hlFld-ContribAuthor ">Marat  Korsik</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Todd</span>. </span><span class="cited-content_cbyCitation_article-title">The past, present and future of anti-malarial medicines. </span><span class="cited-content_cbyCitation_journal-name">Malaria Journal</span><span> <strong>2019,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12936-019-2724-z" title="DOI URL">https://doi.org/10.1186/s12936-019-2724-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12936-019-2724-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12936-019-2724-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMalaria%2520Journal%26atitle%3DThe%252Bpast%25252C%252Bpresent%252Band%252Bfuture%252Bof%252Banti-malarial%252Bmedicines%26aulast%3DTse%26aufirst%3DEdwin%2BG.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanpeng  Liu</span>, <span class="hlFld-ContribAuthor ">Lixue  Lu</span>, <span class="hlFld-ContribAuthor ">Haipin  Zhou</span>, <span class="hlFld-ContribAuthor ">Feijie  Xu</span>, <span class="hlFld-ContribAuthor ">Cong  Ma</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Chemodivergent synthesis of
              N
              -(pyridin-2-yl)amides and 3-bromoimidazo[1,2-
              a
              ]pyridines from Î±-bromoketones and 2-aminopyridines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (59)
                                     , 34671-34676. <a href="https://doi.org/10.1039/C9RA06724H" title="DOI URL">https://doi.org/10.1039/C9RA06724H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA06724H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA06724H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DChemodivergent%252Bsynthesis%252Bof%252BN%252B-%252528pyridin-2-yl%252529amides%252Band%252B3-bromoimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bfrom%252B%2525CE%2525B1-bromoketones%252Band%252B2-aminopyridines%26aulast%3DLiu%26aufirst%3DYanpeng%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D59%26spage%3D34671%26epage%3D34676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Felipe Santos  Fernandes</span>, <span class="hlFld-ContribAuthor ">William Alexander  Denny</span>, <span class="hlFld-ContribAuthor ">Jean Leandro  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Boron in drug design: Recent advances in the development of new therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 791-804. <a href="https://doi.org/10.1016/j.ejmech.2019.06.092" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.092%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBoron%252Bin%252Bdrug%252Bdesign%25253A%252BRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Bnew%252Btherapeutic%252Bagents%26aulast%3DFernandes%26aufirst%3DGuilherme%2BFelipe%2BSantos%26date%3D2019%26volume%3D179%26spage%3D791%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dharmendra K.  Yadav</span>, <span class="hlFld-ContribAuthor ">Surendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Mahesh K.  Teli</span>, <span class="hlFld-ContribAuthor ">Ravikant  Yadav</span>, <span class="hlFld-ContribAuthor ">Sandeep  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targets for Malarial Chemotherapy: A Review. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (10)
                                     , 861-873. <a href="https://doi.org/10.2174/1568026619666190603080000" title="DOI URL">https://doi.org/10.2174/1568026619666190603080000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190603080000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190603080000%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BTargets%252Bfor%252BMalarial%252BChemotherapy%25253A%252BA%252BReview%26aulast%3DYadav%26aufirst%3DDharmendra%2BK.%26date%3D2019%26volume%3D19%26issue%3D10%26spage%3D861%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagaraju  Vodnala</span>, <span class="hlFld-ContribAuthor ">Raghuram  Gujjarappa</span>, <span class="hlFld-ContribAuthor ">Chinmoy K.  Hazra</span>, <span class="hlFld-ContribAuthor ">Dhananjaya  Kaldhi</span>, <span class="hlFld-ContribAuthor ">Arup. K.  Kabi</span>, <span class="hlFld-ContribAuthor ">Uwe  Beifuss</span>, <span class="hlFld-ContribAuthor ">Chandi C.  Malakar</span>. </span><span class="cited-content_cbyCitation_article-title">CopperâCatalyzed SiteâSelective Oxidative CâC Bond Cleavage of Simple Ketones for the Synthesis of Anilides and Paracetamol. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (1)
                                     , 135-145. <a href="https://doi.org/10.1002/adsc.201801096" title="DOI URL">https://doi.org/10.1002/adsc.201801096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201801096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201801096%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCopper%2525E2%252580%252590Catalyzed%252BSite%2525E2%252580%252590Selective%252BOxidative%252BC%2525E2%252588%252592C%252BBond%252BCleavage%252Bof%252BSimple%252BKetones%252Bfor%252Bthe%252BSynthesis%252Bof%252BAnilides%252Band%252BParacetamol%26aulast%3DVodnala%26aufirst%3DNagaraju%26date%3D2019%26date%3D2018%26volume%3D361%26issue%3D1%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean  Fotie</span>. </span><span class="cited-content_cbyCitation_article-title">Marine natural products as strategic prototypes in the development of a new generation of antimalarial agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 7-47. <a href="https://doi.org/10.1016/B978-0-12-815723-7.00002-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-815723-7.00002-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-815723-7.00002-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-815723-7.00002-X%26sid%3Dliteratum%253Aachs%26atitle%3DMarine%252Bnatural%252Bproducts%252Bas%252Bstrategic%252Bprototypes%252Bin%252Bthe%252Bdevelopment%252Bof%252Ba%252Bnew%252Bgeneration%252Bof%252Bantimalarial%252Bagents%26aulast%3DFotie%26aufirst%3DJean%26date%3D2019%26spage%3D7%26epage%3D47%26pub%3DElsevier%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BTherapeutics%252Bfrom%252BNatural%252BProducts%252BAgainst%252BNeglected%252BTropical%252BDiseases%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piyush N.  Kalaria</span>, <span class="hlFld-ContribAuthor ">Sharad C.  Karad</span>, <span class="hlFld-ContribAuthor ">Dipak K.  Raval</span>. </span><span class="cited-content_cbyCitation_article-title">A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 917-936. <a href="https://doi.org/10.1016/j.ejmech.2018.08.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252Bdiverse%252Bheterocyclic%252Bcompounds%252Bas%252Bthe%252Bprivileged%252Bscaffolds%252Bin%252Bantimalarial%252Bdrug%252Bdiscovery%26aulast%3DKalaria%26aufirst%3DPiyush%2BN.%26date%3D2018%26volume%3D158%26spage%3D917%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Begolo</span>, <span class="hlFld-ContribAuthor ">Isabel M.  Vincent</span>, <span class="hlFld-ContribAuthor ">Federica  Giordani</span>, <span class="hlFld-ContribAuthor ">Ina  PÃ¶hner</span>, <span class="hlFld-ContribAuthor ">Michael J.  Witty</span>, <span class="hlFld-ContribAuthor ">Timothy G.  Rowan</span>, <span class="hlFld-ContribAuthor ">Zakaria  Bengaly</span>, <span class="hlFld-ContribAuthor ">Kirsten  Gillingwater</span>, <span class="hlFld-ContribAuthor ">Yvonne  Freund</span>, <span class="hlFld-ContribAuthor ">Rebecca C.  Wade</span>, <span class="hlFld-ContribAuthor ">Michael P.  Barrett</span>, <span class="hlFld-ContribAuthor ">Christine  Clayton</span>, . </span><span class="cited-content_cbyCitation_article-title">The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2018,</strong> <em>14 </em>
                                    (9)
                                     , e1007315. <a href="https://doi.org/10.1371/journal.ppat.1007315" title="DOI URL">https://doi.org/10.1371/journal.ppat.1007315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1007315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1007315%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DThe%252Btrypanocidal%252Bbenzoxaborole%252BAN7973%252Binhibits%252Btrypanosome%252BmRNA%252Bprocessing%26aulast%3DBegolo%26aufirst%3DDaniela%26date%3D2018%26date%3D2018%26volume%3D14%26issue%3D9%26spage%3De1007315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gautam R.  Mereddy</span>, <span class="hlFld-ContribAuthor ">Anjali  Chakradhar</span>, <span class="hlFld-ContribAuthor ">Ryan M.  Rutkoski</span>, <span class="hlFld-ContribAuthor ">Subash C.  Jonnalagadda</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoboroxoles: Synthesis and applications in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2018,</strong> <em>865 </em>, 12-22. <a href="https://doi.org/10.1016/j.jorganchem.2018.03.017" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2018.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2018.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2018.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DBenzoboroxoles%25253A%252BSynthesis%252Band%252Bapplications%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMereddy%26aufirst%3DGautam%2BR.%26date%3D2018%26volume%3D865%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Yang</span>, <span class="hlFld-ContribAuthor ">Mingyan  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Huchen  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of biologically active boron-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 201-211. <a href="https://doi.org/10.1039/C7MD00552K" title="DOI URL">https://doi.org/10.1039/C7MD00552K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00552K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00552K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Bof%252Bbiologically%252Bactive%252Bboron-containing%252Bcompounds%26aulast%3DYang%26aufirst%3DFei%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Okombo</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>. </span><span class="cited-content_cbyCitation_article-title">Recent updates in the discovery and development of novel antimalarial drug candidates. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 437-453. <a href="https://doi.org/10.1039/C7MD00637C" title="DOI URL">https://doi.org/10.1039/C7MD00637C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00637C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00637C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Bupdates%252Bin%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bnovel%252Bantimalarial%252Bdrug%252Bcandidates%26aulast%3DOkombo%26aufirst%3DJohn%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D437%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhua  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenghui  Huang</span>, <span class="hlFld-ContribAuthor ">Wanyan  Wang</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Longfei  Guan</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Huang</span>, <span class="hlFld-ContribAuthor ">Lubin  Jiang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6467-6478. <a href="https://doi.org/10.1016/j.bmc.2017.10.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bantimalarial%252Bagents%25253A%252BSecond-generation%252Bdual%252Binhibitors%252Bagainst%252BFP-2%252Band%252BPfDHFR%252Bvia%252Bfragments%252Bassembely%26aulast%3DChen%26aufirst%3DWenhua%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6467%26epage%3D6478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Building on previous antimalarial benzoxaborole molecules (<b>1</b> and <b>2</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> novel compounds (<b>3</b>â<b>51</b>) were designed and synthesized for a lead optimization program to improve potency, pharmacokinetic property, and <i>in vivo</i> efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of a Common Benzoxaborole Intermediate <b>58</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, N<sub>2</sub>, 0â20 Â°C, 16 h, then iceâwater, 1 h; (b) BnBr, NaHCO<sub>3</sub>, MeCN, 90 Â°C, 48 h; (c) Tf<sub>2</sub>O, TEA, DCM, 0â20 Â°C, 4 h; (d) Pin<sub>2</sub>B<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, 1,4-dioxane, N<sub>2</sub>, 80 Â°C, 12 h; (e) NaBH<sub>4</sub>, MeOH, THF, 5 Â°C to rt, 2 h; (f) H<sub>2</sub>, Pd/C, EtOAc, 50 psi, 25 Â°C, 12 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-Amino-2-alkylethanol Intermediates <b>66</b> and <b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Mg, I<sub>2</sub>, THF, N<sub>2</sub>, reflux, 3 h; (b) Ti(OEt)<sub>4</sub>, DCM, 50 Â°C, 16 h; (c) Grignard reagent <b>60</b>, THF, rt, 1 h; (d) KHCO<sub>3</sub>, KF, H<sub>2</sub>O<sub>2</sub>, 45 Â°C, 2 h; (e) 4 N HCl, MeOH, rt, 2 h; (f) methods for <b>66</b> were used for <b>68</b>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2-Amino-2-alkylethanol Intermediate <b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Tf<sub>2</sub>O, 2,6-lutidine, DCM, â25 Â°C for 2 h and rt for 1 h; (b) LDA, THF, â78 Â°C to rt, 4 h; (c) 50% HCl, MeOH, reflux, 16 h; (d) LAH, THF, 70 Â°C for 16 h, workup, then HCl, 1,4-dioxane, rt, 30 min.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 2-Amino-2-alkylethanol Intermediates <b>80</b> and <b>86</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClCH<sub>2</sub>CH<sub>2</sub>Cl, 84 Â°C, 16 h; (b) LAH, THF, 0 to 70 Â°C, 2 h; (c) NaH, MeI, 0 Â°C to rt, 16 h; (d) 4 N HCl, reflux, 16 h; (e) SOCl<sub>2</sub>, MeOH, 60 Â°C, 16 h; (f) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, rt, 16 h; (g) MeI, DIPEA, DCM, rt, 16 h; (h) 4 N HCl, 1,4-dioxane, rt, 16 h; (i) LAH, THF, 70 Â°C, then HCl, 1,4-dioxane.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Substituted 2-Aminoethanol Intermediates <b>93</b>â<b>95</b> and <b>102</b>â<b>104</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SOCl<sub>2</sub>, MeOH, 0 Â°C to reflux, 2 h; (b) MeMgBr, THF, 0 Â°C to rt, 16 h.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of 3-Alkylazetidin-3-ol Intermediates <b>112</b>â<b>117</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) for intermediates <b>106</b>â<b>110</b>, RMgBr, THF, â78 Â°C for 2 h and rt; for <b>111</b>, Me<sub>3</sub>SiCF<sub>3</sub>, CsF, THF, rt, 1 h; (b) H<sub>2</sub>, Pd/C, MeOH, rt, 16 h.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compounds <b>3</b>â<b>51</b> Using Two General Methods<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) four methods used to synthesize amides: (i) the carboxylic acid, SOCl<sub>2</sub>, DCM, 50 Â°C, 16 h, then the corresponding amino alcohol, pyridine or TEA, 50 Â°C, 3 h; or (ii) HATU, DIPEA, DMF, rt, 1â2 h; or (iii) CMPI, DIPEA, NMP, rt, 16 h; or (iv) the corresponding acid, isobutyl chloroformate, TEA, DCM, 0 Â°C, 30 min, then the corresponding amino alcohol, 10 min; (b) <b>58</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 Â°C, 16 h; (c) Cs<sub>2</sub>CO<sub>3</sub>, DMF, rt, 16 h; (d) LiOHÂ·H<sub>2</sub>O, MeOH, and H<sub>2</sub>O, rt, 16 h, then 1 N HCl; (e) the corresponding amino alcohol, HATU, DIPEA, DMF, rt, 0.5â2 h.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>46</b> demonstrated rapid <i>in vivo</i> parasite clearance in the <i>P. falciparum</i>-infected mouse model, similar to artesunate and chloroquine of the two well-known fast parasite-killing antimalarial agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/medium/jm-2017-006219_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Parasite-killing curves of compound <b>46</b> at 10Ã, 30Ã, and 100Ã IC<sub>50</sub> doses indicating that the concentration required for <b>46</b> to achieve a maximal rate of parasite-killing was 10Ã to 30Ã IC<sub>50</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-13/acs.jmedchem.7b00621/20170707/images/large/jm-2017-006219_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00621&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i94">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>World Health Organizationâs World Malaria Report 2016; <a href="http://www.who.int" class="extLink">www.who.int</a> (accessed Jul 17,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organization%E2%80%99s+World+Malaria+Report+2016%3B+www.who.int+%28accessed+Jul+17%2C+2017%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Collaboration Research Group for Qinghaosu</span><span> </span><span class="NLM_article-title">A new sesquiterpene lactoneâqinghaosu</span> <span class="citation_source-journal">Kexue Tongbao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1977&pages=142&author=Collaboration+Research+Group+for+Qinghaosu&title=A+new+sesquiterpene+lactone%E2%80%94qinghaosu"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DA%2520new%2520sesquiterpene%2520lactone%25E2%2580%2594qinghaosu%26jtitle%3DKexue%2520Tongbao%26date%3D1977%26volume%3D3%26spage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Liu, J. M.</span><span> </span><span class="NLM_article-title">Structure and reaction of qinghaosu</span> <span class="citation_source-journal">Acta Chimi. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADyaL3cXpsVGqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1979&pages=129-143&author=J.+M.+Liu&title=Structure+and+reaction+of+qinghaosu"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and reaction of arteannuin</span></div><div class="casAuthors">Liu, Jing-Ming; Ni, Mu-Yun; Fan, Ju-Fen; Tu, You-You; Wu, Zhao-Hua; Wu, Yu-Lin; Chou, Wei-Shan</div><div class="citationInfo"><span class="NLM_cas:title">Huaxue Xuebao</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-43</span>CODEN:
                <span class="NLM_cas:coden">HHHPA4</span>;
        ISSN:<span class="NLM_cas:issn">0567-7351</span>.
    </div><div class="casAbstract">Arteannuin (I), along with the known arteannuin B (II), were isolated from Artemisia annua and the mol. structure of I detd. on the basis of its IR, NMR, and mass spectra and by chem. correlations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpmAcfTOb8-bVg90H21EOLACvtfcHk0lj6k4fiaVETnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXpsVGqtg%253D%253D&md5=9b557a87886e2423c4a58860e46892c0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520and%2520reaction%2520of%2520qinghaosu%26jtitle%3DActa%2520Chimi.%2520Sin.%26date%3D1979%26volume%3D37%26spage%3D129%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Collaboration research group for Qinghaosu</span><span> </span><span class="NLM_article-title">Studies on new anti-malarial drug qinghaosu</span> <span class="citation_source-journal">Yaoxue Tongbao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1979&pages=49-53&author=Collaboration+research+group+for+Qinghaosu&title=Studies+on+new+anti-malarial+drug+qinghaosu"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DStudies%2520on%2520new%2520anti-malarial%2520drug%2520qinghaosu%26jtitle%3DYaoxue%2520Tongbao%26date%3D1979%26volume%3D14%26spage%3D49%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Collaboration research group for Qinghaosu</span><span> </span><span class="NLM_article-title">Antimalarial studies on qinghaosu</span> <span class="citation_source-journal">Chin. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">â</span> <span class="NLM_lpage">816</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=117984" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1979&pages=811-816&author=Collaboration+research+group+for+Qinghaosu&title=Antimalarial+studies+on+qinghaosu"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAntimalarial%2520studies%2520on%2520qinghaosu%26jtitle%3DChin.%2520Med.%2520J.%26date%3D1979%26volume%3D92%26spage%3D811%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Tu, Y. Y.</span>, Ed.  <span class="citation_source-book">Qinghao Ji Qinghaosulei Yaowu (Artemisia annua L., Artemisinin and Its Derivatives)</span>; <span class="NLM_publisher-name">Chemical Industry Press</span>, <span class="NLM_publisher-loc">Beijing, China</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Y.+Tu&title=Qinghao+Ji+Qinghaosulei+Yaowu+%28Artemisia+annua+L.%2C+Artemisinin+and+Its+Derivatives%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DY.%2BY.%26btitle%3DQinghao%2520Ji%2520Qinghaosulei%2520Yaowu%2520%2528Artemisia%2520annua%2520L.%252C%2520Artemisinin%2520and%2520Its%2520Derivatives%2529%26pub%3DChemical%2520Industry%2520Press%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tu, Y. Y.</span><span> </span><span class="NLM_article-title">the discovery of artemisinin (qinghaosu) and gifts from Chinese medicine</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">â</span> <span class="NLM_lpage">1220</span><span class="refDoi">Â DOI: 10.1038/nm.2471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnm.2471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=21989013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12iu7vK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=1217-1220&author=Y.+Y.+Tu&title=the+discovery+of+artemisinin+%28qinghaosu%29+and+gifts+from+Chinese+medicine&doi=10.1038%2Fnm.2471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine</span></div><div class="casAuthors">Tu, Youyou</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1217-1220</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria, caused by Plasmodium falciparum, has been a life-threatening disease for thousands of years.  After the failure of international attempts to eradicate malaria in the 1950s, the disease rebounded, largely due to the emergence of parasites resistant to the existing antimalarial drugs of the time, such as chloroquine.  This created an urgent need for new antimalarial medicines.  In 1967, a national project against malaria was set up in China under the leadership of the Project 523 office.  My institute quickly became involved in the project and appointed me to be the head of a malaria research group comprising both phytochem. and pharmacol. researchers.  Our group of young investigators started working on the extn. and isolation of constituents with possible antimalarial activities from Chinese herbal materials.  During the first stage of our work, we investigated more than 2,000 Chinese herb prepns. and identified 640 hits that had possible antimalarial activities.  More than 380 exts. obtained from â¼200 Chinese herbs were evaluated against a mouse model of malaria.  However, progress was not smooth, and no significant results emerged easily.  The turning point came when an Artemisia annua L. ext. showed a promising degree of inhibition against parasite growth.  However, this observation was not reproducible in subsequent expts. and appeared to be contradictory to what was recorded in the literature.  Seeking an explanation, we carried out an intensive review of the literature.  The only ref. relevant to use of qinghao (the Chinese name of Artemisia annua L.) for alleviating malaria symptoms appeared in Ge Hong's A Handbook of Prescriptions for Emergencies: "A handful of qinghao immersed with 2 L of water, wring out the juice and drink it all" (Fig. 1).  This sentence gave me the idea that the heating involved in the conventional extn. step we had used might have destroyed the active components, and that extn. at a lower temp. might be necessary to preserve antimalarial activity.  Indeed, we obtained much better activity after switching to a lower-temp. procedure.  We subsequently sepd. the ext. into its acidic and neutral portions and, at long last, on 4 Oct. 1971, we obtained a nontoxic, neutral ext. that was 100% effective against parasitemia in mice infected with Plasmodium berghei and in monkeys infected with Plasmodium cynomolgi.  This finding represented the breakthrough in the discovery of artemisinin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPPcf3cZ2WFLVg90H21EOLACvtfcHk0lj6k4fiaVETnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12iu7vK&md5=d751f12196cf4f3d316bdaada5d38e02</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnm.2471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2471%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DY.%2BY.%26atitle%3Dthe%2520discovery%2520of%2520artemisinin%2520%2528qinghaosu%2529%2520and%2520gifts%2520from%2520Chinese%2520medicine%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D1217%26epage%3D1220%26doi%3D10.1038%2Fnm.2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Dondorp, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phyo, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarning, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lwin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanpithakpong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silamut, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imwong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chotivanich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhasivanon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, N. P.J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindegardh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socheat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. J.</span><span> </span><span class="NLM_article-title">Artemisinin resistance in <i>Plasmodium falciparum</i> malaria</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">â</span> <span class="NLM_lpage">467</span><span class="refDoi">Â DOI: 10.1056/NEJMoa0808859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1056%2FNEJMoa0808859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=19641202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=455-467&author=A.+M.+Dondorpauthor=F.+Nostenauthor=P.+Yiauthor=D.+Dasauthor=A.+P.+Phyoauthor=J.+Tarningauthor=K.+M.+Lwinauthor=F.+Arieyauthor=W.+Hanpithakpongauthor=S.+J.+Leeauthor=P.+Ringwaldauthor=K.+Silamutauthor=M.+Imwongauthor=K.+Chotivanichauthor=P.+Limauthor=T.+Herdmanauthor=S.+S.+Anauthor=S.+Yeungauthor=P.+Singhasivanonauthor=N.+P.J.+Dayauthor=N.+Lindegardhauthor=D.+Socheatauthor=N.+J.+White&title=Artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa0808859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Dondorp, Arjen M.; Nosten, Francois; Yi, Poravuth; Das, Debashish; Phyo, Aung Phae; Tarning, Joel; Lwin, Khin Maung; Ariey, Frederic; Hanpithakpong, Warunee; Lee, Sue J.; Ringwald, Pascal; Silamut, Kamolrat; Imwong, Mallika; Chotivanich, Kesinee; Lim, Pharath; Herdman, Trent; Sam An, Sen; Yeung, Shunmay; Singhasivanon, Pratap; Day, Nicholas P. J.; Lindegardh, Niklas; Socheat, Duong; White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-467</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease.  There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance.  METHODS: In two open-label, randomized trials, we compared the efficacies of two treatments for uncomplicated falciparum malaria in Pailin, western Cambodia, and Wang Pha, northwestern Thailand: oral artesunate given at a dose of 2 mg per kg of body wt. per day, for 7 days, and artesunate given at a dose of 4 mg per kg per day, for 3 days, followed by mefloqine at two doses totaling 25 mg per kg.  We assessed in vitro and in vivo Plasmodium-falciparum susceptibility, artesunate pharmacokinetics, and mol. markers of resistance.  RESULTS: We studied 40 patients in each of the two locations.  The overall median parasite clearance times were 84 h (interquartile range, 60 to 96) in Pailin and 48 h (interquartile range, 36 to 66) in Wang Pha (P < 0.001).  Recrudescence confirmed by means of polymerase-chain-reaction assay occurred in 6 of 20 patients (30%) receiving artesunate monotherapy and 1 of 20 (5%) receiving artesunate-mefloqine therapy in Pailin, as compared with 2 of 20 (10%) and 1 of 20 (5%), resp., in Wang Pha (P = 0.31).  These markedly different parasitol. responses were not explained by differences in age, artesunate or dihydroartemisinin pharmacokinetics, results of isotopic in vitro sensitivity tests, or putative mol. correlates of P.falciparum drug resistance (mutations or amplifications of the gene encoding a multidrug resistance protein [PfMDR1] or mutations in the gene encoding sarco-endoplasmic reticulum calcium ATPase6 [PfSERCA]).  Adverse events were mild and did not differ significantly between the two treatment groups.  CONCLUSIONS: P.falciparum has reduced in vivo susceptibility to artesunate in western Cambodia as compared with northwestern Thailand.  Resistance is characterized by slow parasite clearance in vivo without corresponding redns. on conventional in vitro susceptibility testing.  Containment measures are urgently needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfVvi4ozTDSLVg90H21EOLACvtfcHk0lh6y-cnC3UphQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1CrsLk%253D&md5=ae3098a15e9fb82c80fa0ddd05378220</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808859%26sid%3Dliteratum%253Aachs%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DLwin%26aufirst%3DK.%2BM.%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DHanpithakpong%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DHerdman%26aufirst%3DT.%26aulast%3DAn%26aufirst%3DS.%2BS.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DSinghasivanon%26aufirst%3DP.%26aulast%3DDay%26aufirst%3DN.%2BP.J.%26aulast%3DLindegardh%26aufirst%3DN.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DArtemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D455%26epage%3D467%26doi%3D10.1056%2FNEJMoa0808859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span> </span><span class="NLM_article-title">The interplay between drug resistance and fitness in malaria parasites</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">â</span> <span class="NLM_lpage">1038</span><span class="refDoi">Â DOI: 10.1111/mmi.12349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1111%2Fmmi.12349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=23899091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWrurzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=1025-1038&author=P.+J.+Rosenthal&title=The+interplay+between+drug+resistance+and+fitness+in+malaria+parasites&doi=10.1111%2Fmmi.12349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The interplay between drug resistance and fitness in malaria parasites</span></div><div class="casAuthors">Rosenthal, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1025-1038</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Summary : Controlling the spread of antimalarial drug resistance, esp. resistance of Plasmodium falciparum to artemisinin-based combination therapies, is a high priority.  Available data indicate that, as with other microorganisms, the spread of drug-resistant malaria parasites is limited by fitness costs that frequently accompany resistance.  Resistance-mediating polymorphisms in malaria parasites have been identified in putative drug transporters and in target enzymes.  The impacts of these polymorphisms on parasite fitness have been characterized in vitro and in animal models.  Addnl. insights have come from analyses of samples from clin. studies, both evaluating parasites under different selective pressures and detg. the clin. consequences of infection with different parasites.  With some exceptions, resistance-mediating polymorphisms lead to malaria parasites that, compared with wild type, grow less well in culture and in animals, and are replaced by wild type when drug pressure diminishes in the clin. setting.  In some cases, the fitness costs of resistance may be offset by compensatory mutations that increase virulence or changes that enhance malaria transmission.  However, not enough is known about effects of resistance mediators on parasite fitness.  A better appreciation of the costs of fitness-mediating mutations will facilitate the development of optimal guidelines for the treatment and prevention of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDYsc1v8XWbrVg90H21EOLACvtfcHk0lh6y-cnC3UphQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWrurzP&md5=425130d0f9f72ae19408290c825a28f1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fmmi.12349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fmmi.12349%26sid%3Dliteratum%253Aachs%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520interplay%2520between%2520drug%2520resistance%2520and%2520fitness%2520in%2520malaria%2520parasites%26jtitle%3DMol.%2520Microbiol.%26date%3D2013%26volume%3D89%26spage%3D1025%26epage%3D1038%26doi%3D10.1111%2Fmmi.12349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ariey, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouchier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuor, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bout, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ©nard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandeur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miotto, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ringwald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bras, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ©nard, D.</span><span> </span><span class="NLM_article-title">A molecular marker of artemisinin-resistant <i>Plasmodium falciparum</i> malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span><span class="refDoi">Â DOI: 10.1038/nature12876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnature12876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=24352242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=50-55&author=F.+Arieyauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=J.+Beghainauthor=A.-C.+Langloisauthor=N.+Khimauthor=S.+Kimauthor=V.+Duruauthor=C.+Bouchierauthor=L.+Maauthor=P.+Limauthor=R.+Leangauthor=S.+Duongauthor=S.+Srengauthor=S.+Suonauthor=C.+M.+Chuorauthor=D.+M.+Boutauthor=S.+M%C3%A9nardauthor=W.+O.+Rogersauthor=B.+Gentonauthor=T.+Fandeurauthor=O.+Miottoauthor=P.+Ringwaldauthor=J.+L.+Brasauthor=A.+Berryauthor=J.-C.+Baraleauthor=R.+M.+Fairhurstauthor=F.+Benoit-Vicalauthor=O.+Mercereau-Puijalonauthor=D.+M%C3%A9nard&title=A+molecular+marker+of+artemisinin-resistant+Plasmodium+falciparum+malaria&doi=10.1038%2Fnature12876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular marker of artemisinin-resistant Plasmodium falciparum malaria</span></div><div class="casAuthors">Ariey Frederic; Beghain Johann; Barale Jean-Christophe; Witkowski Benoit; Khim Nimol; Kim Saorin; Duru Valentine; Amaratunga Chanaki; Langlois Anne-Claire; Bouchier Christiane; Ma Laurence; Lim Pharath; Leang Rithea; Duong Socheat; Sreng Sokunthea; Suon Seila; Chuor Char Meng; Bout Denis Mey; Menard Sandie; Berry Antoine; Rogers William O; Genton Blaise; Fandeur Thierry; Miotto Olivo; Ringwald Pascal; Le Bras Jacques; Fairhurst Rick M; Benoit-Vical Francoise; Mercereau-Puijalon Odile; Menard Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7481</span>),
    <span class="NLM_cas:pages">50-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide.  To monitor the spread of artemisinin resistance, a molecular marker is urgently needed.  Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo.  Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia.  Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance.  K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTg24yBOxa0oSjiVMCqkKxVfW6udTcc2ea0W5oZtWhVNLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns1aqtg%253D%253D&md5=e25f4dcc9ccc361de4c35e650391b7ca</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature12876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12876%26sid%3Dliteratum%253Aachs%26aulast%3DAriey%26aufirst%3DF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DBeghain%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DA.-C.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DBouchier%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DLeang%26aufirst%3DR.%26aulast%3DDuong%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DBout%26aufirst%3DD.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DS.%26aulast%3DRogers%26aufirst%3DW.%2BO.%26aulast%3DGenton%26aufirst%3DB.%26aulast%3DFandeur%26aufirst%3DT.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DRingwald%26aufirst%3DP.%26aulast%3DBras%26aufirst%3DJ.%2BL.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DBarale%26aufirst%3DJ.-C.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DA%2520molecular%2520marker%2520of%2520artemisinin-resistant%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D50%26epage%3D55%26doi%3D10.1038%2Fnature12876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbe-Barnes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creek, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papastogiannidis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriraghavan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stingelin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vennerstrom, J. L.</span><span> </span><span class="NLM_article-title">Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">4400</span><span class="NLM_x">â</span> <span class="NLM_lpage">4405</span><span class="refDoi">Â DOI: 10.1073/pnas.1015762108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1073%2Fpnas.1015762108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=21300861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=4400-4405&author=S.+A.+Charmanauthor=S.+Arbe-Barnesauthor=I.+C.+Bathurstauthor=R.+Brunauthor=M.+Campbellauthor=W.+N.+Charmanauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=J.+C.+Craftauthor=D.+J.+Creekauthor=Y.+Dongauthor=H.+Matileauthor=M.+Maurerauthor=J.+Morizziauthor=T.+Nguyenauthor=P.+Papastogiannidisauthor=C.+Scheurerauthor=D.+M.+Shacklefordauthor=K.+Sriraghavanauthor=L.+Stingelinauthor=Y.+Tangauthor=H.+Urwylerauthor=X.+Wangauthor=K.+L.+Whiteauthor=S.+Wittlinauthor=L.+Zhouauthor=J.+L.+Vennerstrom&title=Synthetic+ozonide+drug+candidate+OZ439+offers+new+hope+for+a+single-dose+cure+of+uncomplicated+malaria&doi=10.1073%2Fpnas.1015762108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</span></div><div class="casAuthors">Charman, Susan A.; Arbe-Barnes, Sarah; Bathurst, Ian C.; Brun, Reto; Campbell, Michael; Charman, William N.; Chiu, Francis C. K.; Chollet, Jacques; Craft, J. Carl; Creek, Darren J.; Dong, Yuxiang; Matile, Hugues; Maurer, Melanie; Morizzi, Julia; Nguyen, Tien; Papastogiannidis, Petros; Scheurer, Christian; Shackleford, David M.; Sriraghavan, Kamaraj; Stingelin, Lukas; Tang, Yuanqing; Urwyler, Heinrich; Wang, Xiaofang; White, Karen L.; Wittlin, Sergio; Zhou, Lin; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4400-4405, S4400/1-S4400/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Ozonide OZ439 is a synthetic peroxide antimalarial drug candidate designed to provide a single-dose oral cure in humans.  OZ439 has successfully completed Phase I clin. trials, where it was shown to be safe at doses up to 1,600 mg and is currently undergoing Phase Ila trials in malaria patients.  Herein, we describe the discovery of OZ439 and the exceptional antimalarial and pharmacokinetic properties that led to its selection as a clin. drug development candidate.  In vitro, OZ439 is fast-acting against all asexual erythrocytic Plasmodium falciparum stages with ICs0 values comparable to those for the clin. used artemisinin derivs.  Unlike all other synthetic peroxides and semisynthetic artemisinin derivs., OZ439 completely cures Plasmodium berghei-infected mice with a single oral dose of 20 mg/kg and exhibits prophylactic activity superior to that of the benchmark chemoprophylactic agent, mefloquine.  Compared with other peroxide-contg. antimalarial agents, such as the artemisinin derivs. and the first-generation ozonide OZ277, OZ439 exhibits a substantial increase in the pharmacokinetic half-life and blood concn. vs. time profile in three preclin. species.  The outstanding efficacy and prolonged blood concns. of OZ439 are the result of a design strategy that stabilizes the intrinsically unstable pharmacophoric peroxide bond, thereby reducing clearance yet maintaining the necessary Fe(II)-reactivity to elicit parasite death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQxoUteI8z2bVg90H21EOLACvtfcHk0liU73yxV5XDGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2jtL4%253D&md5=5da13be1d57a8dd58b21246814f6c268</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1015762108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1015762108%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DArbe-Barnes%26aufirst%3DS.%26aulast%3DBathurst%26aufirst%3DI.%2BC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DCraft%26aufirst%3DJ.%2BC.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DMaurer%26aufirst%3DM.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPapastogiannidis%26aufirst%3DP.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSriraghavan%26aufirst%3DK.%26aulast%3DStingelin%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DSynthetic%2520ozonide%2520drug%2520candidate%2520OZ439%2520offers%2520new%2520hope%2520for%2520a%2520single-dose%2520cure%2520of%2520uncomplicated%2520malaria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D4400%26epage%3D4405%26doi%3D10.1073%2Fpnas.1015762108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kappe, S. H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boddey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowman, A. F.</span><span> </span><span class="NLM_article-title">That was then but this is now: malaria research in the time of an eradication agenda</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">â</span> <span class="NLM_lpage">866</span><span class="refDoi">Â DOI: 10.1126/science.1184785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.1184785" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=862-866&author=S.+H.+I.+Kappeauthor=A.+M.+Vaughanauthor=J.+A.+Boddeyauthor=A.+F.+Cowman&title=That+was+then+but+this+is+now%3A+malaria+research+in+the+time+of+an+eradication+agenda&doi=10.1126%2Fscience.1184785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1184785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1184785%26sid%3Dliteratum%253Aachs%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26aulast%3DVaughan%26aufirst%3DA.%2BM.%26aulast%3DBoddey%26aufirst%3DJ.%2BA.%26aulast%3DCowman%26aufirst%3DA.%2BF.%26atitle%3DThat%2520was%2520then%2520but%2520this%2520is%2520now%253A%2520malaria%2520research%2520in%2520the%2520time%2520of%2520an%2520eradication%2520agenda%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D862%26epage%3D866%26doi%3D10.1126%2Fscience.1184785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mackinnon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span> </span><span class="NLM_article-title">The selection landscape of malaria parasites</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">866</span><span class="NLM_x">â</span> <span class="NLM_lpage">871</span><span class="refDoi">Â DOI: 10.1126/science.1185410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.1185410" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=866-871&author=M.+J.+Mackinnonauthor=K.+Marsh&title=The+selection+landscape+of+malaria+parasites&doi=10.1126%2Fscience.1185410"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1185410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1185410%26sid%3Dliteratum%253Aachs%26aulast%3DMackinnon%26aufirst%3DM.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%26atitle%3DThe%2520selection%2520landscape%2520of%2520malaria%2520parasites%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D866%26epage%3D871%26doi%3D10.1126%2Fscience.1185410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Enserink, M.</span><span> </span><span class="NLM_article-title">Redrawing Africaâs malaria map</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">842</span><span class="refDoi">Â DOI: 10.1126/science.328.5980.842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.328.5980.842" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2010&pages=842&author=M.+Enserink&title=Redrawing+Africa%E2%80%99s+malaria+map&doi=10.1126%2Fscience.328.5980.842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.328.5980.842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.328.5980.842%26sid%3Dliteratum%253Aachs%26aulast%3DEnserink%26aufirst%3DM.%26atitle%3DRedrawing%2520Africa%25E2%2580%2599s%2520malaria%2520map%26jtitle%3DScience%26date%3D2010%26volume%3D328%26spage%3D842%26doi%3D10.1126%2Fscience.328.5980.842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rottmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharia, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Paez, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarayana, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwanarusk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jegla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T. T.</span><span> </span><span class="NLM_article-title">Spiroindolones, a potent compound class for the treatment of malaria</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">â</span> <span class="NLM_lpage">1180</span><span class="refDoi">Â DOI: 10.1126/science.1193225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1126%2Fscience.1193225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=20813948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=1175-1180&author=M.+Rottmannauthor=C.+McNamaraauthor=B.+K.+Yeungauthor=M.+C.+Leeauthor=B.+Zouauthor=B.+Russellauthor=P.+Seitzauthor=D.+M.+Plouffeauthor=N.+V.+Dhariaauthor=J.+Tanauthor=S.+B.+Cohenauthor=K.+R.+Spencerauthor=G.+E.+Gonzalez-Paezauthor=S.+B.+Lakshminarayanaauthor=A.+Gohauthor=R.+Suwanaruskauthor=T.+Jeglaauthor=E.+K.+Schmittauthor=H.+P.+Beckauthor=R.+Brunauthor=F.+Nostenauthor=L.+Reniaauthor=V.+Dartoisauthor=T.+H.+Kellerauthor=D.+A.+Fidockauthor=E.+A.+Winzelerauthor=T.+T.+Diagana&title=Spiroindolones%2C+a+potent+compound+class+for+the+treatment+of+malaria&doi=10.1126%2Fscience.1193225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Spiroindolones, a Potent Compound Class for the Treatment of Malaria</span></div><div class="casAuthors">Rottmann, Matthias; McNamara, Case; Yeung, Bryan K. S.; Lee, Marcus C. S.; Zou, Bin; Russell, Bruce; Seitz, Patrick; Plouffe, David M.; Dharia, Neekesh V.; Tan, Jocelyn; Cohen, Steven B.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Lakshminarayana, Suresh B.; Goh, Anne; Suwanarusk, Rossarin; Jegla, Timothy; Schmitt, Esther K.; Beck, Hans-Peter; Brun, Reto; Nosten, Francois; Renia, Laurent; Dartois, Veronique; Keller, Thomas H.; Fidock, David A.; Winzeler, Elizabeth A.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">5996</span>),
    <span class="NLM_cas:pages">1175-1180</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Recent reports of increased tolerance to artemisinin derivs.-the most recently adopted class of antimalarials-have prompted a need for new treatments.  The spirotetrahydro-Î²-carbolines, or spiroindolones, are potent drugs that kill the blood stages of Plasmodium falciparum and Plasmodium vivax clin. isolates at low nanomolar concn.  Spiroindolones rapidly inhibit protein synthesis in P. falciparum, an effect that is ablated in parasites bearing nonsynonymous mutations in the gene encoding the P-type cation-transporter ATPase4 (PfATP4).  The optimized spiroindolone NITD609 shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6O1WaX-1b7Vg90H21EOLACvtfcHk0lgHUwSee8sBCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2hsr%252FJ&md5=239bc9babd5cb5f07e2be38741038e2c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1193225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1193225%26sid%3Dliteratum%253Aachs%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DYeung%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BC.%26aulast%3DZou%26aufirst%3DB.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSeitz%26aufirst%3DP.%26aulast%3DPlouffe%26aufirst%3DD.%2BM.%26aulast%3DDharia%26aufirst%3DN.%2BV.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DSpencer%26aufirst%3DK.%2BR.%26aulast%3DGonzalez-Paez%26aufirst%3DG.%2BE.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DJegla%26aufirst%3DT.%26aulast%3DSchmitt%26aufirst%3DE.%2BK.%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DSpiroindolones%252C%2520a%2520potent%2520compound%2520class%2520for%2520the%2520treatment%2520of%2520malaria%26jtitle%3DScience%26date%3D2010%26volume%3D329%26spage%3D1175%26epage%3D1180%26doi%3D10.1126%2Fscience.1193225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span>Medicines for Malaria Venture 2015 Annual Report. <a href="http://www.mmv.org" class="extLink">www.mmv.org</a> (accessed Jul 17, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Medicines+for+Malaria+Venture+2015+Annual+Report.+www.mmv.org+%28accessed+Jul+17%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis of antimalarial agents</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">â</span> <span class="NLM_lpage">374</span><span class="refDoi">Â DOI: 10.1080/00304948.2012.697708</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1080%2F00304948.2012.697708" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFejsbnI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=340-374&author=Y.-K.+Zhangauthor=M.+Geauthor=J.+J.+Plattner&title=Recent+progress+in+the+synthesis+of+antimalarial+agents&doi=10.1080%2F00304948.2012.697708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Synthesis of Antimalarial Agents</span></div><div class="casAuthors">Zhang, Yong-Kang; Ge, Min; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">340-374</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent progress in the synthesis of Antimalarial agents is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0FJDs0_g-BbVg90H21EOLACvtfcHk0lhzQERU87na3g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFejsbnI&md5=e102da32695f98afe7cf7cde0886b755</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F00304948.2012.697708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304948.2012.697708%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520of%2520antimalarial%2520agents%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2012%26volume%3D44%26spage%3D340%26epage%3D374%26doi%3D10.1080%2F00304948.2012.697708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wells, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span> </span><span class="NLM_article-title">Malaria medicines: a glass half full?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">â</span> <span class="NLM_lpage">442</span><span class="refDoi">Â DOI: 10.1038/nrd4573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnrd4573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=26000721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=424-442&author=T.+N.+Wellsauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhis&title=Malaria+medicines%3A+a+glass+half+full%3F&doi=10.1038%2Fnrd4573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria medicines: a glass half full?</span></div><div class="casAuthors">Wells, Timothy N. C.; Hooft van Huijsduijnen, Rob; Van Voorhis, Wesley C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">424-442</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite substantial scientific progress over the past two decades, malaria remains a worldwide burden that causes hundreds of thousands of deaths every year.  New, affordable and safe drugs are required to overcome increasing resistance against artemisinin-based treatments, treat vulnerable populations, interrupt the parasite life cycle by blocking transmission to the vectors, prevent infection and target malaria species that transiently remain dormant in the liver.  In this Review, we discuss how the antimalarial drug discovery pipeline has changed over the past 10 years, grouped by the various target compd. or product profiles, to assess progress and gaps, and to recommend priorities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAJNZa5gyvg7Vg90H21EOLACvtfcHk0lhzQERU87na3g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemsbvM&md5=43f35590f86c240a4150b5cb4f5670ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd4573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4573%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DT.%2BN.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26atitle%3DMalaria%2520medicines%253A%2520a%2520glass%2520half%2520full%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D424%26epage%3D442%26doi%3D10.1038%2Fnrd4573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mytelka, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunwiddie, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persinger, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munos, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindborg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schacht, A. L.</span><span> </span><span class="NLM_article-title">How to improve R&D productivity: the pharmaceutical industryâs grand challenge</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">â</span> <span class="NLM_lpage">214</span><span class="refDoi">Â DOI: 10.1038/nrd3078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1038%2Fnrd3078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=20168317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=203-214&author=S.+M.+Paulauthor=D.+S.+Mytelkaauthor=C.+T.+Dunwiddieauthor=C.+C.+Persingerauthor=B.+H.+Munosauthor=S.+R.+Lindborgauthor=A.+L.+Schacht&title=How+to+improve+R%26D+productivity%3A+the+pharmaceutical+industry%E2%80%99s+grand+challenge&doi=10.1038%2Fnrd3078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">How to improve R&D productivity: the pharmaceutical industry's grand challenge</span></div><div class="casAuthors">Paul, Steven M.; Mytelka, Daniel S.; Dunwiddie, Christopher T.; Persinger, Charles C.; Munos, Bernard H.; Lindborg, Stacy R.; Schacht, Aaron L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-214</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements.  In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the no. and quality of innovative, cost-effective new medicines, without incurring unsustainable R&D costs.  However, it is widely acknowledged that trends in industry R&D productivity have been moving in the opposite direction for a no. of years.  Here, we present a detailed anal. based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall R&D productivity.  We then propose specific strategies that could have the most substantial impact in improving R&D productivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY67PCIhaBVLVg90H21EOLACvtfcHk0lhzQERU87na3g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsbg%253D&md5=2f32bcc48c869290eef18ff9400afcc5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd3078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3078%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DMytelka%26aufirst%3DD.%2BS.%26aulast%3DDunwiddie%26aufirst%3DC.%2BT.%26aulast%3DPersinger%26aufirst%3DC.%2BC.%26aulast%3DMunos%26aufirst%3DB.%2BH.%26aulast%3DLindborg%26aufirst%3DS.%2BR.%26aulast%3DSchacht%26aufirst%3DA.%2BL.%26atitle%3DHow%2520to%2520improve%2520R%2526D%2520productivity%253A%2520the%2520pharmaceutical%2520industry%25E2%2580%2599s%2520grand%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D203%26epage%3D214%26doi%3D10.1038%2Fnrd3078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easom, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. Part 4. discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5344</span><span class="NLM_x">â</span> <span class="NLM_lpage">5354</span><span class="refDoi">Â DOI: 10.1021/acs.jmedchem.5b00678</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVans7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5344-5354&author=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=E.+E.+Easomauthor=R.+T.+Jacobsauthor=D.+Guoauthor=V.+Sandersauthor=Y.+Freundauthor=B.+Campoauthor=P.+J.+Rosenthalauthor=W.+Buauthor=F.-J.+Gamoauthor=L.+M.+Sanzauthor=M.+Geauthor=L.+Liauthor=J.+Dingauthor=Y.+Yang&title=Benzoxaborole+antimalarial+agents.+Part+4.+discovery+of+potent+6-%282-%28alkoxycarbonyl%29pyrazinyl-5-oxy%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1021%2Facs.jmedchem.5b00678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Easom, Eric E.; Jacobs, Robert T.; Guo, Denghui; Sanders, Virginia; Freund, Yvonne R.; Campo, Brice; Rosenthal, Philip J.; Bu, Wei; Gamo, Francisco-Javier; Sanz, Laura M.; Ge, Min; Li, Liang; Ding, Jie; Yang, Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5344-5354</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Hetaryloxy benzoxaborole compds. were designed and synthesized for a structure-activity relation (SAR) study to assess the changes in antimalarial activity which result from 6-aryloxy structural variation, substituent modification on the pyrazine ring, and optimization of the side chain ester group.  This SAR study discovered highly potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles (9, 27-34) with IC50s = 0.2-22 nM against cultured Plasmodium falciparum W2 and 3D7 strains.  Compd. 9 also demonstrated excellent in vivo efficacy against P. berghei in infected mice (ED90 = 7.0 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNOCdVBsF4LVg90H21EOLACvtfcHk0lhW84JrGEeqGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVans7jK&md5=32ac4a49fdf60084bfc351c74f6a6c67</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00678%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DSanders%26aufirst%3DV.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520Part%25204.%2520discovery%2520of%2520potent%25206-%25282-%2528alkoxycarbonyl%2529pyrazinyl-5-oxy%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5344%26epage%3D5354%26doi%3D10.1021%2Facs.jmedchem.5b00678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JimÃ©nez-DÃ­az, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">JimÃ©nez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regadera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GÃ³mez de las Heras, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span> </span><span class="NLM_article-title">A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2252</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0002252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1371%2Fjournal.pone.0002252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=18493601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2252&author=I.+Angulo-Barturenauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=T.+Muletauthor=J.+Rullasauthor=E.+Herrerosauthor=S.+Ferrerauthor=E.+Jim%C3%A9nezauthor=A.+Mendozaauthor=J.+Regaderaauthor=P.+J.+Rosenthalauthor=I.+Bathurstauthor=D.+L.+Pomplianoauthor=F.+G%C3%B3mez+de+las+Herasauthor=D.+Gargallo-Viola&title=A+murine+model+of+falciparum-malaria+by+in+vivo+selection+of+competent+strains+in+non-myelodepleted+mice+engrafted+with+human+erythrocytes&doi=10.1371%2Fjournal.pone.0002252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes</span></div><div class="casAuthors">Angulo-Barturen Inigo; Jimenez-Diaz Maria Belen; Mulet Teresa; Rullas Joaquin; Herreros Esperanza; Ferrer Santiago; Jimenez Elena; Mendoza Alfonso; Regadera Javier; Rosenthal Philip J; Bathurst Ian; Pompliano David L; Gomez de las Heras Federico; Gargallo-Viola Domingo</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e2252</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To counter the global threat caused by Plasmodium falciparum malaria, new drugs and vaccines are urgently needed.  However, there are no practical animal models because P. falciparum infects human erythrocytes almost exclusively.  Here we describe a reliable falciparum murine model of malaria by generating strains of P. falciparum in vivo that can infect immunodeficient mice engrafted with human erythrocytes.  We infected NOD(scid/beta2m-/-) mice engrafted with human erythrocytes with P. falciparum obtained from in vitro cultures.  After apparent clearance, we obtained isolates of P. falciparum able to grow in peripheral blood of engrafted NOD(scid/beta2m-/-) mice.  Of the isolates obtained, we expanded in vivo and established the isolate Pf3D7(0087/N9) as a reference strain for model development.  Pf3D7(0087/N9) caused productive persistent infections in 100% of engrafted mice infected intravenously.  The infection caused a relative anemia due to selective elimination of human erythrocytes by a mechanism dependent on parasite density in peripheral blood.  Using this model, we implemented and validated a reproducible assay of antimalarial activity useful for drug discovery.  Thus, our results demonstrate that P. falciparum contains clones able to grow reproducibly in mice engrafted with human erythrocytes without the use of myeloablative methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSGBUV1EinlYVHFYivNCdPRfW6udTcc2eZHgGgpQ3h2m7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czjtVahsg%253D%253D&md5=02f4475ecc0524005f4538e98a0649d8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002252%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRegadera%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DG%25C3%25B3mez%2Bde%2Blas%2BHeras%26aufirst%3DF.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26atitle%3DA%2520murine%2520model%2520of%2520falciparum-malaria%2520by%2520in%2520vivo%2520selection%2520of%2520competent%2520strains%2520in%2520non-myelodepleted%2520mice%2520engrafted%2520with%2520human%2520erythrocytes%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2252%26doi%3D10.1371%2Fjournal.pone.0002252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De-CÃ³zar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llergo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GarcÃ­a-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J. P.</span><span> </span><span class="NLM_article-title">falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30949</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-C%C3%B3zarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.-J.+P.+Gamo&title=falciparum+in+vitro+killing+rates+allow+to+discriminate+between+different+antimalarial+mode-of-action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0lhW84JrGEeqGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-C%25C3%25B3zar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.-J.%2BP.%26atitle%3Dfalciparum%2520in%2520vitro%2520killing%2520rates%2520allow%2520to%2520discriminate%2520between%2520different%2520antimalarial%2520mode-of-action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Maron, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B. N.</span><span> </span><span class="NLM_article-title">Revised Methods for the Salmonella Mutagenicity Test</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">â</span> <span class="NLM_lpage">215</span><span class="refDoi">Â DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+Methods+for+the+Salmonella+Mutagenicity+Test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0lgl3kyubnFqPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520Methods%2520for%2520the%2520Salmonella%2520Mutagenicity%2520Test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tice, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakey, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch-Volders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleson, F. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchierotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannier, B.</span><span> </span><span class="NLM_article-title"><i>In vivo</i> rodent erythrocyte micronucleus assay</span> <span class="citation_source-journal">Mutat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">â</span> <span class="NLM_lpage">304</span><span class="refDoi">Â DOI: 10.1016/0165-1161(94)90039-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=10.1016%2F0165-1161%2894%2990039-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=7514741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1yksr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=1994&pages=293-304&author=M.+Hayashiauthor=R.+R.+Ticeauthor=J.+T.+MacGregorauthor=D.+Andersonauthor=D.+H.+Blakeyauthor=M.+Kirsch-Voldersauthor=F.+B.+Olesonauthor=F.+Pacchierottiauthor=F.+Romagnaauthor=H.+Shimadaauthor=S.+Sutouauthor=B.+Vannier&title=In+vivo+rodent+erythrocyte+micronucleus+assay&doi=10.1016%2F0165-1161%2894%2990039-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo rodent erythrocyte micronucleus assay</span></div><div class="casAuthors">Hayashi, Makoto; Tice, Raymond R.; MacGregor, James T.; Anderson, Diana; Blakey, David H.; Kirsh-Volders, M.; Oleson, Frederick B. Jr.; Pacchierotti, Francesca; Romagna, Felix; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-304</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The anal. of immature erythrocytes in either bone marrow or peripheral blood is equally acceptable for those species in which the spleen does not remove micronucleated erythrocytes.  In the mouse, mature erythrocytes are also an acceptable cell population for micronucleus anal. when the exposure duration exceeds 4 wk.  Org. solvents such as DMSO are not recommended.  Freshly prepd. solns. or suspensions should be used unless stability data demonstrate the acceptability of storage.  Vegetable oils are acceptable as solvents or vehicles.  Suspension of the test chems. is acceptable for p.o. or i.p. administration but not for i.v. injection.  The use of any unusual solvent should be justified.  Any commonly used lab. rodent species is acceptable.  There is no strain preference.  The size of expt. (i.e., no. of cells per animal, no. of animals per group) should be finalized based on statistical considerations.  Although a consensus was not achieved, operationally it was agreed that 2000 cells per animal and four animals per group was a min. requirement.  In general, the available database suggests that the use of one gender is adequate for screening.  However, if there is evidence indicating a significant difference in the toxicity between male and female, then both sexes should be used.  No unique treatment schedule can be recommended.  Results from extended dose regimens are acceptable as long as pos.  For neg. studies, toxicity should be demonstrated or the limit dose should be used, and dosing continued until sampling.  At least three dose levels sepd. by a factor between 2 and 10 should be used.  The highest dose tested should be the max. tolerated dose based on mortality, bone marrow cell toxicity, or clin. symptoms of toxicity.  The limit dose is 2 g/kg/day for treatment periods of 14 days or less and 1 g/kg/day for treatment periods greater than 14 days.  A single dose level (the limit dose) is acceptable if there is no evidence of toxicity.  Concurrent solvent (vehicle) controls should be included at all sampling times.  A pretreatment sample, however, may also be acceptable only in the short treatment period peripheral blood studies.  A concurrent pos. control group should be included for each expt.  It is acceptable that the pos. control may be administered by a route different from the test agent and sampled at only a single time.  For the bone marrow assay, two sample times (24 and 48 h) should be used after a single administration, or one sample time between 18 and 24 h after the last of two or more repeated administrations.  For the peripheral blood assay, two sample times (48 and 72 h) are used after a single administration, or one sample time between 36 and 48 h is used after the last of two or more repeated administrations.  For a longer treatment study, one sample time any time up to 48 h after the last dose is acceptable.  All slides should be coded.  The frequency of micronucleated immature erythrocytes is the principal endpoint.  The frequencies of micronucleated mature erythrocytes in the mouse can also be the endpoint for the longer repeated treatment study (4 wk or more).  When analyzing slides, the percentage of immature erythrocytes among total erythrocytes should not be less than 20% of the control value (i.e., 10% for 50% in the control).  To assess cytotoxicity, at least 200 bone marrow erythrocytes per animal or at least 1000 peripheral blood erythrocytes per animal should be obsd.  Although a consensus was not achieved, it was generally agreed that both a trend test and also pairwise tests were appropriate.  Historical neg. control data should be used to det. if the concurrent control response is acceptable.  The test response will be deemed pos. if there is a statistically significant increase in micronucleated erythrocytes and the increase is significantly dose-dependent.  If neither of the above conditions is met, the test response will be classified as neg.  If either, but not both, of the above conditions is met, the assay results will be classified as equivocal and, only in this case, a repeat or confirmatory test will be required.  These topics were discussed by all participants involved in the in vivo micronucleus and chromosomal aberration groups.  Some general topics were also discussed at the in vivo working group.  Many of these topics had been discussed by mail between invited discussants (members listed above plus those who could not attend the workshop) and the Chairmen prior to the Melbourne workshop.  This proposed protocol is based on the following principles. (1) Recognition of the minimal requirements to produce a reliable, interpretable assay. (2)That uniform criteria should be applied to different in vivo assays. (3)That the primary purpose of these assays is hazard identification and not risk assessment. (4)That acceptable criteria should be based on exptl. data whenever possible, rather than theor. expectations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb8eiS6oiDh7Vg90H21EOLACvtfcHk0lgl3kyubnFqPQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1yksr4%253D&md5=0d477bbcd12e8ff78c6dfeb3b63d3cab</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2894%2990039-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252894%252990039-6%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DTice%26aufirst%3DR.%2BR.%26aulast%3DMacGregor%26aufirst%3DJ.%2BT.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DBlakey%26aufirst%3DD.%2BH.%26aulast%3DKirsch-Volders%26aufirst%3DM.%26aulast%3DOleson%26aufirst%3DF.%2BB.%26aulast%3DPacchierotti%26aufirst%3DF.%26aulast%3DRomagna%26aufirst%3DF.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSutou%26aufirst%3DS.%26aulast%3DVannier%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520rodent%2520erythrocyte%2520micronucleus%2520assay%26jtitle%3DMutat.%2520Res.%26date%3D1994%26volume%3D312%26spage%3D293%26epage%3D304%26doi%3D10.1016%2F0165-1161%2894%2990039-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>OECD Guidelines for Testing of Chemicals, Guideline 474 (Genetic Toxicology: Mammalian Erythrocyte Micronucleus Test); updated guidance adopted Sep 26,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=OECD+Guidelines+for+Testing+of+Chemicals%2C+Guideline+474+%28Genetic+Toxicology%3A+Mammalian+Erythrocyte+Micronucleus+Test%29%3B+updated+guidance+adopted+Sep+26%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DOECD%2520Guidelines%2520for%2520Testing%2520of%2520Chemicals%252C%2520Guideline%2520474%2520%2528Genetic%2520Toxicology%253A%2520Mammalian%2520Erythrocyte%2520Micronucleus%2520Test%2529%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00621">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32247"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00621">10.1021/acs.jmedchem.7b00621</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures illustrating mouse survival and efficacy ED<sub>90</sub> data from a <i>P. berghei</i> mouse malaria model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings with the associated biochemical and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_001.pdf">jm7b00621_si_001.pdf (2.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00621/suppl_file/jm7b00621_si_002.csv">jm7b00621_si_002.csv (3.89 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00621&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00621%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00621" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679945c33c713cbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
